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ABSTRACT 
 
The research work within the wide field of nanomedicine that is 
presented in this thesis is centred on the development of new 
nanostructured multifunctional materials for future theranostic 
applications. The rational that it has been followed is inspired to a 
supramolecolar approach, therefore, we have been starting with the 
study of various components able to play different functions that could 
be then implemented in more complex multifunctional platform.  
I describe the design, preparation and characterization of very different 
supramolecular, nanostructured and microstructured species suitable to 
be implemented, in a future, in theranostic agents, but already able to 
perform useful functions for bio-medical applications (imaging, sensing 
and drug delivery). 
The results will be presented following a sort of ‘increasing in dimension’ 
logic, in fact, in the first chapter will deal with luminescent molecular 
components for sensing, that will be followed by the description of 
phosphorescent nanostructures and then microstructures, to continue 
with electrospun composite materials for the delivery in time of active 
nanoagents. The very last chapter, instead, gathers some interesting 
results obtained developing basic research on luminescent metal 
complexes and gold nanoparticles. 
In Chapter 2, is presented a new luminescent chemosensor for Mg2+ 
detection in mitochondria based on a diaza-18-crown-6 appended with 
two 8-hydroxyquinoline(8-HQ) derivative. Starting from the knowhow of 
the group I have worked with it has been synthesized a new species, 
precisely designed to detect and quantify Mg ions selectively inside 
mitochondria, thanks to the insertion of two phosphonium moieties on 
the periphery of the chemosensor. The photophysical characterization 
will be presented, as well as the results on the efficiency and sensitivity of 
the new species. The preliminary in vitro test (on a human leukemia 
(HL60) and osteosarcoma tumor (U2Os) cell lines) have allowed to 
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evaluate the suitable non-toxic concentration to be use for further 
investigation on the mitochondria target ability of the chemosensor.  
In Chapter 3 is reported report a new synthetic strategy based on the 
micellar assisted method, to prepare silica core/PEG shell nanoparticles 
doped with phosphorescent emitters such as organic molecules called 
“asterisks” and metal-phorphyrins. It has been obtained very promising 
nanostructured phosphorescent chemosensors for molecular oxygen, 
suitable also for two-photon excitation. They present appropriate 
features for oxygen sensing in the physiological pO2 range, they are 
water soluble, stable and biocompatible. The final ambitious step was to 
optimize the most promising structures for in vivo applications. In a pilot 
test, in collaboration with Professor B. Weber from the University of Zurich, 
the injection into the tail vein of a sample of metallo-porphyrin doped 
NPs allowed the phosphorescence intensity decays measurement in 
mouse brain at increasing depths and the signal was detectable up to 
400 μm below the tissue surface. 
 
In Chapter 4 will be shown the study carried out at the New York 
University, centred on the synthesis of microstructures suitable to mimic 
invading microbial pathogens. Their study can allow a full physical-
mechanical understanding of how particle morphologies and motilities 
affect phagosomal antigen degradation. Based on previous 
achievements, a novel and reproducible method to obtain irregurlarly-
shaped colloids is described, that allows to obtain colloids with 
dimensions in the range of 10-12μm. The efficient biotinylating method 
that it has been also optimized results in synthetic-mimetic materials that 
are better recognized by primary dendritic cells as shown by a 
preliminary in vitro test. In parallel, there were also prepared other active 
colloids able to be propelled by the oxygen bubbles formed by a 
chemical reaction that is UV-light activated in the presence of hydrogen 
peroxide. These species called ‘swimmers’ aim to be of help in the 
elucidation of how particle motilities affect phagosomal antigen 
degradation by dendritic cells.  
 
Chapter 5 will deal with bioresorbable electrospun nanofiber mat that, if 
doped with theranostic agents can be used to thelease the active 
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species, during their degradation after post-surgical implantation. The 
fine tuning of the electrospinning parameters was pivotal in order to 
prepare fibers doped with luminescent targeted nanoparticles that 
present uniform dimensions and dispersion of the included agents. 
Photophysical characterization is reported together with a study of the 
PLGA fibers degradation that proves that the nanoparticle release 
correlates very well with the degradation profile in physiological 
conditions. This can allow to tune the release over time simply 
modulating the polymer composition.  
Chapter 6 merged some research works that have been developed on 
different species that could have, or could take to, interesting properties 
to be exploited in building block moieties for the design of 
multifunctional platforms. In particular, the attention has been focused 
on NIR emitters that are luminescent component of election for medical 
application in vivo due to the maximum depth of penetration in tissues 
of light falling in the range 650-1350 nm. It has been discussed the results 
obtained with rhenium(I) and lanthanide metal complex from a 
photophysical point of view both in solution and in the solid state. 
Moreover, in this section is also presented a basic study that aims to 
assess the possible pro-oxidant or antioxidant effects induced by gold 
nanoparticles, key features determining their safety and suitability for 
specific applications 
 
 
 
 
 
 
 
 
 
 
 
 
CAP. 1 
INTRODUCTION 
 
1.1 Nanotechnologies for Theranostic applications  
 
The term “theranostics” was coined to define ongoing efforts in 
clinics to develop more specific, individualized therapies for various 
diseases, and to combine diagnostic and therapeutic capabilities into a 
single agent. The rationale arose from the fact that diseases, such as 
cancers, are immensely heterogeneous, and all existing treatments are 
effective for only limited patient subpopulations and at selective stages 
of disease development. The hope was that a close marriage of 
diagnosis and therapeutics could provide therapeutic protocols that are 
more specific to individuals and, therefore, more likely to offer improved 
prognoses. For this reason, theranostics. Is also a highly inter-disciplinary 
field. Infact , with its combining action od diagnosis and therapy, 
Theranostics works at the intersection of several different scientific fields 
(Fig.1.0). 
The emergence of nanotechnology has offered an elegant pathway to 
prepare new and effective materials able to merge diagnosis and 
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therapy. Nanoparticle (NP)-based imaging and therapy have been 
investigated separately and their single understanding has now evolved 
to a point enabling the birth of NP-based theranostics. These materials 
can be seen as nanoplatforms that can co-deliver therapeutic and 
imaging functions. It adds to the previous paradigm the possibility for 
imaging to be performed not only before or after, but also during a 
treatment regimen. Interestingly, that many nanostructured imaging 
agents could be readily “upgraded” to theranostic ones by integrating 
therapeutic functions on them. One underlying driving force of such a 
combination is that imaging and therapy both require enough 
accumulation of agents in diseased areas. This common targeting 
requirement brings the two research domains closer and, ultimately, will 
blur the boundary between them, since many techniques to enhance 
imaging can, at least in theory, be readily transferred to the therapeutic 
domain, and vice versa.  
Moreover, nanostructured materials are generally very versatile and 
allow the application of different targeting strategies to address the 
desired application. Above all, the NPs systems with multimodal 
capabilities, in the specific a theranostic agent (Fig 1.0B), offer the 
opportunity to develop novel strategies for the effective treatment of 
human diseases that may result in paired or alternative therapeutic 
options. In recent years, a variety of biomaterial-based multifunctional 
Figure 1.0 Left: cartoon of union between therapy and diagnostic to create a 
theranostin agent. Right: combination of the multiple field covedered by 
theranostic application 
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nanoparticles have been evaluated for targeted cancer therapeutics 
and biomedical imaging. The principals characteristics which could 
occur to the functionalized agent after its modifications are the specific 
targetability, minimizing toxicity and expanding therapeutic efficiency, 
the promotion of the Intracellular internalization, due to the modification 
in the pharmacokinetic profile; the functionalization could also bring to 
the possibility to pursue bioimaging allowing real-time monitoring of the 
progress of the biological actions and nanoparticle distribution in vivo 
and, furthermore, work on the biocompatibility and stability of the entire 
systems, extending residence time in systemic circulation and 
maintaining therapeutic level of bioactive(s) in the blood.  
Imaging nanoparticles and, 
parallel, nanomaterials for 
therapeutic application have 
been deeply investigated in the 
last years, and the know-how in the 
field is now exploited in many 
laboratories worldwide to design 
theranostic nanoparticles, that is to 
say nanoplatforms which can 
allow a close monitoring of the 
region of interest not only before or 
after, but also during treatment34. 
Liposomes, gold, silver, iron (magnetic) and silica nanoparticles are only 
few examples of the many substrates investigated nowadays for 
theranostic purposes. Nanomaterials as diagnostic tools are already in 
clinical trials in many modern imaging techniques such as: magnetic 
resonance imaging (MRI), computed X-ray tomography (CT), positron 
emission tomography (PET), single-photon emission computed 
tomography (SPECT), ultrasound imaging (US) and optical imaging 
(OI)35-37.  
 
In the case of cancer, it is a common approach to identify a biomarker 
that is aberrantly expressed on the surface of cancer cells, and then to 
load its congenial binding vector onto probes/carriers to achieve 
recognition and tumor homing. To this goal, however, size is a stringent 
issue since an efficient tumor targeting also depends upon the carrier 
Fig. 1.0B Schematic representation of a 
multifunctional system for 
nanomedicine 
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capability to reach all the areas in the human body, that is to say to cross 
different tissues and membranes and to present a sufficient persistence 
to be traced and active.  Nanoplatforms, due to their size scale, already 
present an enhanced-permeability-and-retention (EPR)1,2 effect in tumor 
targeting even if, care must be taken with the particles’ surfaces to avoid 
innate immune system recognition and to secure sufficiently long 
circulation half-lives for the agents to reach their targets (see sec. 1.1.3 
for the details).  
 
At the basis of the development of efficient theranostic agents, there is 
a deep understanding of three different actions to be merged in one 
single object: sensing, imaging and delivery. 
1.1.1 Sensing 
A sensor is a device that detects and responds to some type of 
input from the physical environment transducing it in a detectable and 
quantitative way. The specific input could be light, heat, motion, 
moisture, pressure, or any one of a great number of other environmental 
phenomena. The output is generally a signal that is converted to human-
readable display at the sensor location or transmitted electronically over 
a network for reading or further processing. I list hereafter some very well-
known examples of different sensor devices. a) In a mercury-based glass 
thermometer, the input is temperature. The liquid contained expands 
and contracts in response, causing the level to be higher or lower on the 
marked gauge, which is human-readable. b) An oxygen sensor in a car's 
emission control system detects the gasoline/oxygen ratio, usually 
through a chemical reaction that generates a voltage. A computer in 
the engine reads the voltage and, if the mixture is not optimal, readjusts 
the balance. c) Motion sensors in various systems including home security 
lights, automatic doors and bathroom fixtures typically send out some 
type of energy, such as microwaves, ultrasonic waves or light beams and 
detect when the flow of energy is interrupted by something entering its 
path. The active chemical sensing species in a macroscopic device or 
the sensing molecular species that can be used as such and not 
integrated in a device are called chemosensors. The action of a 
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chemosensor, relies on an interaction occurring at the molecular level 
among the analyte of interest and the receptor that is connected with 
the signalling moiety, able to generate a detectable variation. Usually 
they are used for monitoring the activity of a chemical species in a given 
matrix such as solution, air, blood, tissue, waste effluents, drinking water, 
etc. The signalling moiety and the recognition one are connected either 
directly to each other or through a some kind of connector or a spacer7–
9 and when the signalling is based on the variation of either the 
absorption or the emission of light it is generally referred as an optical 
chemosensor. 
Among them, Luminescent 
ones present many 
advantages; luminescence is 
a very sensitive, low cost and 
rapid technique that is 
suitable for a wide range of 
clinical, biological and 
environmental applications 
offering a submicrometer 
spatial and submillisecond 
temporal resolution. The most 
common ones are based on an induced fluorescent intensity variation 
by the recognition event, but there are other possibilities such as emission 
wavelength or lifetime changes. In chapter 2 is reported the work on 
chemosensors able to detect magnesium cations, involved in most 
important cellular processes and consequently diseases10, via chelation 
enhanced fluorescence effect (CHEF effect).  
 
1.1.2 Imaging 
In general, imaging is the process of producing an exact picture 
of the visualized area by scanning it with a detector and, therefore, 
medical imaging creates visual representations of the body, organs, 
tissues and of their functions for clinical analysis and intervention. Among 
all the possible techniques, fluorescent imaging is very convenient being 
Figure 1.2 schematization of an OFF-ON 
luminescent chemosensor 
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non-invasive, very sensitive, requiring relatively cheap instrumentation 
compared to MRI or PET whose handling requires moderate levels of 
training and protection. Other advantages involve the imaging agents 
required that present low hazard, low costs and stability (fluorescently 
molecules can be stored for months differently from radiolabels that 
decay over a few days11). However, some disadvantages of luminescent 
imaging agents have to be taken into consideration such as 
photobleaching, limiting resolving power, parasite quenching effects, 
and environmental susceptibility and autofluorescence. For these 
reasons a lot of researcher work is now ongoing worldwide to find 
solutions taking advantage of all the most recent achievement in the 
fields of organic synthesis and material science. The goal is also more 
ambitious since it also involves the possibility to include imaging agents 
in a more complex platform able to act as a theranostic material and 
also my research work can be included in this framework. 
1.1.3 Delivery 
In order to obtain a theragnostic agent, imaging has to be paired 
by therapy and the most straightforward way is drug delivery. Drug 
delivery involves a carrier that contains a drug and its administration via 
implant, injection or ingestion allows for a controlled and localized 
release. This can take to great advantages with respect to traditional 
administration of a drug, for example the entire dose for the therapy can 
be given in only one administration and then gradually released in a 
controlled way. On the other side the possibility of driving the carrier in a 
precise site avoids the potential harmful contact of the drug with other 
tissues and permits to use much reduced drug amounts. Many different 
ways can be exploited for drug release such as diffusion, degradation, 
swelling, and affinity-based mechanisms12 13.   
Drug delivery technologies can therefore modify drug release profiles, 
absorption, distribution and elimination with the advantage of 
increasing the therapy efficacy and safety, together with a patient 
convenience in terms of time and reduction of the possibility of human 
mistake in administration. Moreover there are some medications such as 
peptide and protein, antibody, vaccine and gene based drugs that, in 
general, may not be delivered using the common routes of 
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administration that include the enteral (gastrointestinal tract), parenteral 
(via injections), inhalation, transdermal, topical and oral ones14 15. In fact, 
they might be susceptible to enzymatic degradation or they cannot be 
absorbed into the systemic circulation efficiently due to their molecular 
size and/or charge. For this reason, many protein- and peptide-based 
drugs have to be delivered by injection or with a nanoneedle array and 
specific carriers, in these cases, could dramatically improve their 
therapeutic effectiveness. 
Current research efforts in the area of drug delivery include the 
development of targeted delivery in which the carrier is able to 
specifically and efficiently recognize a targeted species and it will stop 
and accumulate only in its presence (for example tumour markers in 
cancerous tissues), sustained release formulations in which the drug is 
released over a period of time in a controlled manner, and methods to 
increase survival of peroral agents which must pass through the 
stomach's acidic environment. In order to achieve efficient targeted 
delivery, the designed system must avoid the host's defence 
mechanisms and circulate for a sufficient time to reach its intended site 
of action and this is not trivial since it has to be mediated with clearance 
issues to avoid toxicity.16 In the case sustained release formulations are 
required, different species have been tested including liposomes17, drug 
loaded biodegradable microspheres18, drug polymer conjugates19 and 
also naoparticles20.As mentioned before, an important role in the 
delivery process is played by the EPR effect, which permits the 
accumulation of macromolecules, and in general of nano scaled 
objects, in the interstitial of tumor tissues with concentration higher than 
the blood plasma. In the field of cancer treatment, the EPR effect (Fig. 
1.1), studied and proposed by Maeda1 as an efficient way to hit solid 
angiogenic tissues (that is to say not only tumors but also inflammatory 
tissues3) is principally associated with fenestrations formed by the 
endothelial cels in vasculature. This effect offers one of the most 
attractive way to gain a selective accumulation of a nanostructure in a 
tumor tissue. This is an intrinsic property and it is made possible by the 
abnormal vasculature of the angiogenic tissues together with the longer 
circulation time of nanoparticles in comparison with single molecules. 
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The selective accumulation of nanostructures is usually localized in the 
interstitial space4.  
A key factor for the efficient entrapment in tumoral tissue by EPR effect 
is the size of the nanostructure. Objects of different sizes present very 
different circulating times, and this means that with a proper design of 
the size and shape of the nanoobject it is possible to tune the amount of 
entrapped material. Objects smaller than 6 nm are excreted too rapidly 
via urine to accumulate in tumor tissues since they can pass the nephron 
membranes in the kidneys (this excretion pathway is the best one for 
optimum body clearance but too fast for an efficient delivery).  
Objects bigger than 100-150 nm circulate for a much longer time inside 
the body, this is helpful for tissue accumulation, but it can result in 
undesired high toxicity by bioaccumulation. Therefore, the 
nanostructure size is a very important parameter in the design of 
targeting materials, but it is not the only one since the nanostructure 
toxicity depends widely upon the composition, functionalization and 
properties of its surface. In the framework of medicine, nanomaterials 
are extensively studied for cancer treatment applications thanks to the 
possibility given by EPR of their spontaneous accumulation in damaged 
tissues. Indeed, different therapies are currently in study such as 
photodynamic and photothermal therapies or local chemotherapy by 
Figure 1.1 Schematic representation of the entrapment of NPs inside a tumor tissue by 
EPR effect 
 
9 
 
1 
drug delivery5,6. Photodynamic and photothermal therapies exploit the 
nanomaterials to convert, respectively, the light stimuli into the 
production of reactive species (singlet oxygen, nitrogen oxide…) or into 
an increase of local temperature, both able to kill the surrounding cells. 
Nanoparticle-based imaging and therapy are therefore a very 
promising area and even more nanoparticle-based theranostic agents 
despite still in their early stages of development. However, the advances 
in nanotechnology and the need for personalized medicine have 
already made nanoparticle-based theranostics a research hotspot.  
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1.2 Light trough the biological tissue 
It is clear the fact that there is a necessary need of improvements 
in the detection and, moreover, in the cure of malignant human 
diseases. It is necessary the development of something non-invasive and 
specific to understand and directly works on the zone which need to be 
cured or investigate. Photochemistry should be the perfect solution, both 
separately with detection using fluorescence or phosphorescent 
phenomena, and together, using something able to detect and cure in 
the same time, or, using different ways like delivery systems mentioned 
before.  
Figure 1.3 Interaction between light and tissue1 
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When the attention regarding photochemistry want to be moved in 
biology applications, especially in the interaction between light and 
human body, some details must be discussed. When the light is 
propagated through such a medium, are implicated many processes of 
refraction, reflection, absorption and scattering (Fig. 1.3). Fresnel’s law 
and Snell’s law govern reflection from the interface between two media 
and refraction, respectively, and their impact on the loss of intensity are 
determined by the relative values of their refractive indices21.  
When a light beam is applied perpendicular to the interface between 
the two media it is possible minimize both processes since their 
proportionality to the angle of incidence. Scattering of light in tissue has 
the most marked effect on light intensity and directionality.  
Scattering causes, together with refraction, a widening of the light 
beam, resulting in a loss of fluence rate (given as power per unit area of 
light in [Wm−2 ]) and a change in the directionality of the light beam. 
Scattering in tissue is quite complex (Fig. 1.3). Inelastic scattering (Brillouin 
scattering and Raman scattering) does not seem to play an important 
role in this case. For elastic scattering, neither Rayleigh scattering nor Mie 
scattering completely describes the effects observed in tissue; here, 
photons are mainly scattered in the forward direction. The 
experimentally observed scattering shows weaker wavelength 
dependence than that predicted by Rayleigh’s theory, but the effect is 
stronger than that given by Mie scattering22. Besides scattering, 
absorption of light quanta is most relevant for the loss of light intensity 
with the penetration depth. It is possible mathematically describe the 
reduction in intensity caused by both processes using an exponential 
function similar to Lambert–Beer’s law. The intensity at a given depth x 
can be calculated by equation (1), with Ix being the intensity at depth x 
and I0 the intensity at the media interface. The parameters αabs and αsca 
represent the absorption and scattering coefficients, respectively.  
Ix=I0e-( αabs + αabs)x                                                                            1 
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The most important chromophores in tissue are water, oxyhemoglobin 
(HbO2) and deoxyhemoglobin, melanin and cytochromes. The 
absorption spectra of these molecules define the optical window for use 
for example of 
techniques like PDT 
(explained better in cap 
3) in tissue (Fig. 1.4, 22,23). 
 One should keep in 
mind that hemoglobin 
(Hb) and HbO2 show 
different absorption in 
the range of 600– 800 
nm, which is commonly 
used for PDT. In vivo, 
there might be a 
significant difference in 
the amounts of HbO2 
and Hb between non-
tumor and tumor tissue 
due to a possible lower oxygenation and pH of the latter24. For PDT on 
solid tumors, the effective penetration depth is of great relevance. It is 
defined by the depth x, where I(x) decreases to 37% of I021. For clinical 
treatment with Photofrin, a hematoporphyrin derivative for excitation at 
630 nm, the light penetration depth is approximately 3– 5 mm, 
depending on the tissue25. The use of PSs with absorption peaks at 
wavelengths >700 nm (or even higher) should, at least, double the 
penetration depth and thus enable treatment of thicker tumors26. 
However, the upper limit for the excitation wavelength is given for the 
minimal energy required for singlet oxygen production. Properly for these 
reasons, the use of Oxygen as tool fot diagnostic and/or therapy should 
be the principal techniques to investigate for the development of new 
theranostic agents. 
 
 
 
Figure 1.4 The optical window for PDT. Absorption of light 
by tissue chromophores limits the wavelength range 
suitable for PDT to about 650-1200 nm 
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1.3 NPs and colloids 
A Nanoparticle (NP) is define by ISO Technical Specification 
80004 as nano object, with all three external dimensions in the 
nanoscale, whose longest and shortest axes do not differ significantly, 
with a significant difference typically being a factor of at least 3. 
Nanoparticles can exhibit size-related properties significantly different 
from those of either fine particles or bulk materials27–29. 
Nanoparticles with range between 1 and 100 nm in size are synonymous 
of, "Ultrafine particles" opposite to "fine particles" sized between 100 and 
2,500 nm and "coarse particles" ranging from 2.5 to 10 μm. For the period 
of the 1970s and 80s, during the first thorough fundamental studies with 
nanoparticles in the United States by Granqvist and Buhrman30, and in 
Japan within an ERATO Project31, the term utilized was Ultrafine particles.  
In the 90s, the term nanoparticle had become more common, before 
the National Nanotechnology Initiative was launched in the United 
States. Sometimes the words nanoparticles and colloids are used with 
the same meaning but, the terms colloid and nanoparticle are not 
interchangeable. A colloid is one of the three primary types of mixtures, 
with the other two being a solution and suspension. A colloid is a solution 
that has particles ranging between 1 and 1000 nanometers in diameter 
yet are still able to remain evenly distributed throughout the solution. 
These are also known as colloidal dispersions because the substances 
remain dispersed and do not settle to the bottom of the container. In 
colloids, one substance is evenly dispersed in another. The substance 
being dispersed is referred to as being in the dispersed phase, while the 
substance in which it is dispersed is in the continuous phase. 
In 1905 Albert Einstein created the mathematic model which describes 
the phenomenon of the irregular zig-zag motion of the small particles in 
a solution discovered by Robert Brown in 1827. These erratic particles 
behavior can be attributed to the collective bombardment of a myriad 
of thermally agitated molecules in the liquid suspending medium 
bringing to the impacts between the particles not equal in every 
direction. As a result, the sol particles show a random trajectory creating 
the such called Brownian motion or Brownian movement. The Brownian 
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motion becomes progressively less prominent, as the particles grow in 
size or the viscosity of the medium increases, indeed, If the particles are 
larger, their dynamic behavior within the suspension is governed by 
forces of gravity and sedimentation. Such random motion is visible under 
ultramicroscopes and for bigger particles even under ordinary 
microscopes. 
A common method of classifying colloids is based on the phase of the 
dispersed substance and what phase it is dispersed in. The types of 
colloids include sol, emulsion, foam, and aerosol. 
• Sol is a colloidal suspension with solid particles in a liquid. 
• Emulsion is between two liquids. 
• Foam is formed when many gas particles are trapped in a liquid 
or solid. 
• Aerosol contains small particles of liquid or solid dispersed in a 
gas. 
 
1.3.1 Colloidal stability  
Colloidal dispersions are subject to several kinds of instability. This 
is due to the attraction and repulsive forces such as Van der Waals forces 
electrostatic forces, steric and solvation forces too. All these forces 
involving in aggregation, coagulation, flocculation or they can stick to 
surrounding surfaces by deposition and they can separate under gravity 
bringing to sedimentation or creaming. These mechanisms all can be 
counteracted by strong electrostatic repulsion, and the strength of that 
repulsion can be parameterized by the zeta potential (see experimental 
section for the explanation). In some cases, however, electrostatic 
interactions can destabilize the dispersion.   
In general every particle follow the Lennard-Jones theory32.  In particular, 
for colloidal solutions it has been formulated an extension of LJ theory, 
the DLVO model (Fig 1.5). This theory is named after Derjaguin, Landau, 
Verwey, and Overbeek and is the explanation of the stability of colloidal 
suspension.  The theory assumes that the electrostatic double layer 
forces and the van der Waals forces are independent and therefore can 
be superimposed or added at each interacting distance for two 
particles.  
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Figure 1.5 Schematization of potential energy graph in DLVO theory  
The DLVO theory33 explains the tendency of colloids to agglomerate or 
separate by combining two forces described by two curves: 
electrostatic repulsion due to the so called double layer of counterions, 
and van der Waals attraction. The total potential energy is described as 
the sum of the attraction potential and the repulsion potential. When 
two particles approach each other, electrostatic repulsion increases 
and the interference between their electrical double layers increases. 
Meanwhile, the van der Waals attraction increases as they get closer.  
At each distance, the net potential energy of the smaller value is 
subtracted from the larger value. The combination of these forces results 
in a deep attractive shaft, which is referred to as the primary minimum. 
At maximum energy barrier, repulsion is greater than attraction. Particles 
rebound after interparticle contact and remain dispersed throughout 
the medium. The maximum energy needs to be greater than the thermal 
energy, otherwise, particles will aggregate due to the attraction 
potential. The height of the barrier indicates how stable the system is. 
Since particles have to overcome this barrier in order to aggregate, two 
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particles on a collision course must have sufficient kinetic energy due to 
their velocity and mass. If the barrier is cleared, then the net interaction 
is all attractive, and as a result the particles aggregate. This inner region 
is often referred to as an energy trap since the colloids can be 
considered to be trapped together by Van der Waals forces. For a 
colloidal system, the thermodynamic equilibrium state may be reached 
when the particles are in deep primary minimum. At primary minimum, 
attractive forces overpower the repulsive forces at low molecular 
distances. Particles coagulate and this process is not reversible. 
However, when the maximum energy barrier is too high to overcome, 
the colloid particles may stay in the secondary minimum, where particles 
are held together weaker than the primary minimum. Particles form 
weak attractions but are easily re-dispersed. Thus, the adhesion at 
secondary minimum can be reversible. At larger distances, the energy 
profile goes through a maximum energy barrier, and subsequently 
passes through a shallow minimum, which is referred to as the secondary 
minimum. At each distance, the smaller value is subtracted from the 
larger value to obtain the net energy. In the regime where there is 
repulsion, energy can be thought to be an energy barrier.  
It is possible work on the surface of the particles modifying the particles 
double layer, then their stability. The criteria of stability in which is possible 
to work to obtain a stable system are: 
• Salt concentration 
• Counter-ion valency 
• Z-potential  
• Particle size 
• Polymeric stabilization 
It is possible increase or decrease the energy barrier working on the 
abovementioned parameters, by changing the ionic or pH environment 
or adding surfactants to affect the surface charge of the colloid. In this 
case, zeta potential can be measured to know the stability of dispersion. 
There are many other effects which are to be considered for sure, but 
steric stabilization is the most important thing. Adsorbed layer on each 
particle prevents the particles from coming close enough for van der 
Waals attraction to cause flocculation. There are no long-range 
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repulsive forces unlike electrostatic stabilization and the particles are 
subject to attractive forces until the outer regions of the molecules. 
 
1.4 Aim of the thesis 
The research work presented in this thesis can be inserted within 
the wide field of nanomedicine and it is centred on the development of 
new nanostructured multifunctional materials for future theranostic 
applications. The rational that has been followed in these years has been 
inspired to a supramolecular approach, therefore, the research started 
with the study of various components able to play different functions that 
could be then implemented in more complex multifunctional platforms.  
Have been designed, prepared and characterized some very different 
supramolecular, nanostructured and microstructured species suitable to 
be implemented, in a future, in theranostic agents, but already able to 
perform useful functions for bio-medical applications (imaging, sensing 
and drug delivery). 
I list hereafter the specific goal pursue in each chapter that describes a 
different component/material. 
Chapter 2: the preparation of a new luminescent chemosensor for Mg2+ 
quantitative detection selectively in mitochondria is the goal of this part 
of the work. We will realize it functionalizing with two phosphonium 
moieties the periphery of the chemosensor based on a diaza-18-crown-
6 appended with two 8-hydroxyquinoline(8-HQ) derivatives.  
Chapter 3 aims to prepare and optimize nanostructured phosphoreshent 
chemosensors for molecular oxygen, presenting the appropriate 
features for oxygen sensing in the physiological pO2 range, water 
solubility, stability and biocompatibility. A new synthetic strategy will be 
specifically conceived to prepare silica core/PEG shell nanoparticles 
highly doped with water insoluble phosphorescent emitters such as 
organic molecules called asterisks and metal-phorphyrins. The final 
ambitious step will be to optimize the most promising structures for in vivo 
applications.  
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In chapter 4 will be shown the study carried out at the New York University 
that aims to allow a full physico-mechanical understanding of how 
particle morphologies and motilities can affect phagosomal antigen 
degradation and presentation. To study the influence of morphology the 
first step is the preparation of irregurlarly-shaped microstructures suitable 
to mimic invading microbial pathogens of cells. In parallel, to evaluate 
the motility impact on phagosomal antigen degradation by dendritic 
cells I also prepared other active colloids called ‘swimmers. Under UV-
light activation they are propelled by the oxygen bubbles formed by a 
chemical reaction that takes place in the presence of hydrogen 
peroxide.  
Chapter 5 Aim of this part of my research is to prepare luminescent 
nanoparticles bearing a targeting agent for tumor tissues and to explore 
the possibility to release them from a carrier in a controlled way in view 
of medical applications. In particular, we want to evaluate if, using the 
electrospinning method, it is possible to create a bioresordable mat, 
containing targeted dye doped PluS NPs, able to release them in a 
degradation dependent regime. The goal is to implant the scaffold in a 
patient after a tumour reset operation to release the theranostic 
nanoparticles in time during the reabsorption of the fibers, allowing to 
monitor, and in case to cure, the neighboring tissues. 
Chapter 6 merges some research work that on different species that 
could have, or could take to, interesting properties to be exploited in 
building block moieties for the design of multifunctional platforms. In 
particular, we aim to study new NIR emitters based on rhenium(I) and 
lanthanide metal complexes both in solution and in the solid state, to 
gain the knowhow for tuning their electronic and photophysical 
properties. In parallel, we will also carry on a basic study on gold 
nanoparticles that aims to assess the possible pro-oxidant or antioxidant 
effects induced by the particles, they are in fact key features to 
determine their safety and suitability for specific applications. 
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CAP. 2 
MOLECULAR CHEMOSENSOR 
FOR Mg2+ DETECTION IN 
MITOCHONDRIA  
 
2.0 Cationic sensing 
Molecular design for the detection of cation has attracted great 
interest for scrutiny outstanding to its potential applications in biomedical 
and environmental monitoring1–3. Chemistry of molecular recognition, 
well known as Host–guest chemistry, is associated with the study of 
selective recognition of a molecule (guest) by another molecule (host) 
via the formation of non-covalent interactions, which constitutes the 
fundamental and traditional concept for the design of cation sensors4,6. 
The creation of traditional cation sensors generally involves the 
combination of an ionophore for selective recognition of the target 
cation, with a chromophore or luminophore to signal the binding events 
with a respective colorimetric or luminescent response occurring from 
the alteration of its photophysical properties upon cation complexation. 
The higher sensitivity of the luminescent sensors respect colorimetric 
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ones, put them a step forward in their use in quantification in analytical 
and clinical purpose, where the sensitivity plays a critical role2,3. 
Supramolecular chemistry, first termed by Lehn who was awarded the 
Nobel Prize in Chemistry together with Pedersen and Cram for their 
contribution to this field, combines the fields of host–guest chemistry and 
the chemistry of molecular assembly to a unified concept8,10.This 
concept has long been an interest of study in the research field because 
through the incorporation of different functionalities into the molecular 
structures (such as ionophores), these systems would respond differently 
upon the introduction of external stimuli (such as a target cation) and 
arrange into interesting supramolecular structures. Such characteristic 
ingenuity endows these systems with versatile potential to be employed 
in the field of cation detection. Photoinduced electron transfer12,13 (PET), 
photoinduced charge transfer15 (PCT) and Forster resonance energy 
transfer17 (FRET) have been the com-mon mechanisms utilized in the 
design of traditional cation sensors for governing the signal response of 
luminophores upon cation-binding. Anyway, many fluorescent probes 
exhibit cation-induced photophysical changes that cannot be 
explained along the same lines just mentioned. Interaction of a cation 
with a fluorophore often leads to changes in radiative, nonradiative 
and/or intersystem crossing rate constants, and consequently, changes 
in fluorescence quantum yield and lifetime (whereas shift of spectra is 
not a general rule). To this category belongs the oxyquinoline-based 
fluorescent chelators. The first of them is 8-hydroxyquinoline (8-HQ), often 
called oxine, and its derivatives. The most noteworthy aspect of 8-HQ is 
its fluorogenic character, i.e. its very low quantum yield in aqueous or 
organic solutions and the fluorescence enhancement occurring from 
cation binding. The non/fluorescent character of 8-HQ in neutral water 
has been satisfactorily explained only recently26,27 by the occurrence of 
excited-state proton transfer reactions coupled to an intramolecular 
electron transfer. In fact, photoinduced deprotonation of the –OH group 
and protonation of the heterocyclic nitrogen atom can occur either with 
surrounding water molecules or intramolecularly, depending on the 
possible existence of H-bonding between the two functions. 
Deexcitation of the resulting tautomer occurs mainly via a nonradiative 
pathway. In contrast, many metal chelates of 8-HQ and derivates (e.g. 
Cd, Zn, Mg, Al, Ga, In) present strong yellow–green fluorescence 
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because the above-described photo processes are reduced by a 
bound cation. However, the changes in electronic distribution upon 
excitation are likely to weaken the bond between the oxygen atom and 
the metal ion, thus allowing some charge transfer from the phenolate –
O- to the nitrogen atom of the adjacent ring12. 
 
2.1 State of the art 
One of the main protagonist among the divalent cations in the 
cells is Mg2+ being involved in many fundamental processes such as 
proliferation5 and cell death7. Magnesium ions have also a role in the 
regulation of enzymes and other species such as ATP, forming MgATP2- 
which varies directly with cytosolic Mg2+ and plays the effettive key role 
activating protein kinase in a molecular pathway that regulates the 
initiation of translation in the cells.9 Alteration in total or free magnesium 
levels can have significant consequences for cell metabolism and cell 
functions. Mg2+ biochemistry has been thoroughly studied in vitro, 
nevertheless it has not been achieved yet a fully understanding of 
cellular magnesium homeostasis. Plasma membrane and organelle 
transport regulate the cytosolic Mg2+ concentration and this level is 
maintained far from electrochemical equilibrium given by a transport 
mechanism inside/outside the cells11. Cytosolic free Mg2+ levels are 
reported to be 0.2-1 mM1416 representing less than 10% of the total Mg2+; 
the rest is bound or sequestered in different cellular organelles. It has 
been presumed that cellular magnesium, the free form, is kept constant 
at the level necessary for cellular metabolic demands and that, in 
physiological conditions, its concentration does not undergo drastic and 
rapid changes. The need for a sensitive and reliable tool to measure 
concentrations and fluctuations of cellular Mg2+ becomes very stringent, 
since available techniques have serious limitations. Atomic absorption 
spectroscopy is very sensitive and accurate but requires volatilization of 
the sample and a relatively high number of cells, and it does not 
discriminate between free and bound forms. On the other hand, in vivo 
NMR spectroscopy allows an accurate measurement of cytosolic free 
Mg2+ but supplies no information on the total Mg2+ concentration and its 
distribution among cellular sub compartments. Electron probe 
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microanalysis has been exploited to measure Mg2+ content in distinct 
cellular sub compartments in freeze dried cryosections. This technique 
again does not provide information on free and bound Mg2+ and does 
not allow kinetic measurements of Mg2+ fluxes19. Fluorescent techniques 
can offer a suitable solution. If properly designed, a fluorescent probe 
could be the perfect, non-invasive and precise solution. Their 
application in fluorescence confocal imaging allows dynamic 
measurements of cellular content and distribution of the targeted ion, 
allowing analyte mapping in the sample. The available fluorescent 
probes for intracellular magnesium are mainly derived from those 
designed for calcium18, but they retain cross reactivity for Ca2+ and 
dependence on pH. These Mg2+-specific fluorophores are characterized 
by a Kd in the millimolar range, which is appropriate to measure mainly 
the free fraction of cellular Mg2+ (only 5% of the total). In fact, cytosolic 
free Mg2+ concentrations are in the range of 10-4 M, while total cellular 
Mg2+ is up to 100-fold higher. Experimental evidences shows that 
fluctuations of free intracellular Mg2+ concentrations are modest 
compared to massive changes of total cellular Mg2+20; thus, 
modifications of Mg2+ availability to influence different biological 
functions are thought to be accomplished by substantial modifications 
of the distribution of total Mg2+ among cellular sub compartments. In this 
scenario, a tool able to detect and/or discriminate between free and 
total Mg2+ and between Mg2+ content of cytosolic and intracellular sub 
compartments would be particularly useful. Recently, a new family of 
magnesium ions binding fluorescent probes named KMGs has been 
designed, and their application to the study of intracellular Mg2+ 
homeostasis seems promising22. The unavailability of more specific and 
selective commercial compounds for total magnesium currently 
represents a technical limitation in the study of the intracellular content 
and distribution of this cation. Compelling evidence, in fact, 
demonstrates that cellular magnesium homeostasis is quite unusual: 
significant fluxes of Mg2+ cross the cell membrane in either direction, with 
consequent major changes in plasma Mg2+ levels21 which, result in 
limited variations of free Mg2+ intracellular concentration, although large 
changes in total Mg content within tissues and organelles have been 
observed23. This suggests that modifications of magnesium availability 
that influence different biological functions may be accomplished by 
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changes in the distribution (binding) of magnesium among cellular 
ligands and/or sub-compartments rather than by major modifications of 
the free fraction24. The development of chemosensors able to detect 
total magnesium in vivo and discriminate specific intracellular ligands 
and/or compartments is particularly appealing. Since a few years, a new 
class of luminescent chemosensors for different metal cations was 
designed, synthesized and characterized in collaboration by professors 
M. Lombardo,  L.Prodi and N. Zaccheroni that recently reported a 
complete study on those for Mg2+ ion based on diaza-18-crown-6 
appended with two 8-hydroxyquinoline(8-HQ) groups (DCHQ) bearing 
different substituents25. 8-HQ, that is the second major Mg2+ chelating 
agent after EDTA26, is mostly nonfluorescent in aqueous or organic 
solutions and undergoes a fluorescence enhancement upon cation 
binding, which results in an intense yellow–green luminescence signal. 
Furthermore, the fluorescence of the complexed species depends on 
the environment and becomes higher as lipophilicity increases27. 
However, the selectivity of 8-HQ for specific cations is poor and it needs 
to be improved by appropriate substitution. The study reported a 
complete synthesis, photophysical characterization and in vitro 
investigation of molecules members of a DCHQ family, with the most 
efficient one for Mg2+detection being DCHQ5 (Fig 2.1) able to detect 
the intracellular level of Mg2+.  
Mitochondria redistribute 
cytosolic and mitochondrial 
Mg2+ amount sufficient to 
change the cytosolic Mg2+ 
concentration ([Mg2+]cyto) in 
response to several 
physiological stimuli28,29 
Recent studies using novel 
Mg2+ fluorescent probes successfully visualized that mitochondrial Mg2+ 
concentration ([Mg2+]mito) dynamically change30,31. However, it is not 
clear, in cells, how the changes of [Mg2+]mito comprehensively affect the 
cellular energy metabolism in detail. Although regulation of [Mg2+]mito 
has not been elucidated in detail, mitochondrial Mg2+ channel MRS2 is 
known to be a molecular machinery associated with Mg2+ influx into 
mitochondria32,33. Mg2+ uptake into mitochondria via MRS2 is essential for 
Figure 2.1 Molecular structure of DCHQ5 
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the maintenance of respiratory chain and cell viability. For these reasons 
is fundamental to find a specie able to penetrate the mithocondria 
membranes and to detect the Mg2+ concentration directly inside these 
organelles. 
 
2.2 Aim of the work 
The aim of this part of my research work was to functionalize and 
study a new luminescent chemosensor of the class of DHQC, that is to 
say a diaza-18-crown-6 appended with two 8-hydroxyquinoline(8-HQ) 
derivatives, precisely designing it to detect and quantify Magnesium ions 
selectively inside mitochondria. Starting from the knowhow on DHQC 
moieties already developed by the group25 we decided to introduce in 
each 8-hydroxyquinoline component a terminal functional group able 
to target mitochondria. Many experimental evidences in the literature34 
show that phosphonium groups permeate mitochondrial membranes 
very efficiently and the challenge was to introduce these functions 
preventing negative drawbacks on both the binding event (receptor-
ion interaction and affinity) and on the luminescence variations of the 
chemosensor in response to metal ion complexation. We chose, 
therefore, to insert phosphonium functions far from the binding sites at 
the end of long spacers to avoid their hindrance.  
 
 
 
 
 
 
 
 
 
Figure 2.2 schematic representation of mitochondrial Mg2+detection 
 
28 
 
2 
The nature of these spacers had to be carefully evaluated in order to 
avoid inducing parasite non-radiative decay pathways that could 
quench the chemosensor luminescence, resulting in a much lower 
detection sensitivity. In order to optimize the final new chemosensor, a 
photophysical characterization of all the derivatized units before the 
final assembly is needed to verify the possible changes in their 
recognition and detection ability toward Mg2+. The final chemosensor, 
instead, must be carefully characterized not only from a photophysical 
point of view but also in vitro (on a human leukemia (HL60) and 
osteosarcoma tumor (U2Os) cell lines) to test if the derivatization affects 
the toxicity of the system and/or the cell internalization efficiency.  
 
2.3 Synthesis and photophysical characterization 
In collaboration with Prof. M. Lombardo from University of 
Bologna, was synthesized firslty molecule 2. Click reaction with 
CuBr(PPh3)3 10%  in dry DCM was performed, and deprotection using 
acidic condition has given to product 2. Several trials were necessary to 
find suitable catalyst amount and precise solvent, but with the final 
conditions the yield is 99% (data reported in the experimental part). 
At this point has been conducted the first attempt to obtain the 
chemosensor. The idea, shown in Fig 2.4, was to use a Mannich reaction 
in a reflux condition. Even in this case were performed many trials not 
reported here, changing the reaction solvents, Toluene, CH2Cl and EtOH 
and following the formation of the product by 1H-NMR analysis. 
Figure 2.3 Synthesis of molecule 2 
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Figure 2.4 first attempt for Synthesis of chemosensor using mannich reaction 
The strategy has given no results. Probably the presence of phosphonium 
group disturbs the reaction, in particular the difficult solubility of product 
2 could be the cause. Then, to obtain molecule 4 it was decided to 
change the reaction pattern, making first the Mannich reaction and, 
after, to use the click step with phosponium azide, as shown in Fig. 2.5 
 
This time the synthesis of the sensor 4, DHCQPPh3, was well performed. In 
this way, it is also possible to avoid further purification steps, in fact to the 
molecule 3 is added directly the catalyst and the azide resulting in a very 
to a clean 1H-NMR spectrum of molecule 4 protected (see experimental 
section). After a simple evaporation of the solvent under vacuum, 4 is 
obtained. 
The photophysical characterization was performed, first of all, it has 
been conducted the characterization of the species 3 in order to verify 
the influence of the derivatization on the complexation and on the 
photophysical properties of the quinoline. 3 was dissolved in DMF to 
obtain a 1mM solution then a very small amount of this solution was 
added to 2.5mL of PBS 0.01M with a pH of 7.4 to mimic the physiological 
conditions. This procedure was necessary to guarantee the complete 
Figure 2.5 Scheme of the complete synthesis to obtain molecule 4, DHCQPPh3 
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solubilization of 3 since its very low solubility in water. The absorption and 
fluorescence spectra of 3 are mainly the attended ones for the 8-HQ 
derivative as it can be seen in Fig. 2.6. The absorption spectrum (Figure 
6 on the left) of 3 in PBS 10 mM at pH 7.4, shows an intense band at 
around 240–250 nm (ε = 70000–83000 M-1 cm-1 ) and a smaller and 
broader band at around 310–330 nm (ε = 5200–9000 M-1 cm-1). The former 
can be attributed to a π–π* transition, while the latter presents a main 
charge transfer character with charge density moving from the hydroxyl 
oxygen atom to the quinoline. 35,36 
The titration of molecule 3 was performed using three different salts in 
order to exlude anion interferences and in particular with MgSO4, MgNO3 
and Mg(ClO4)2 obtaining the same results and for this reason I report 
hereafter only the data relative with MgSO4.  
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Figure 2.6 absorption (a) and emission (b) spectra of molecule 3 (29 μM) in PBS 10 mM pH 
7.4  at room temperature upon addition of increasing amounts of Mg2+ ions. Λex=328 nm 
Eq of Mg2+ from  0 to 35 
The fitting of the data with the program SpecFit37 using a model L:M 1:1, 
indicate a value of the log Ka of 2.3+0.04. 
The emission band is large and there is a red shift of 47 nm. This trend is 
accordant with the expectation, infact there is increasing in fluorescent 
and a red shift of the maximum in the emission caused by PPT processes 
(see section 2.0). The obtained results are quite different from the ones 
reported for the DCHQ chemosensor family, as expected for this single 
derivatized ‘arm’. First of all, the association constant is much lower since 
in the DCHQ class the complexation is templated by the crown and 
helped by two side arms. Moreover the emission enhancement after 
reaching the plateau with the addition of 35 equivalents is only of 50 
EM in PBS
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times, much lower than, for example in DCHQ5. All these results indicate 
that the derivatization with phosphonium did not significantly affect the 
quinoline properties, but it does not help metal ion complexation and 
the bounding with the crown ether is necessary for an efficient 
recognition. The photophysical characterization of the entire 
chemosensor was obtained following the same procedure used for 3.  
 
Mg2+ binding causes a dramatic 
enhancement of the emission 
spectra up to 300 times the 
fluorescence intensity of the free 
ligand that can be appreciated 
also at naked eye as shown in Fig 
2.7. The addition of increasing 
amounts of Mg2+ caused changes 
in the absorption spectra in line 
with the complexation event as already observed for other DCHQ 
derivatives: the decrease of the bands centred at 240–250 nm and at 
310–330 nm and the appearance of new bands around 260–265 and 
370–390 nm. These new bands are characteristic of 8-HQ derivatives 
when the complexation process is accompanied by the deprotonation 
of the hydroxyl group in position 838,39. The logKa is well fitted (data not 
showed) both for absorption and emission titration giving respectively 
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Figure 2.7 Absorption (left) and emission (right) spectra of 4 (25μM) in the presence of 
increasing amounts o fMg2+.(from 0 to 35 equivalents) in PBS 1 0 mM pH 7.4.  (λex=340nm) 
Figure 2.8 Photography of increasing in 
emission of 4 upon addition of crescent 
amount of magnesium 
 
32 
 
2 
values 4.5+0.06 and 4.7+0.03. The quantum yield for the 4 complex is, 
0.032. Comparing the results obtained with the previous studies25, the 
complexation behavior of 4 is quite comparable with the DHCQ family 
compounds complexed with Mg2+ which present a fluorescent quantum 
yield in the range 6.7x10-3-3.5x10-2. . As for the previous chemosensors of 
the same class we have studied their selectivity with respect to the other 
possible competitors i.e Zn2+, Cd2+, Hg2+, Cu2+, Ni2+, Na+, K+, Ca2+, Fe2+, 
Fe3+, Al3+ and we evidenced that in agreement with previous results also 
4 does not complex  Na+, K+, Ca2+, Fe2+, Fe3+ ions in the investigated 
concentration range. Hg2+, Cu2+, Ni2+, were efficiently bonded but 
formed non-luminescent complexes. All measurements were performed 
using SO4- as counterion and using the same equivalent amount, from 0 
to 35. Among all considered metal ions, only Mg2+, and Zn2+ and Al3+ 
induced a significant enhancement of the fluorescence of the system. 
The results for Cd2+ Zn2+  and Al3+ reported an increasing in the emission; 
respectively, for 35 eq. of salts,  the emission of the 4 complexed with Zn2+ 
and Cd2+,  is comparable with the 4-Mg2+ complex, while with Al3+ the 
data collected were very undetectable due to the precipitation of 
something in solution (data not-shown). Maybe, gives the very low 
solubility of the Al(OH)3, it is possible their formation. To be sure, further 
analysis changing pH value should occur. Anyway, intracellular Zn2+ 
concentration is around 100 times lower than Mg2+ and, moreover, most 
of Zn2+ is bound to Zn fingers with particularly high association constant28, 
cadmium is not presented in non-poisoned cells; for this reasons they 
can’t create competitors for Mg sensing. The selectivity respects to the 
principal competitors in physiological environment, Na+, K+, Ca2+ was 
well investigated (Fig. 2.9) All the measurements were performed in PBS 
10 mM at pH 7.4 using SO42- as counterion. 
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Figure 2.9 Graph of normalized emission intensity of 4 (25μM) with Na+ Ca2+ K+ Mg2+ and 
picture of the same samples  
As Very interestingly, the complexation behavior of 4 is quite 
comparable with the DHCQ family compounds complexed with possible 
cations competitors inside the cells, as shown in chart in Fig. 2.9. These 
interesting results led to conclude that the new functions introduced in 
the chemosensor 4 compared to the previous studies on DHCQ family 
indicate that the derivatization with phosphonium ions does not 
significantly affects the complexation properties of the chemosensor.  
 
2.3 Preliminary tests in vitro. 
In collaboration with Prof. Iotti group, we studied the toxicity and 
internalization of the new probe in cells. In order to establish the 
maximum non-toxic concentration regime that is possible to use to stain 
cells we loaded HL60 cells with different concentrations of 4, and 
counterstained them with propidium iodide (PI). HeLa is an immortal cell 
line used in scientific research. It is the oldest and most commonly used 
human cell line40. The line was derived from cervical cancer cells taken 
on February 8, 195141 from Henrietta Lacks, a patient who died of cancer 
on October 4, 1951. The cell line was found to be remarkably durable 
and prolific, which warrants its extensive use in scientific research42. The 
analysis of these cells by flow cytometry to discriminate live cells from 
damaged ones and selectively analyze the intracellular fluorescence of 
the chemosensors gave very promising results. We tested several 
concentrations in the range 5–40 μM in order to identify the best 
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concentration to obtain a high signal/noise ratio together with a low b 
cytotoxicity.  
Fig. 2.10 reports information about cells dimension (FS: forward 
scattering) and internal morphology of the cells (SS: side scattering): if 
the cells are healthy, all cells should be found in the same area of the 
graph with respect to the control, while if they are suffering, the size and 
morphology change, giving a displacement from the coordinates 
describing the control cells. Fig. 2.10C shows that only 40 μM of 4 induces 
substantial changes in cell morphology, even if the majority of the cells 
are still inside the region R1 corresponding to the healthy area. Further 
analyses were performed to support the non-toxicity of the chemosensor 
and in Fig.2.11 are reported cytograms of control HL60 cells and treated 
with 20 μM of 4 for 30 minutes. All cells were previously treated with PI 
which reacts only with dead or dying cells and its detection causes the 
positioning of the cells in the sectors A (dead non-stained cells) or B 
(dead stained cells). As it can be seen in Fig. 2.11 left, the control cells 
occupy quadrant C (live non-stained cells) while cells stained with 4 (Fig. 
2.11 right) present a high fluorescence and are in great majority in 
quadrant D (live stained cells). There is, however, a minor percentage of 
healthy cells that was not efficiently stained and a slightly higher 
percentage of dead stained cells with respect to the control.  These 
results confirm that 4 stains live cells with a very good efficacy and after 
about 30 minutes from loading, seems to be well tolerated by the cells 
A B C 
Figure 2.10 A: scatterplots of the control cells; B: HL60 (5x105 cell/mL)+4 20μM; C: HL60 
(5x105 cell/mL)+4 40μM 
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at a loading concentration of 40 μM, which resulted in a good 
fluorescence signal.  
Moreover, from Fig. 2.11 centre bottom line blue it is possible see how the 
emission signal remains almost unchanged after washing the cells with 
toxic components used to fix the cells on the glass and that induce their 
death and a great increase of porosity. This data indicates that 4 remains 
internalized despite the drastic increase of cell permeation and this 
could be explained by the possible segregation or the strong interaction 
of 4 in/with some cellular compartments.  It has been speculated that 
these compartments could be mitochondria and in order to 
experimentally support this scenario, we performed some preliminary 
confocal microscopy imaging mitochondria marked cells. 
Preliminary assays were performed on 4 stained osteosarcoma tumoral 
cells (U2Os) marked with a specific red marker for mithocondria 
(Mitotracker CMROS). The cells were marked following two different 
procedures that I will call “pre-fixed” and “post-fixed”. 
4 40μM 
Figure 2.11 Left: cytogram of control live non-stained cells; right: cytogram of cells 
incubated with 4 20 μM for 30 minutes; centre bottom: fluorescence signal of 4 20μM after 
different incubation time.  
A B 
C D 
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In the “pre-fixed” one the Mitotraker and 4 were added simultaneously 
to the cells for 20 min and then washed and fixed to the glass with 4% of 
p-formaldeyde in PBS, washed with PBS and analysed after 24h. In “post-
fixed” sample, the 4 addition was made after fixation and then they 
were analysed after 24h.  
 
 
Fig. 2.12 seems to indicate that staining and marking are more efficient 
in the “post-fixed” sample. However, the Mitotraker is completely diffuse 
in all the cell and this is a clear indication that an efficient and selective 
marking of the mitochondria can be obtained only on live cells when 
the mitochondria are carrying out their functions and participate to the 
metabolic activities of the cells. The fixing step causes damages in the 
cell membranes including mitochondria ones and causes a dispersion of 
the Mitotraker throughout the cell. In these conditions it is evident that it 
is not possible to test any selective mitochondria staining of 4 and 
confocal investigation on live cells are mandatory for this goal. 
Unfortunately, this technique was not available in our laboratories, but 
new measurements are now scheduled in the framework of another 
collaboration of the group that will afford access to the needed 
technology. 
 
 
Figure 2.12 Confocal images of U2Os cells stained with 4 and marked with a red 
Mitotracker. Left “pre-fixed” sample, right: “post-fixed” sample 
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2.4 Conclusion and future steps 
During this project, carried out in collaboration with prof. M. 
Lombardo of the University of Bologna, a new chemosensor for selective 
intracellular magnesium detection in mitochondria was prepared and 
fully photophysically characterized. The introduction of the targeting 
phosphonium groups on the 8-hydroxyquinoline branches of the 
chemosensor was not trivial and Professor Lombardo developed a new 
functional total synthetic pattern involving Mannich-type and click 
reaction steps able to give the chemosensor in very high yield.  The 
photophysical characterization evidenced that the derivatization did 
not affect the  selectivity of the system toward Mg2+ in buffered solutions 
mimicking the physiological environment, and it even increases its 
sensitivity, in fact, the emission of the complexed specie results higher of 
up to 300 times with respect to the un-complexed chemosensor in 
solution. 
Preliminary tests on a human leukemia cell line (HL60) in collaboration 
with Prof. S. Iotti of the University of Bologna, confirmed a very low 
cytotoxicity of the chemosensor until a concentration of 40 μM and its 
efficient internalization in live cells. Moreover, cytofluorimetric 
investigations on cells incubated with 4 40 μM, then treated with fixing 
components that highly enhance their permeability and finally washed 
several times, showed a negligible liking of the chemosensor possibly 
due to its segregation or strong interaction in/with some cellular 
compartments. Further confocal investigation on live cells are 
mandatory in order to collect experimental evidences on the 
localization of 4 in the cells and on its envisaged selectivity for 
mitochondria, but unfortunately it was not possible to have access to the 
necessary instrumentation during my PhD work. These measurements are 
now scheduled for the next future in the framework of another 
collaboration of the group.  
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CAP. 3 
NANOSTRUCTURED CHEMOSENSORS 
FOR O2 DETECTION IN 
BIOMEDICAL APPLICATIONS  
 
Cells undergo on a variety of biological responses when placed 
in hypoxic conditions, including activation of signalling pathways that 
regulate proliferation, angiogenesis and death. Cancer cells have 
adapted these pathways, allowing tumours to survive and even grow 
under hypoxic conditions, and tumour hypoxia is associated with poor 
prognosis and resistance to radiation therapy. Many elements of the 
hypoxia-response pathway are therefore good candidates for 
therapeutic targeting and the detection of variations in oxygen levels at 
the cellular level could take to great step forward for the early 
diagnoses.  
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3.0 State of the art  
In the so wide chemosensor scenario, the variation in oxygen 
levels is very often detected taking advantage of metal complexes and 
in particular metallo-porphyrins1. Recently many researches are focused 
on the development of metal-free molecules or nanostructures. A 
promising class of compounds includes dendrimers, already deeply 
studied in view of drug delivery applications. Dendrimers are 
monodispersed, three dimensional, hyperbranched, nanoscaled 
polymeric architectures with a very high density of surface functional 
groups. With a definite molecular weight, shape and size, they are 
suitable species for many and different applications2. Dendrimers are 
composed of three distinct domains, the cores, the dendrons and the 
terminal functional groups. The space among the branches of a 
dendrimer molecule forms cavities which are known as dendrimeric 
crevices and they can host and transport different species. These kinds 
of structures can mimic natural aggregates, for example natural 
porphyrin derivatives, including hemes, chlorophylls, and 
bacteriochlorophylls, are integrated into protein scaffolds that are 
essential for their biological activities. The development of dendrimer 
porphyrins has been inspired and prompted by many interesting 
functions of porphyrin derivatives in biological systems. In particular, their 
potentialities in oxygen sensing and/or photodynamic therapy (PDT) 
make them promising moieties to be used both for diagnostic and 
therapeutic applications especially in cancer fields. This has taken to 
great efforts in the preparation of dendrimers that are designed to be 
highly biocompatible, water soluble and even biodegradable. 
The exploitation of new complex species for PDT or oxygen sensing has 
also been favoured by new techniques in the field of in vivo imaging 
such as Two-Photon (or, more generally, Multiphoton) Laser Scanning 
Microscopy (2PLSM)3. Its combination with the imaging of the variation 
of phosphorescence (intensity, lifetime) versus the oxygen concentration 
could allow to develop a high-resolution oxygen imaging method4. 
2PLSM is based on the two-photon absorption (2PA) phenomenon4, 
which occurs with high efficiency only at extremely high local 
instantaneous intensities of the excitation light, i.e., in the focus of an 
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ultrafast pulsed laser beam. Raster-scanning such a beam in the axial 
plane at a selected depth (usually no more than 500 µm) within the 
object permits its effective 3D optical sectioning, provided that the 
object contains a 2P absorbing luminescent dye. 2PA is typically initiated 
by lasers operating in the NIR region of the spectrum, where absorption 
by natural tissue chromophores is diminished, and light can penetrate 
deeper into the tissue. It has to be also underlined that photodamage, 
associated with high laser power5, is confined in the case of 2PLSM into 
the immediate vicinity of the focal plane, being minimal along the 
excitation path, unlike in conventional linear optical methods. A difficulty 
in using 2PLSM in combination with phosphorescence quenching is that 
the phosphors for biological oxygen measurements are typically based 
on metal porphyrins complexes6, whose 2PA cross-sections are very low, 
in the range of a few GM units (Goeppert-Mayer = 10-50 cm4 s photon-
1molecule-1). While in principle phosphorescence of metalloporphyrins 
can be induced via 2P excitation7, for practical applications 2PA cross-
sections of biological probes must be considerably higher. Prof. S. 
Vinogradov from University of Pennsylvania developed an efficient 
system based on a dendrimer able to overcome this problem8,9. 
However, these branched moieties present a major drawback that is 
their demanding synthesis often associated with low yields. Therefore, this 
research field could undergo a great burst reaching the same results but 
with material is requiring relatively simple preparation steps with high 
yields. In the work described in this chapter I report my results in this 
direction. 
 
3.1 Molecular Oxygen: a tool for diagnosys and therapy 
Molecular oxygen O2, is at the bases of many natural processes10. 
The properties and behavior of oxygen reflect its unique electronic 
structure. Oddly, oxygen’s electronic ground state, O2(X3Σg-), presents a 
triplet spin multiplicity11 while its two lowest exited electronic states, 
O2(a1Δg) O2(b1Σg+), are singlet states (Fig 3.1) . 
Even though the higher energy b1Σg+ state doesn’t react with other 
molecules12,13, at least in solution-phase systems, the a1Δg state, 
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commonly called “singlet oxygen”, has a rich chemistry that differs 
significantly from that of the X3Σg- state 14.  
Singlet oxygen stays at the forefront for biological research because its 
unique reactivity as a synthetic agent15, as an intermediate in 
oxygenation reactions of polymers16 and, perhaps most significantly, 
forming the so called “reactive oxygen species”, ROS, useful in a range 
of biologically pertinent systems17. Singlet oxygen can be produced in a 
variety of ways18, a convenient method involves electronic energy 
transfer from an excited state of a molecule called sensitizer to O2(X3Σg-
), Fig 3.1. Very interestingly, light is not only a useful tool by which singlet 
oxygen can be produced, but it is also at the basis of convenient 
methods to monitor events that result in the sensitized formation of singlet 
oxygen.  
Variations in sensitizer emission are, for example, a very useful method to 
understand oxygen singlet production or quenching, especially in 
inhomogeneous systems like biological ones. 
Even though Singlet oxygen can be produced upon O2(X3Σg-) quenching 
of the S1 state18, the lowest energy T1 state is generally the most efficient 
singlet oxygen precursor for molecules used as sensitizers and its 
photophysical characteristics (quantum yield, lifetime, energy) are the 
Figure 3.1 Jablonski Diagram illustrating the one- and two-photon-initiated, triplet-state 
photosensitized production of singlet oxygen 
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fundamental features to take into account to design a diagnostic or 
therapeutic tool. 
As already mentioned, a powerful, non-invasive, and selective 
technique useful in the treatment of cancer, and proposed in the last 
decades also for anti-bacterial applications, is PDT, that in contrast to 
chemotherapy, presents minor side-effects. The application of PDT in 
oncology involve a PS which opportunely excited by suitable 
wavelength by the light, induces a cytotoxic event respect to the tumour 
tissue. The first step involves an administration of an inert PS to the patient. 
When the light with a suitable wavelength is irradiated (often using laser 
sources), the irradiated tissue containing PS is rapidly destroyed. A 
suitable PS should have many characteristic: well-known composition 
with high purity level, selectivity to tumoral cell which could be also 
inducted with the PS functionalization, high yield in cytotoxic species 
formation, no toxicity in the dark, high efficiency in triplet state formation 
followed by long lifetimes in that state and high absorption in the red 
and NIR spectrum zone, which represent the therapeutic window most 
suitable  for the penetration of the tissue (see Introduction). Following the 
triplet state formation, PS must show as prevalent way of deactivation 
the formation of the triplet state. In that condition the molecule could 
interact with the oxygen and forms the cytotoxic species by energy 
transfer. Activated PSs then, can induce chemical changes in a 
neighboring molecule via two competing pathways type 1 and type 2 
19. Type 1 involves the formation of radical superoxide anion, not so 
reactive, but able to react with itself to form hydrogen peroxide, which 
can easily cross the cell membrane. High concentrations of hydrogen 
peroxide could also bring to very reactive hydroxyl radical, formed by 
Haber Weiss reaction20. Type 2 reaction instead, is a direct energy 
transfer to molecular oxygen from the PS, forming singlet oxigen21. Both 
types can occur but generally, type 2 represents the dominant process22. 
 
3.2 Luminescent silica nanoparticles as chemosensors 
 
Silica-based nanostructures represent an extremely versatile and 
effective platform for the organization of different units23,24 in order to 
obtain diagnostic and/or theranostic tools via a relatively simple 
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preparation and with high yields. Silica is an innocent matrix from a 
photophysical point of view, and this allows to obtain luminescent 
materials simply doping the nanostructure. The photophysical properties 
of the resulting architectures completely depend upon the included dye 
and they are mostly determined by two factors: (i) the effect of the 
nanoenvironment on the behavior of each molecular component25–28 
and (ii) the strength of the intercomponent interactions.23,27,29  Several 
examples have been reported in the literature that show how 
luminescent quantum yields and photostability of light emitting 
molecular species can be improved simply by including them in silica 
matrix, for example, in the core of a silica nanoparticle (NPs)30. 
Segregation of the fluorophores strongly reduces their interaction with 
the solvent as well as their excited-state conformational mobility and 
their accessibility to the atmospheric oxygen27. The mixture of these 
factors in most cases inhibits nonradiative decay processes and prevents 
photoreactions that could cause the irreversible degradation of the 
dyes. On the other hand, the inclusion could protect some type of 
molecules from oxygen quenching, often NIR emitting species, 
enhancing their emission quantum yield (see section 1.1.2). In addition, 
even if the doping species are water insoluble, the water solubility of 
silica NPs allows their vehiculation in this solvent. Besides, a very important 
point is that the doping molecules are segregated in a very small volume 
and this forces their vicinity. Therefore, the properties of these 
multichromophoric nano-objects depend, as in the case of rigorously 
supramolecular systems,23 on the kind and on the strength of the 
interactions among the molecular units, either at the ground or at the 
excited state.31 In the simplest case, that is, in absence of any kind of 
intramolecular interaction, the photophysical features of each NP are 
simply the combination of those of the trapped molecules. Even this 
trivial effect has important applicative implication: the presence of 
many absorbing moieties in a single NP proportionally increases the 
probability that at least one of them is excited upon irradiation. The 
molar absorption coefficient of heavily doped NPs is hence often 
extraordinarily higher than the one of molecular species. This feature, 
combined with its high fluorescence quantum yields, bestows, on a 
single NP, a much higher brightness than the one typical of molecular 
dyes.  
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Silica NPs are hence, for their high brightness, low intrinsic toxicity of their 
composition, and optical transparency, ideal for application in fields of 
high impact such as medical diagnostics and imaging both in vitro and 
in vivo32–34.  
A further step toward more sophisticated nanosystems with the aim to 
use them as chemosensors or as theranostic agents requires synthesis 
able to include many big and hydrophobic molecules in the silica matrix 
that is usually prepared in water based solvent mixtures.  
However, this is worth an effort since there are many advantages in 
passing from conventional molecular emitters to complex 
architectures. In this framework, luminescent silica nanoparticles are 
one of the most interesting and promising systems to be exploited in 
many fields like energy production and storage, catalysis, and sensing 
for medical or environmental applications. To obtain sensitive 
luminescent chemosensors, many requirements must be satisfied. In 
particular the material should be (photo)chemically stable, should 
present photophysical properties that do not depend on the 
environment or on a specific analyte; for marketing in general it should 
be obtained with an easy synthesis and low cost starting materials, and 
for their use in the medical field they should be biocompatible, nontoxic 
and environmental friendly as far as their disposal is concerned. 
In more detail luminescent silica nanoparticles have all the crucial 
features listed hereafter. 
• Silica is photophysically inert, i.e. it is transparent to visible 
light and is not involved in energy- and electron-transfer 
processes. All the photochemical properties of the 
luminescent silica nanoparticles are mainly conferred by the 
doping material and, when present, by the capping agents. 
• Silica does not present intrinsic toxicity, and for this reason 
silica NPs are environmentally friendly and can be suitable 
for in vivo applications because they do not undergo 
microbial attack. 
• Silica nanoparticles can contain many photochemically 
active species. Thanks to these large amounts of dyes 
incorporated in a small volume, obtaining a particle with 
brighter luminescence is easy35 since its extinction 
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coefficient is equal to the sum of those of the single 
chromophores. 
• The silica matrix protects the active material segregated 
inside the nanoparticle from external chemicals. 
Permeability for large species, in fact, is forbidden inside the 
nanoparticle, while small ones can penetrate with a much-
reduced diffusion coefficient. This feature decreases the 
possibility of undesired photoreactions (the excited state of 
the dye cannot undergo bimolecular reactions), thus 
increasing the photostability of the fluorophores inside the 
nanoparticle, in the same time allows to use them as sensors 
for small molecules like oxygen. 
• The versatility of the synthesis allows one to design 
luminescent nanoparticles with chemical properties 
suitable for the desired applications, including in vivo ones. 
Surface modification with well-known chemical 
procedures36 allows the optimization of their already good 
compatibility with water, and with the biological 
microenvironment (cellular membranes, biomolecules, 
etc.). It is also possible a simple tuning of the diameter 
through the control of the synthetic parameters. A fine 
control of size and functionalization often has a synergic 
action to obtain long-life systems in which the nanoparticle 
heads off by RES (Reticulo-Endothelial System) is delayed. 
RES is a mechanism by which alien particles are removed 
from blood or lymph by macrophages in vertebrate 
organisms. The great versatility of the synthetic strategies 
opens also up the possibility to adapt these materials for very 
different applications without requiring each time the 
design of the synthesis from scratch.  
These five points make clear how luminescent silica nanoparticles are 
suitable to be used to engineer efficient fluorescent chemosensors, 
due both to their intrinsic properties and to their versatility. Anyway, 
again, all the photophysical properties of luminescent silica 
nanoparticles are conferred by the doping species, and therefore the 
photophysical properties of the dyes are the first determining point of 
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the performance of these systems in sensing and imaging fields.  
Then, using sol–gel processes37, by tuning parameters such as catalytic 
conditions and nanoparticle nucleation-growth confinement, a lot of 
types of silica nanoparticles in solution can be obtained. All these 
synthetic strategies, however, usually involve TEOS like silica precursor 
and characteristics such as simplicity, low cost, versatility and control 
over nanoparticle dimensions. The main synthetic approaches are the 
Stoeber–Van Blaaderen method and others involving hydrolysis and 
condensation confinement, known as reverse microemulsions (water-
in-oil) 3839 and direct micelle assisted methods (Fig. 2).40. Each synthetic 
approach has advantages and limitations that are transferred to the 
resulting nanostructures, designed to suit precise applications. It is 
recommended the use of trialkoxysilane derivatized dyes4142 which 
prevent the leaching of dye from the particles, especially in biological 
applications, where the release of hydrophobic dyes, even if not 
observed in pure water, could be promoted by the proteins and a 
lipophilic cellular microenvironment. The number of molecular dyes that 
can be used for doping of NPs is usually quite high depending on the 
synthetic strategy adopted. Limitations are mainly related to solubility in 
the reaction batch and to the synthetic accessibility of the 
trialkoxysilane derivatives. Another important point is the electrostatic 
interaction among dyes and the silica matrix which generally favors the 
inclusion of positively charged dye and hampers negatively charged 
species. In the case of diagnostic applications, the combination of 
several factors such as the brightness of the system, spatial control over 
 
49 
 
3 
nanoparticle functionalization and the colloidal stability of the NP 
suspension determines the suitability of the synthetic method.  
In this part of my thesis I have particularly focused my attention on the 
possibility to overcome the limitations related to solubility of the doping 
species in the reaction batch. Fig. 3.2 schematizes the most common 
chemical preparations of silica nanoparticles, but I will describe in detail 
only the direct micelle assisted methods that is the one that I have 
followed for the preparation of the materials described in this chapter. 
 
3.2.1 Stöber method 
 
The study of Kolbe, successively developed by Stöber43, to obtain 
colloidal silica was later implemented by Van Blaaderen to obtain 
fluorescent NPs, thanks to the incorporation of trialkoxysilane modified 
dyes44. This method is far from dated, thanks to an accessible dimensional 
range spanning from 10 to several hundreds of nanometers with one-pot 
procedures, very simple synthetic mixtures (TEOS, water and ammonia), 
mild conditions, bringing to very monodisperse NPs. In this strategy, 
ammonia promotes TEOS hydrolysis and NP formation in water using 
ethanol as the TEOS co-solvent. Controlling the concentrations and ratio 
between the components its possible set the dimension of the NPs. 
Covalent doping of the NPs is achieved by using alkoxysilane derivatized 
dyes, with some limitations due to their solubility in ethanol–water mixtures. 
Figure 3.2 Schematic representation of Stöber method A, Reverse microemulsion method 
B and Micellar assisted method C. 
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Briefly, the Stöber method involves a first hydrolysis step proceeding 
through a bimolecular nucleophilic substitution (Sn2) on the silicon atom, 
characterized by a negatively charged, pentacoordinate transition 
state.4546 The nucleophile involved in this step is OH⁻, therefore an increase 
in the concentration of NH3 and/or H2O leads to an increase in the reaction 
rate. Moreover, since the hydrolysis decreases the electron density on the 
silicon atom – OH is more electron-withdrawing than OEt – the negative 
charge of the transition state is more stabilized for each subsequent step; for 
this reason, the rate-determining step for monomers is the hydrolysis of the first 
ethoxy group. The condensation step is very similar to hydrolysis: it 
proceeds through a Sn2 type nucleophilic substitution at the silicon atom, 
which results in a negatively charged, pentacoordinate transition state; 
the nucleophile is a deprotonated silanol group, so the reaction rate is still 
influenced by the concentration of NH3 and/or H2O; and it decreases the 
electron density on the silicon atom – OSi is more electron withdrawing 
than OH. 
The preparation of the first dye doped silica nanoparticles was possible 
thanks to van Blaaderen’s idea of modifying the structure of fluorophores, 
by coupling APTES with fluorescein isothiocyanate and rhodamine B 
isothiocyanate.42 The resulting triethoxysilane derivatized molecules are 
then able to co-condense with TEOS during the nanoparticle growth, 
yielding systems in which the organic dyes are covalently grafted to the 
silica matrix. This is a fundamental improvement, because, apart from 
minimizing leaching issues, allows to reach very high doping levels. 
In the Stöber-derived strategies, the presence of deprotonated Si–OH 
groups on the surface of the NPs usually generates colloidal suspensions 
that are strongly stabilized by electrostatic repulsion and are 
characterized by very large negative z-potential values. 
Functionalization of NPs exploits the presence of the Si–OH groups and is 
usually carried out in solution, adding alkoxysilane components tailored 
for different applications. This second step is quite delicate since it often 
induces aggregation or leads to incomplete surface passivation. 
Purification steps are necessary to separate uncondensed dyes, 
oligomers and condensation catalysts, and to change suspending 
media when necessary. These strategies may include precipitation–
centrifugation, ultrafiltration (UF), size exclusion chromatography (SEC), 
dialysis or instrumental techniques such as Flow Field Flow Fractionation 
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(FIFFF)47. These last three purification methods involve very mild 
conditions and consequently stand out for the prevention of NP 
aggregation. 
 
3.2.2 Reverse microemulsion method 
Reverse micelles are formed mixing an appropriate amount of a 
surfactant and a hydrocarbon. They are capable of housing a limited 
amount of water forming a macroscopically isotropic reverse 
microemulsion (water-in-oil), with water cores that can be exploited as 
nano-containers to confine the Stöber synthetic process. Several 
protocols have been proposed to give simple way to access to 
nanoparticle preparation and surface modification in the dimensional 
range of circa 15–200 nm39,48 with the dimension depending largely 
upon the surfactant type and the surfactant-to-water molar ratio.49 The 
most used method was developed by Arriagada and Osseo-Asare,49 
and later improved by Tan and co-workers50. This process is based on the 
same described in the previous section; except that the medium where 
hydrolysis and condensation of TEOS take place, is the core of a reverse 
microemulsion. Surfactants are amphiphilic long-chain organic 
compounds, miscible both in hydrocarbons and in water, characterized 
by two fundamental parameters: the critical micelle concentration 
(CmC) and the critical micelle temperature (Cmt). Above these threshold 
values, when they are dissolved in a hydrocarbon solution, they create a 
macroscopically isotropic dispersion, the orientation of the surfactant 
molecules is not random: they forms spherical aggregates, where the 
hydrophilic heads are aligned toward the center, while the hydrophobic 
tails extend into the bulk oil phase. If water is added to this system, it 
places itself at the center of these aggregates: these stabilized water 
droplets then act as small nanoreactors, where the hydrolysis and 
condensation of TEOS is confined, yielding highly monodisperse, 
spherical particles with diameters ranging from 20 to 100 nm.  
The main drawback of the reverse microemulsion approach is that these 
work-up procedures usually involve concentration–dispersion steps that 
can lead to irreversible aggregation. 
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3.2.3 Direct micelle assisted methods 
This approach is based on the use of a surfactant in a water solution 
where the micellar aggregates (or co-aggregates) act as hydrophobic 
templates, where the formation of the nanoparticle structure takes 
place.  
On the wave of ORMOSIL51, and inspired by the work of Liu and co-
workers who have  described a new kind of core–shell (silica-PEG) 
nanoparticles as platform for drug-delivery, Prodi et al. have 
proposed52 a synthetic strategy that affords monodispersed and 
ordered core–shell silica nanoparticles. Such systems allow the inclusion 
of dye molecules in the silica core and present a stable, biocompatible 
and water soluble polymeric protective shell. For these reasons these 
materials appear particularly promising in the development of 
luminescent probes for in vitro and, hopefully, in vivo medical and bio-
analytical applications. The synthetic strategy is based on the 
formation of direct micelles of Pluronic® F127 in water. PF127® is a non-
ionic triblock copolymer surfactant terminating in primary hydroxyl 
groups and presenting a PEG-PPO-PEG structure (MW 12600 Da) that is 
non-toxic. These surfactants have a general molecular formula of 
PEOx–PPOy–PEOx, with coefficients x and y determining their overall 
polarity and aggregation behavior in water. In particular, the high 
molecular weight PF127 surfactant is the most used in the fabrication 
of silica NPs due to the capability of its aggregates (or co-
aggregates) to act as templates in the formation of the NPs. 
The subsequent addition of TEOS in acidic (or even neutral) 
conditions leads to the formation of a silica core following the same 
steps mentioned in the Stöber approach, due to the fact that, 
especially before hydrolysis, alkoxysilane are rather apolar species and 
tend to migrate and accumulate in the central part of the polymeric 
micelles, the more hydrophobic area where the silicate condensation is 
promoted. This induces the formation of the silica nanoparticles only 
inside the micelles, as the condensation proceeds, leading to the 
entrapment of the surfactant’s molecules and to the final silica core-
PEG shell architecture, that I will call from here after PlusNPs. (Fig. 2). 
To control and avoid the inclusion in the matrix of the whole PEG 
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segments, or the aggregation through inter-particles polymerization, 
the introduction in the mixture of a capping agent in due time like 
DEDMS or TMSCl is needed, to stop the silica condensation. 
The addition of the trialkoxysilane derivatized dyes in the reaction 
mixture leads to their co-condensation with TEOS, resulting in robust and 
stablle luminescent systems. Thus, this method allows the physical or 
covalent entrapment of dozens of molecules into a small silica core, 
providing very bright nanosystems. The silanization of the dye and its 
purification after coupling reaction, represent the most difficult and 
long step in the NPs synthesis but we have found, as described in 
paragraph 3.6, an efficient way overcome this issue. 
Another great potentiality of this material is the possibility to insert 
targeting moieties on their surface, including biological relevant 
species that would account for bio-recognition and bio-specificity, 
opening the way to several possibilities in biomedical and analytical 
applications. Modifying the terminal moieties of PF127  its possible to 
obtain nanoparticles that, as prepared, exhibit functional groups on the 
surface, such as –COOH, –NH2, –SH, –N3, alkynes, that can subsequently 
undergo different chemical reactions to link the particle to a variety of 
targeting moieties. 
These core–shell nanoparticles are extremely soluble and stable (up to 
years) in water (or phosphate buffered saline solutions, PBS) in which 
they maintain an outstanding monodispersity. The strength of this 
strategy is mainly being a one-pot method, in which very cheap and 
basically non-toxic components are used even if the synthesis pertains 
to functionalized nanoparticles. Moreover, the PEG shell boosts the 
performances of the colloidal system envisaging in vivo and in vitro bio-
analytical applications. The PEG shell provides a stabilizing stealth 
layer53,54 and these colloidal systems retain their stability and mono-
dispersion in simulated physiological or bio-analytical work-up 
conditions (PBS 1x, bovine serum albumin up to 10 wt%). 
Another feature is the ability to host in the outer PEG shell water 
insoluble materials such as dyes55 or chemosensors. In perspective these 
systems seem to be good candidates for the development in an easy 
and rapid fashion of chemosensors presenting valuable features like 
signal amplification due to light harvesting properties. 
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 PluSNPs were characterized using several experimental techniques, 
such as TEM and DLS (Dynamic Light Scattering)47, AFM measurements40. 
The dH obtained by DLS is around 25 nm and from TEM is possible estimate 
the interal diameter of the silica core around 11 nm (Fig 3.3). 
 
1H-NMR and TGA (Thermo Gravimetric Analysis) were also use for the 
characterization and they, respectively, showed the outward 
orientation of the PEG chains and an invariant mass ratio between the 
organic and inorganic parts of samples subjected to ultrafiltration 
treatments of different durations (membrane cut-off 100 kDa). 
 
3.4 Oxygen chemosensors based on silica nanoparticles 
The design of silica nanomaterials starts from the choice of the 
synthetic procedure that has to take into account the solubility of the 
doping and functional moieties needed in the final nanoobject.  The 
research group I worked with, had already demonstrated, for example, 
that following the Stöber preparation, non-polar dyes spontaneously 
accumulate in the center of a nanoparticle, especially at high doping 
concentration regimes, leading to intermolecular interactions, possibly 
resulting in emission self-quenching and favoring energy or electron 
transfer processes52. 
 PLuSNPs 
dHa(nm)+SD 23.7+3.5 
PDI 0.07 
aZ-Average. Exp. section  
6 7 8 9 10 11 12
Figure 3.3 TEM image of standard PluSNPs (scale bas 100 nm) and it DLS measurements in 
table 
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More recently, the research of the group has been focused on silica 
core/PEG shell nanoparticles obtained through the direct micelle-
assisted template synthesis described above, leading to a range of 
luminescent materials47,52 for applications in in vitro56 and in vivo57,58 
optical and photoacoustic59 imaging, as chemosensors60 or as 
electrochemiluminescent probes61. 
In order to design and prepare new oxygen chemosensors based on this 
preparation the main problem, as already mentioned, is solubility, in fact, 
phosphorescent Pt and Pd porphyrins are the election doping 
candidates for optical sensing of oxygen in biological systems62. 
However, porphyrins are known to be difficult-to-solubilize targets, often 
exhibiting great propensity toward π-stacking and aggregation. On the 
other hand, porphyrins and their metal complexes form a group of 
versatile dyes with exceptionally rich optical and electrochemical 
properties, which present interest for applications in many areas of 
technology and medicine, from catalysis to biomedical imaging and 
phototherapy  In order to ensure aqueous solubility, tune the sensitivity 
of the phosphorescence into the optimal range for biological oxygen 
detection and simultaneously make porphyrin signals selective for 
oxygen in complex biological environments, porphyrins need to be 
incorporated into a protective shell with inert hydrophilic periphery. In 
this context, Prof. S. Vinogradov63 presented an efficient set of Pt or Pd 
porphyrin-dendrimers with PEGylated periphery (PEG = 
polyethyleneglycol) that allow quantitative oxygen measurements in 
vivo. 
 
3.4.1 Porphyrins and organic phosphorescent molecules 
As mentioned before, good PSs should work in the range where 
human tissue are transparent, the photophysical properties of porphyrins 
and their high synthetic versatility have made them attractive and 
tunable candidates. Although synthetic routes toward porphyrins lead 
to relatively low yields, their starting materials are typically inexpensive, 
and their synthesis is generally straightforward. The synthesis typically 
requires reaction of pyrrole with the aldehyde of choice to give the 
appropriate substitution at the meso-positions followed by 
chromatographic purification to obtain the final product64. The 
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absorption spectra of porphyrins is very typical and two regions can be 
distinguished: a) the first involves the transition from the ground state to 
the second excited state (S0 → S2), the corresponding band is called the 
Soret or B band and the range of absorption is 380-500 nm depending 
on whether the porphyrin is - or meso-substituted; b) the second region 
is due to a weak transition to the first excited state (S0 → S1) in the range 
between 500-750 nm (the Q bands. The Soret band is characterized by 
very high molar extinction coefficients of the order of magnitude of 105 
M-1 cm-1, while for the weaker, but still considerably intense, Q bands it is 
of 104 M-1 cm-1. The lower energy Q-bands are the transition of interest 
for the absorption of light in the tissue transparency window. In addition, 
porphyrins have been associated with high affinity for tumour sites and 
efficient formation of ROS65. Specifically, cationic porphyrins are widely 
studied for their water solubility and their strong electrostatic interactions 
with negatively charged phosphate oxygen atoms of the DNA 
backbone66. This section will focus on the study of 5 different 
metallophorphyrins synthesized by prof S. Vinogradov group all with 
phosphorescence emission around 700-850 nm that is quenched by 
oxygen and suitable for in in vitro/in vivo tests. 
It is much more difficult to find all-organic molecules suitable for this kind 
of applications, in fact, organic molecules exhibiting phosphorescence 
at ambient temperatures are rare. Emission from triplet states is usually a 
prerogative of metal complexes, in which the presence of metal ions 
enhances spin-orbit coupling and accelerates spin-forbidden transitions. 
In the case of all-organic molecules, phosphorescence is usually 
observed only in rigid matrices at low temperatures (e.g. 77 K). In liquid 
air-equilibrated solutions non-radiative relaxation and/or quenching by 
molecular oxygen completely outcompete very slow emission from the 
triplet states of all-organic chromophores, while much faster 
phosphorescence of metal complexes may still be observable even on 
air. 
In these last years, there has been a burst of interest in non-
phosphorescent fully organic molecules in fluid solutions, but can regain 
emissivity upon rigidification9,67–69. Reducing the mobility of a 
chromophore by restricting bond rotations, has become one of the most 
popular strategies to boost triplet emissivity. All-organic phosphorescent 
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chromophores are subsequently envisioned as luminescent probes, 
sensors, elements of displays and other components of functional 
devices. However, the requirement of a rigid environment significantly 
limits usability of all-organic phosphors. Moreover, for biological 
applications, transferring organic dyes into aqueous environments either 
directly in the crystalline form or by embedding into solid polymeric 
particles presents multiple problems, such as inadequate colloidal 
stability of the latter and/or their high polydispersity. 
Therefore, a biocompatible, easy to synthesize matrix able to constrain 
molecules and to favor aggregation-induced phosphorescence (AIP) 
processes would be a perfect solution for the design and preparation of 
a new generation of oxygen organic chemosensors.  We have worked 
on this topic exploring the potentialities of silica nanoparticles to act as 
a suitable matrix and we have obtained very promising results discussed 
in section. 
 
3.5 Aim of the work 
 
The first goal of this part of the thesis was the development of a 
new optimized synthetic strategy, based on the one already patented 
by L. Prodi et al., in order to introduce inside the silica core of PluSNPs a 
high number of dyes, even in case of big and conjugated water 
insoluble species. The screening of many organic solvents in different 
percentages will help to reach the goal that is fundamental for the 
further steps towards the final aim that is the design and preparation of 
water soluble, stable, biocompatible and efficient molecular oxygen 
chemosensors for biomedical applications. We will take advantage of 
two classes of compounds, precisely metal porphyrins and all-organic 
phosphors, able to interact with O2 and signal its presence in a 
quantitative way via light emission quenching.  
An efficient preparation method will allow the introduction of all-organic 
phosphorescent molecules, called asterisk and synthetized by prof. 
Ceroni group, in the PluSNPs to obtain the first water soluble oxygen 
chemosensor based on all-organic emitters. 
Parallel, 5 different metalloporphyrins synthesized by prof. Vinogradov’s 
goup will be used as doping agents for PluSNPs that then will be tested 
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for the same pupose. The porphyrins structures are reported in Fig 3.11 
and include both platinum and palladium complexes.  
The final ambitious step is to optimize the most promising structures for in 
vivo applications in order to preliminary investigate them in collaboration 
with Prof. B. Weber of the  University of Zurich and his group that has the 
suitable instrumentation to monitor oxygen dynamics in mouse brain via 
two-photon phosphorescence lifetime microscopy (2PLM). The key 
imaging parameters in vivo are speed and depth to obtain a fast 
response to the oxygen changes, while deep imaging is critical because 
both the most metabolically active and most stroke-prone regions are 
often located deep in the cortex36 and even in the white matter. The 
design and optimization of our nanostructured chemosensor will be 
specifically studied to meet these severe requirements. 
 
3.6 Results and discussion  
 
3.6.1 Optimization of PluS NPs synthesis 
 
L.Prodi et al. Patented in 201170 a simple, reproducible and 
cheap method to synthetize SiNPs using a micelle assisted method, This 
protocol make use of the A–B–A triblock copolymer surfactant Pluronic® 
F127, TEOS as silica precursor and  acetic acid 1M as reaction medium. 
Usually the luminescent doping material is composed by triethoxysilane 
functionalized dyes. The versatility of this approach is huge, since it 
provides a one-pot strategy to obtain extremely monodisperse NPs with 
a core–shell silica–PEG structure (hard diameter = 10–12 nm; 
hydrodynamic diameter = 20–30 nm). In the preparation of luminescent 
materials, this strategy shows solubility restrictions regarding the doping 
dye(s), especially in the case of non-polar dyes characterized by an 
extended planar structure. In particular in the preparation of PluS NPs 
doped with alkoxysilane functionalized porphyrins, and with dyes having 
an extended aromatic structure, the solubility restrictions bring to poor 
doping levels and/or to the formation of dye aggregates within the 
nanoparticle core.  In the case of doping dyes like porphyrins, a 
nanoparticles synthetic protocol able to avoid the purification of the dye 
after functionalization with the triethoxysilane moieties is desirable, since 
these molecules can’t be purified by standard purification techniques 
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like precipitation and flash chromatography.  
The standard procedure for the synthesis of PluS NPs70 involves the use of 
PF127, NaCl and alkoxysilanized dye dissolved in acetic acid 1M;  TEOS 
is used as silica precursor. Hydrolysis and condensation of TEOS is 
performed at 30°C for 3h, and after this time is performed the addition 
of an endcapping agent like TMSCl to saturate the uncondensed Si-OH 
groups present on the silica core. PluS NPs purification can be performed 
by dialysis, ultrafiltration or size exclusion chromatography 71. Previous 
work showed the possibility to estimate the concentration of 
nanoparticles obtained by this synthetic protocol47.  
In the perspective to reduce the solubility limitations showed by few kinds 
of doping dye during the Pluronic F127 micellar assisted nanoparticle 
synthesis, we investigate the possibility to perform this synthetic protocol 
with organic solvent-water mixtures. The first screening of the synthetic 
conditions was done evaluating the hydrodynamic properties of Pluronic 
F127 aggregates in the presence of increasing concentrations of 
selected organic solvents. The screening was performed considering a 
set of non-nucleophilic, completely water-soluble solvents (DMF, DMSO, 
2-butanone, acetonitrile). This last characteristic is necessary to form a 
homogeneous water mixture during the nanoparticle synthesis, while an 
inert solvent is useful to perform the in-situ functionalization of the doping 
agent (dye(s), ligand(s), etc.) with trialkoxysilane moieties. We 
considered the PF127 concentration usually employed in the 1 M acetic 
acid synthetic protocol (5.1 mM), and the hydrodynamic behavior of 
PF127 aggregates in solution in the presence of increasing amounts of 
an organic solvent was evaluated by DLS measurements.  
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Table 3.1   
a V/V% concentration (the total volume for each solution was 1550 μL). b Average hydrodynamic diameter distribution by intensity. c 
Average hydrodynamic diameter distribution by volume. d Derived scattering intensity measured by the detector. e Data not available 
because of emulsion formation 
Solvent 
Solvent. 
V/Va (%) 
dH ± SDb 
(nm) 
PdI dHc  (nm) DCRd (kcps) 
Acetic acid 1 M 0 18.4 ± 0.4 0.63 6.4 ± 0.2 276 ± 4 
2-Butanone 1.3 37 ± 13 0.42 6.6 ± 0.2 225 ± 6 
 5.2 20 ± 2 0.64 6.6 ± 0.1 215 ± 6 
 12.9 24 ± 6 0.57 6.8 ± 0.1 228 ± 3 
 38.7 —e —e —e —e 
Acetonitrile 1.3 23 ± 0.1 0.80 6.4 ± 0.1 318 ± 14 
 5.2 21 ± 3 0.63 6.7 ± 0.1 276 ± 25 
 12.9 19 ± 4 0.43 6.5 ± 0.2 244 ± 33 
 38.7 21.4 ± 0.1 0.15 17.8 ± 0.2 970 ± 14 
DMSO 1.3 19 ± 1 0.65 6.0 ± 0.1 280 ± 10 
 3.2 22 ± 2 0.41 9.0 ± 0.3 287 ± 10 
 16.1 26 ± 3 0.56 7.1 ± 0.3 315 ± 20 
 38.7 19 ± 1 0.49 6.6 ± 0.1 310 ± 10 
DMF 1.3 19 ± 5 0.44 6.5 ± 0.2 250 ± 30 
 5.2 42 ± 17 0.42 7.0 ± 1 370 ± 70 
 12.9 24 ± 14 0.42 7 ± 2 230 ± 30 
 38.7 16 ± 3 0.43 7 ± 1 240 ± 60 
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Quite surprisingly, these DLS investigations (Table 3.1) showed that 
with the only exception of 2-butanone, Pluronic F127 aggregates 
maintain hydrodynamic characteristics quite similar to the 
aggregates formed in acetic acid 1M in water, up to ∼40% V/V 
concentration of organic solvent. These experiments showed that 
the presence of organic solvents had only minor effects on the 
average hydrodynamic diameters of the Pluronic F127 
aggregates, and also that in most cases, the  scattering intensity 
(DCR, Table 3.1) produced by surfactant aggregates in organic 
solvent/water mixture was comparable to the one measured in 
acetic acid 1M. This last evidence was an indication that the 
number of Pluronic F127 aggregates and then the number of 
templates available for the NPs formation was rather constant 
increasing the amount of organic solvent in reaction medium. 
These results were used to evaluate the formation of PluS NPs 
with these new solvent conditions. The first experiments were 
focused on the synthesis of non-doped silica nanoparticles using 
TEOS as silica precursor. DLS measurements were performed on 
PluS NPs purified by dialysis. Table 3.2 provides an overview of 
these very good results and shows that most of the solvent 
mixtures were suitable to host the formation of PluS NPs. The only 
exception is represented by  the more concentrated acetonitrile 
mixture that did not lead to the formation of a colloidal system 
due to the formation of a precipitate. The NP suspensions 
obtained in these conditions have a relatively low monodispersion 
(PdI = 0.2) in the entire concentration range we tested for each 
solvent. In particular, the 2-butanone and acetonitrile systems 
cause the formation of nanoparticles with average 
hydrodynamic diameters slightly higher than the ones usually 
obtained in 1 M acetic acid. Probably because of their much 
higher polarity, DMSO and DMF cause the formation of 
nanoparticles with average hydrodynamic diameters that are 
more similar to the ones obtained in the standard acetic acid 
conditions. 
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Table 3.2  
a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V/V% concentration (the total volume for each solution was 3100 μL). bAverage hydrodynamic diameter distribution by intensity. c Average 
hydrodynamic diameter distribution by volume. d Data not available because of precipitation. 
 
 
Solvent Solvent V/Va (%) dH ± SDb (nm) PdI dH c± SD (nm) 
Acetic acid 1 M 0 21.2 ± 0.1 0.13 20.3 ± 0.2 
2-Butanone 1.3 30 ± 1 0.13 23.2 ± 0.3 
 5.2 36.3 ± 0.4 0.11 30 ± 1 
 12.9 26.8 ± 0.4 0.15 23 ± 2 
Acetonitrile 1.3 35.4 ± 0.2 0.25 34 ± 2 
 5.2 31.3 ± 0.1 0.22 30 ± 1 
 
12.9 
38.7 
30.6 ± 0.4 
—d 
0.22 
—d 
29 ± 2 
—d 
DMSO 1.3 36 ± 1 0.21 20 ± 1 
 3.2 17.2 ± 0.3 0.21 15 ± 1 
 5.2 26.6 ± 0.3 0.22 21.7 ± 0.4 
 12.9 21.6 ± 0.2 0.22 20 ± 2 
 16.1 24.0 ± 0.4 0.11 21.0 ± 0.3 
 38.7 24 ± 1 0.21 22 ± 1 
DMF 1.3 20.7 ± 0.3 0.18 19 ± 1 
 5.2 26 ± 1 0.36 22 ± 1 
 12.9 22 ± 2 0.22 20 ± 2 
 38.7 21 ± 1 0.18 19 ± 2 
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3.6.2 AIP induced by NPs: Asterisk@NPs 
 
3.6.2.1 AIP process 
 
Aggregation-induced emission is a phenomenon where a 
chromophore is not emissive in solution but highly emissive in the solid 
state or embedded in a rigid matrix. If the chromophore is 
phosphorescent in the aggregate state, the AIE phenomenon is called 
AIP. For AIE dyes diluted in solution, the excited state energy is dissipated 
through intramolecular motions to reduce drastically the emission, while 
in the aggregate or solid state, the intramolecular motions are restricted. 
Thus, the non-radiative deactivation pathways are reduced, so that 
emission is turned on. Although in many examples the contribution of 
intramolecular rotations has been highlighted in explaining their optical 
properties, other motions, such as vibrations (including bending, twisting, 
scissoring, etc.) should also be considered as they all consume the 
excited-state energy72. AIP is slightly different from the general AIE 
operating mechanisms, because not only restriction of intramolecular 
motions, which include intramolecular rotations and intramolecular 
vibrations are valid, but also quenching of the triplet state by dioxygen 
needs to be considered.  The formation of aggregated structures limits 
the diffusion of dioxygen, thus suppressing this quenching pathway and 
increasing the phosphorescence quantum yield. This mechanism is 
common to all phosphorescent compounds, particularly for 
chromophores exhibiting long-lived phosphorescent excited states. 
There are several examples of AIP chromophores and we could divide 
them in metal complexes and organic compounds; in this thesis it will be 
shown the AIP of organic molecules. One of the strongest AIP 
chromophore in the solid state is hexakis(p-tolylthio)benzene with a 
quantum yield near 1.073, a small benzene-cored organic molecule 
containing six thioether linkages (asterisk). This compound is not emissive 
in solution but is highly phosphorescent in a solid state or in a rigid matrix 
at 77 K. 
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3.6.3 Asterisk@NPs: Synthesis and photophysical characterization  
 
Before the use of the new developed synthetic method of 
PluSNPs, the asterisk molecule (Fig 3.4), was synthetized after several 
synthetic steps, and photochemically characterized by M. Villa PhD from 
P.Ceroni group. The molecule presents a 
λMaxEM as powder at 556 nm with a lifetime 
value of 9.4 µs and an emission quantum 
yield of 10%. To link covalently the molecule 
inside the silica core of the NPs, the 
molecule was modified using a coupling 
reaction with APTES ((3-
Aminopropyl)triethoxysilane) involving 
CDMT (6-Chloro-2,4-dimethoxy-s-triazine) 
and NMM (N-methyl-morpholine) as coupling reagents in DMF 
(see experimental section for the details). The ethoxysilane 
functionalized asterisk was precipitated with Et2O and was 
characterized by IR spectroscopy (see experimental section). In 
the IR spectra the C=O stretching frequency change (1682.61 for blue 
line, 1634.92 for red line) indicated that the carboxylic acid moieties 
were efficiently converted into amide, since also the acid -OH stretching 
disappeared, confirming the complete transformation of the carboxylic 
acid groups (Fig 3.5)(Complete IR spectrum in the experimental section). 
 
wavenumber (cm
-1
)
14001500160017001800
T
ra
s
m
it
ta
n
c
e
 
0.80
0.82
0.84
0.86
0.88
0.90
0.92
0.94
0.96 ast-COOH 
ast-Si
ast-COO- 
N-H st
C=O st
Si-Asterisk
COOH-asterisk
C=O st
Figure 3.4 Asterisk molecule 
Figure 3.5 FTIR analysis on Silanized asterisk powder (red line), asterisk (blue line), 
deprotonated Asterisk (black line) 
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The ethoxysilane derivative of the asterisk was directly introduced inside 
the PF127 micelles using the modified method previously described, with 
the maximum possible amount of DMF with the silanization (38.7% v/v) 
reaction to obtain the silica NPs doped with the molecular asterisk 
Asterisk@NPs presenting different doping levels (0,1%. 0.3%, 0.5%, 1%) of 
the dye respect to the TEOS mol.  
The Asterisk@NPs were purified by several days of dialysis versus water, 
obtaining monodisperse PluS NPs.  
All doping levels NPs are been morphological characterized by TEM 
and DLS showed well PDI values in a range of 0.08-0.13 and a dH range 
from 21-25 nm (Fig 3.7). TEM is reported only for 1% Asterisk@NPs sample 
because representative of all 4 NPs samples (all silica cores diameters 
dimension were reconducted by images extrapolation using ImageJ 
software between 9 and 11 nm). 
  
 
dH+SD 
(nm)  PDI 
0.1% 21+1 0.22 
0.3% 21.6+0.2 0.18 
0.5%a 23.7+0.4 0.22 
1% 22+2 0.39 
Figure 3.7 TEM image of Final Asterisk@NPs 1% scale bar 100nm, DLS analysis reported by 
volume. 
Figure 3.6 Photographs of asterisk@NPs suspension characterized by different doping levels 
of PhP (left to right: 0,1%. 0.3%, 0.5%, 1%).  (left) 
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These NPs were characterized in water by UV-Vis 
spectrophotometric analysis. The suspension of NPs in water at the 
end of the purification have a concentration of 20 µM47,74. The 
molar absorption coefficient has been determinated by dilution 
of the stock solution and the number of dyes per NP was 
calculated by the ratio of the molar absorption coefficient of the 
Asterisk@NPs divided by the molar absorption coefficient of 
Asterisk molecule (Fig 3.8). 
Figure 3.8 Absorption spectra and normalized emission spectra of Asterisk@NPs with 0.3% 
(yellow), 0.5% (green) and 1% (red) loading and deprotonated form of Asterisk (black) in 
water 
 
As reported in the published paper75, the Asterisk@NPs samples show 
absorption spectra that are very similar to the model compound 
Asterisk. The spectra show a band at 280 nm typical for molecules with 
phenyl groups as substituents. Also, the emission spectra are identical 
meaning that the different loading of the NPs doesn't affect the 
electronic state of the molecular asterisks. The average number of dyes 
embedded in the nanoparticle and that main photophysical properties 
for these samples is summarized in table 4. The phosphorescence lifetime 
of the NPs samples is very similar (14.5-14.8 µs) and the quantum yields 
are the same (7%) in air-equilibrated solutions. Since all the 
photophysical parameter are identical except the molar absorption 
coefficient, the 0.5% and 1% loading are the most interesting samples, 
obviously for the high number of dye/NP.  
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Table 3.3 Photophysical properties in air-equilibrated aqueous solution (unless otherwise 
noted) 
 
λMax 
EM/nm 
Dyes/NPs τ /μs Фem 
Asterisk@NPS 0.3% 538 19 14.5 7% 
Asterisk@NPS 0.5% 540 23 14.8 7% 
Asterisk@NPS 1% 536 38 14.7 7% 
Asterisk@NPS 1% DEGAS 536 38 38.8 17% 
 Asterisk in solution- -  - - 
Asterisk as a powdera 556  9.4 10% 
 
PluS NPs samples characterized by higher doping (1.5% and 2%), 
were affected by poor colloidal stability and they precipitated 
during the synthesis or after few days after dialysis. Since the 
highest value of doping was 1%, and this sample was very stable 
(more than 1 year), Asterisk@NPs 1% has been considered the 
most interesting system as potential oxygen sensor. The method 
used was the freeze pump technique; it has been removed 
oxygen from a sealed solution of Asterisk@NPs 1% and an increase 
of the phosphorescence occur, the quantum yield increases from 
7% to 17% as well as the lifetime that increase from 14.7 to 37.4 µs 
(data not showed). Then the solution is left in air-equilibrated 
condition and emission spectra are recorded every 5 minutes to 
observe the decreasing of the emission that return to the initial 
value. 
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Figure 3.9 Emission spectra recorded every 30 minutes of Asterisk@NPs 1% when oxygen 
return to atmospheric pressure (air-equilibrated). 
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The system Asterisk@NPs as oxygen sensor, was studied by prof. S. 
Vinogradov and his group at the University of Pennsylvania 
(USA)Measurements were performed at two different 
temperatures: 22°C and 36.6°C (Fig. 3.10). The lifetime of the 
loaded NPs is recorded at different oxygen concentrations and 
the lifetime decreases increasing the oxygen concentration 
based on the Stern-Volmer equation: 
 
τ0
τ
= 1 + kqτ0[O2] 
 
The Kq calculated at 22°C is 2x107 M-1s-1 and at 36.6°C is 1x107 M-
1s-1. These two values are lower than the diffusion limit 1x1010 M-1s-1 
meaning that the diffusion of oxygen to the dye through the PEG 
shell and into the silica NPs is slowed down. With this system a 
correlation of the lifetime of Asterisk@NPs and the oxygen 
concentration is possible and the system could have an 
application in bioimaging. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The group of Prof. Vinogradov investigated also the two-photon 
absorption (2PA) (see experimental section) properties of the 
system Asterisk@NPs . The idea is to use these NPs as dye for the 
two-photon excitation microscopy and map the oxygen 
Figure 3.10 Oxygen titration by PhP -NPs 0.5% in aqueous solution 
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concentration in a tissue by changes in the lifetime. On system 
Asterisk@NPs 0.5% two photon absorption is recorded by 
luminescence intensity measurements741 and the σ(2) was 
calculated. The NPs show a high cross-section of 1000 GM 
(Goppert-Mayer,10-50moleculecm4sphoton-1) per nanoparticle at 
700nm. The estimated value per dye is ca. 40GMat 700 nm. The 
system Asterisk@NPs is phosphorescent in air-equilibrated 
condition and could be used as oxygen sensor in the two-photon 
excitation microscopy. The oxygen concentration could be 
correlated to the lifetime of Asterisk (data not showed).  
 
3.6.3 Oxygen chemosensors: Phorphyrins@NPs 
 
The optimization of the synthesis of PluS-NPs in organic 
solvent/acetic acid mixture, pave the way for the development 
of new oxygen chemosensors based on Plus NPs doped with 
phosphorescent dyes characterized by poor solubility in 
water/surfactant mixtures such as porphyrins. These dyes are 
good candidates for the development of oxygen chemosensors 
for biomedical applications, because of their photophysical 
properties, and were extensively studied by the group of S. 
Vinigradov (UPenn, US) for the development of porphyrin-core 
PEGylated dendrimers. Among the solvent that were tested in the 
synthetic optimization described in paragraph 3.5.2., DMSO and 
DMF are probably the more interesting and versatile solvents to 
use. DMF in particular, have very high solubilization capability, and 
it is very often the solvent of choice to carry coupling reactions 
with carboxylated porphyrins. This kind of reaction is also needed 
to convert porphyrins bearing carboxylic groups to their 
alkoxysilane derivatives. For example, the coupling of 
carboxylated porphyrin with APTES, can be efficiently achieved 
using CDMT and NMM as coupling reagents (see experimental 
section). The possibility to prepare a porphyrin alkoxysilane 
derivative in situ in DMF, and to use it in the optimized PluS NPs 
synthesis is an extremely valuable feature, since the purification of 
alkoxysilane derivatized porphyrin is feasible only with tedious size 
exclusion or reverse fase chromatographic methods. To test this 
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approach in collaboration with prof. S. Vinogradov,  
I tested four different porphyrins to obtain the corresponding doped 
PluS NPs chemosensor. 
 
 
Figure 3.11 PdTCCP PtOCTP, PdOCTBP, and PtOCTBP phorphyrins 
P1 (PdTCCP), P2 (PtOCTP), P3 (PdOCTBP), and P4 (PtOCTBP) were 
coupled to APTES following a recipe involving CDMT/NMM as 
coupling agent (Fig 3.12). The loading limit for these dyes inside the 
core of the PluS NPs was evaluated using the porphyrin 1, since it is 
commercially available. The optimization of the NPs doping and of 
their brightness is important since too many dyes in each NP bring to 
self-quenching processes, that can decrease the average 
phosphorescent lifetime of the system and hence its dynamic range 
toward the detection of oxygen. 
 
Figure 3.12 Coupling reaction of 1 for silanization 
The doping of the NPs was investigated using a 0.1%, 0.5% and 1% in 
mol respect to the mol of TEOS. The hydrodynamic properties of the 
samples measured by DLS were good for the less doped samples, 
while in the higher doping regime precipitation of the nanoparticles 
occurred during the synthesis or just after dialysis purification. The 
morphological characterization performed by DLS analysis and by 
TEM microscopy (Fig. 3.13) showed uniform hydrodynamic diameters 
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and for the silica core diameters distributions. The doping degree of 
0.5% was choose for the construction of the other chemosensors.  
 
This is due to the fact that from DLS measurements, it has been noted 
the presence of aggregates around 200 nm(data not showed) and 
the number of the dye/NPs were similar found similar( measured as 
the ratio of the molar absorption coefficient of the Dye@NPs 
divided by the molar absorption coefficient of Dye. Table 3.5).  The 
other 3 porphyrins were also silanized using the same synthetic 
protocol, adapting the number of APTES equivalents to the number 
of porphyrin carboxylic groups. The NPs synthesis were conducted 
using DMF (38.7 % v/v)/acetic acid 1M, adding the dye directly in 
surfactant solution. In Fig 3.13 is reported only the TEM image for the 
sample 2, because the similarity with the other 3 sample (11.2+0,2 
nm).  
From TEM analysis it was confirmed the good monodispersity and the 
size of the silica core is in line with the already mentioned dimension 
obtained for general PluSNPs. In table 3.4 are reported the data of 
the dH for all doped NPs. 
 
50 nm 
Figure 3.13 TEM and DLS analysis of 2@NPs 
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Table 3.4 DLS measurements for all doped NPs 
 
 
 
 
 
 
 
 
Once again, the DLS measurements are aligned with the classical dH 
dimension expected for this type of NPs. The morphological 
characterization confirmed that the porphyrins dyes don’t influence the 
synthesis. Then, it has been conducted the entire photophysical 
characterization in Fig. 3.14 are reported normalized absorption and 
emission spectra of NPs in water (filled spectra) and of respective 
porphyrins (dotted line) in THF solutions. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
adH+SD 
(nm) 
PDI 
TEM 
(core d) 
P1 21.7+6.1 0.14 12.1+0.4 
P2 19.8+6.2 0.35 11.8+0.3 
P3 26.9+7.1 0.36 11.2+0.2 
P4 24.1+5.4 0.24 9.9+0.1 
aAverage hydrodynamic diameter distribution by volume  
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From the normalized absorption and emission spectra it is possible 
estimate how the behavior of the porphyrins free in solution is well 
maintained when they are bound inside the core of the NPs, infact the 
shape of the peak in every cases is very similar only a little bit enlarged 
in absorption for the NPs, due to their scattering in solution. Furthermore, 
despite the large number of dyes entrapped covalently inside the silica 
core (Tab 3.5), the absorption spectra of the NPs are very 
superimposable with the respective spectra of the dye free in solution.  
A comparison between the phosphorescent properties of the porphyrin 
doped PluSNPs in aerated and deareated conditions was made 
comparing air equilibrated PluS NPs samples or nanoparticles suspension 
deareated by the freeze pump technique. The quantum yield of the PluS 
NPs samples has been measured and compared to the quantum yield 
of the corresponding carboxylated porphyrin in solution in deareated 
and aerated conditions (Tab 3.5). 
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Table 3.5 Photophysical characterization of the 1@NPs 2@NPs 3@NPs 4@NPs and of the 1 2 3 4 complexes free in solution of THF 
  
 P1 P1@NPs P2 P2@Nps P3 P3@NPs P4 P4@NPs 
Λabs (nm) 
Ɛ1 (104 cm-1M-1) 
415 
39 
406 
2 90 
401 
24 
401 
4 70 
438 
12 
439 
1 90 
429 
12 
429 
230 
Λabs (nm) 
Ɛ2 (104 cm-1M-1) 
526 
3,5 
526 
375 
511 
19,5 
511 
52,5 
625 
4,6 
629 
75 
615 
7,9 
619 
1 05 
Iphosp (nm) 688 703 654 664 805 810 773 778 
N° Dye -- 11 -- 27 -- 17 -- 14 
ΦEM  DEGAS 2.3% 0.7% 1.8% 1% 1.3% 0.2% 2.4% 1.6% 
ΦEM   0.1% 0.3% 0.2% 0.5% 0.06% 0.15% 0.16% 0.4% 
Τ DEGAS (ms) 0.310 0.091 0.026 0.053 0.193 0.153 0.046 0.040 
Τ (ms) - 0.030 0.001 0.002 0.008 0.063 0.010 0.017 
B degas (Ɛ1)  8 970 20 300 4 320 47 000 1 560 38 000 2 880 36 800 
B (Ɛ2)  3 90 8 700 480 23 500 72 2 850 192 920 
aBrightness (B) defins as ε۰Ф76 
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In general, the shape and position of the absorption and of the 
fluorescence bands of the dyes in the NPs are very similar (as shown in 
Fig 3.14 and table 5)  to the ones of the free luminophores in THF solution 
(as could be expected for a transition mostly π−π* in nature) presenting 
only very small red shifts,  evidencing once again that the behavior of 
the dyes don’t change once internalized inside the silica core. Each NP 
entraps several dyes (in a range from 11 to 27), and this confers a very 
high absorption coefficient and overall brightness to these materials. 
Comparing the emission quantum yields of the deareted solution of the 
dyes dissolved in THF respect their behavior inside NPs in water solution, 
it is clear how the results were very interesting. Indeed, as shown better 
in Fig 3.15 below, it is obvious how porphyrins inside NPs maintains their 
increasing in phosphorescence in deareated solutions (full cilinders) and 
are quenched in emission when the oxygen was equilibrated again in 
solutions. It was not granted, because the dyes could have different 
response to the oxygen due to their position inside the silica core.  
 
The emission quantum yield for the NPs were in general low than the 
respective dye free in THF solution (see table 3.5), but this fact could 
depend from the structure of the NPs: infact, firstly the shell, then the silica 
core, could make more difficult the diffusion of the oxygen inside the NP. 
This hypothesis is confirmed also from the behavior of the oxygenated 
φ
EM
 
Figure 3.15 Chart of comparison between Dye free in solution aerated and deaerate, 
respect Dye@NPs deareated/aerated. 
0
0.5
1
1.5
2
2.5
O2 O2
Dye 
THF 
NPs 
H2O 
1
2
3
4
0
0.5
1
1.5
2
O2O2
` 
77 
 
3 
solutions. Undeniably, most important effect to evaluate is the 
differences between aerated solutions: the fluorophores free in solution 
are completely quenched by the presence of the oxygen, while when 
they are inside the silica core of the NPs, they present visible 
phosphorescence, even maintaining their increasing when 
depauperated from the O2. This is a powerful result for a chemosensor, 
because its possibility to be phosphorescence since the administration 
and increase it emission when in hypoxidic environment. 
These very promising preliminary results were finally used to produce a 
PluS NPs oxygen chemosensor containing a much more sophisticated 
metal porphyrin, developed by Prof. Vinogradov. Porphyrin core 
dendrimer containing this porphyrin (PtTAPIP, Fig. 3.17) were recently 
developed for in vivo imaging on mouse, using a two-photon laser 
scanning fluorescence microscopy technique (2PLSM)3 in collaboration 
with Prof. B. Weber at University of Zurich. The alkoxysiane derivative of 
PtTAPIP was obtained by amide coupling with APTES using CDMT/NMM, 
as already described. 
Figure 3.16 Comparison between NPs and corrispective phorphyrins in aerated condition 
Phorphyrins 
NPs 
0 0.1 0.2 0.3 0.4 0.5
1
2
3
4
O2 Complexes and NPs 
ΦEM 
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Figure 3.17 Schematic representation of PtTAPIP silanization synthesis  
The ethoxysilane derivative of PtTAPIP was directly used for the PluSNPs 
synthesis using a DMF/acetic acid 1M mixture (% v/v), with amount of 
dye corresponding to doping level of 0.1, 0.5. 1.0% mol. All the systems 
after synthesis and dialysis purification showed goof hydrodynamic 
characteristics (Fig. 3.18). 
  
Loading dH+SD PDI 
0.1% 21.6+5.5 0.131 
0.3% 19.4+5.5 0.294 
0.5% 19.6+6 0.174 
Figure 3.18 DLS values for 3 different NPs@PtTAPIP batches in different loading of dye 
respect TEOS mol (left). Visible monodispersion of NPs in all three synthesis 
` 
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From the photophysical point of view however, these samples showed a 
low enhancement in emission when in deareated condition, due to self-
quenching processes occurring within the nanoparticles. Infact the 
increasing in emission in deoxygenated solution respect to the 
oxygenated was worst respect to the all other 4 chemosensors studied 
(data non shown). In the Fig. 3.19 is reported a practical visualization of 
the ratio between ФEmDeareated/ФEmAreated PtTAPIP@NPs 0.5%, 0.3% 
and 0.1% and P4@NPs for comparison which shows the low response of 
that PtTAPIP@NPs systems respect the abovementioned 4 
chemosensors. This phenomenon is probably caused by the formation of 
porphyrin aggregates.  
   
Figure 3.19 Ratio between emission quantum yield deareated/aerated for PtTAPIP@NPs 
0,5%, 0,3% and 0.1% in loading respect TEOS mol (green bars)  
For this reason, a set of samples with lower doping levels were 
synthesized, in order to increase the emission properties of the systems. 
In these new samples the level of doping of the silanized PtTAPIP respect 
to the TEOS mol was decreased to 0.05% mol and 0.025% mol. The 
morphology was again characterized by TEM and DLS measurements 
giving good results in terms of monodispersity as shown in Fig 3.20. 
 
Table 3.6 DLS measurements of PtTAPIP@NPs 0.05% and 0.025% loaded 
 
 
 
Loading adH+SD PDI 
0.05% 25.7+4.1 0.09 
0.025% 24.8+5.2 0.10 
aAverage hydrodynamic diameter distribution by volume 
φ
E
M
 O
2
/ 
φ
E
M
 O
2
 
PtTAPIP@NPs 
0
1
2
3
4
5
0.50% 0.30% 0.10% 4@NPs
1.4
1.6
1.8
4.1
 
80 
 
3 
 
The conformational analysis confirmed by TEM the monodispersion and 
the core dimension around 11 nm, followed by a DLS data reporting dH 
around 25 nm for both different batches. 
The photophysical characterization was performed in the new 
PtTAPIP@NPs less doped and showed in Fig 3.21. 
 
 
 
The absorption spectra of the PtTAPIP@NPs for both loading levels show 
a little blue shift (<10nm) respect to the PtTAPIP free in THF and silanized, 
results in trend with the change of the solvent. The decreasing of loading 
percentage clearly has led to less aggregates, which caused a 
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Figure 3.20 TEM analysis of PtTAPIP@NPs left  0.05% and 0.025% loading right. Scale bar 
100nm 
Figure 3.21 LEFT: Absorption spectra of PtTAPIP@NPs o.o5% dark green, 0.025% light green; 
PtTAPIP free in THF solution gray line and in dotted black silanized PtTAPIP in DMF. RIGTH: 
Emission spectra of PtTAPIP@NPS aerated solution dotted line, PtTAPIP@NPS deareated 
solution solid line (light green 0.025% dark green 0.05% ).  The value of doping are in mole 
respect to the mol of the TEOS 
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brightness increase when they are in deoxygenated solution. Infact the 
ФEmDeareated/ФEmAreated values were increased to 2.0 for 
PtTAPIP@NPs 0.05% mol and to 2.4 for PtTAPIP@NPs 0.025% mol respect to 
the data reported in Fig 3.18.  
In collaboration with Prof. S. Vinogradov were performed oxygen 
tritations in the less doped sample, which presented best emission as 
shown in Fig 3.21 and good ФEmDeareated/ФEmAreated. All experiments 
were performed using a solution of NPs in phosphate buffer 20 mM 0.1 
μM, pH 7.1-7.2. A small volume of the stock solution of NPs was added to 
the buffer, equilibrated on air under gentle stirring, until the 
phosphorescence lifetime and the readings of the oxygen electrode 
became stable. Fig 3.22 reports the comparison among 3 different 
titrations on the sample 0.025%.  
Figure 3.22 Oxygen titration of PtTAPIP@NPs 0.025% in aqueous solution (left), fluctuations 
of lifetimes values measurements over the time. 
Fig 3.22 shows a reproducible behavior, but a quite limited dynamic 
range for the measurements, that is strongly influenced by the value of 
the pristine lifetime in oxygenated conditions. As it is possible to see from 
the Fig 3.22 right, the lifetime in physiological conditions has a drift 
around 2 μs which is considerable value for in vivo experiments. Even in 
the presence of this limitation, the probe was tested in vivo to compare 
it with the previous studies by Prof. S. Vinogradov group concerning the 
same porphyrin but as PEG-dendrimers77.  
 
3.6 Biological assays@Zurich University 
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Professor Vinogradov in collaboration with prof. B. Weber from 
the Neuroscience Center of the University of Zurich (Switzerland) have 
recently proposed a new fully PEGylated dendritic oxygen probe that 
enables oxygen microscopy in tissues. Quantitative imaging of oxygen 
distributions in tissue is fundamental to get information about metabolism 
in normal and diseased states. As proof of principle, they monitored 
oxygen dynamics for days in vivo after inducing micro-stroke by 
occlusion of a single capillary in a mouse brain. To this goal, they 
optimized a setup based on two-photon phosphorescence lifetime 
microscopy (2PLM) to perform measurements of oxygen in vivo with 
micronscale resolution in 3D. The results were extremely promising, 
however, the method’s potential to be fully realized needs a great step 
forward in the current phosphorescent probe technology. In fact, 
present phosphorescent probes are often non-biocompatible and/or 
require great synthetic efforts. 
It has been therefore investigated if the doped PluSNPs described in this 
chapter, and in particular PtTAPIP@NPs, could be a valid alternative as 
phosphorescent probes for the same application, being much more 
versatile platforms, relatively easy and cheap to prepare and 
biocompatible. I joined the Professor Weber’s group for a few days, and 
we performed some in vivo experiments following the same procedures 
already tested for the previous PEGylated dendritic oxygen probe 
prepared by professor Vinogradov. 
The key imaging parameters in vivo are speed and depth, since a fast 
response to the oxygen changes and deep imaging are critical78. 
Moreover, intravascular measurements are much less invasive than 
extravascular ones, since the probe can be injected far away from the 
measurement site (e.g., into the tail vein) and it distributes throughout 
the entire body. Generally, its concentration in the measurement 
medium (blood plasma) is uniform, facilitating accurate comparison of 
the signals acquired at different imaging depths. 
The first investigation that we performed aimed to determine if 
PtTAPIP@NPs injected into the tail vein would allow the signal monitoring 
in time, in mouse brain, without having to inject the probe directly into 
the imaged region. The most important feature to measure was the 
possibility to detect the signal in depth and until which depth. We did 
preliminary tests injecting PtTAPIP@NPs in a concentration of circa 10 M 
` 
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and only few minutes were needed to perform the measurements in vivo 
in the brain. Quite remarkably this first attempts were done using a very 
high particle concentration (the solution was almost dense), 
nevertheless it did not cause any evident negative conseguence to the 
mouse and it was urinary excreted very efficiently in circa 24 hours. A first 
(not exhaustive) investigation of the mouse health in the next days after 
injection indicates a benign nature of the probe, in line with all the 
experimental evidences collected until now on the non-toxic nature of 
PluS NPs56.  
The phosphorescence intensity decays measured e Cortical Surface at 
increasing depths (Fig. 3.23) show that the phosphorescence signal of 
this probe is detectable up to 400 m below the tissue surface. This value 
is lower in comparison with the 600 m of the PEGylated dendritic oxygen 
probe prepared by professor Vinogradov, but higher than the 300 m 
previously possible with other probes. It has to be underlined that this is 
really remarkably for a very first attempt with a non-optimized NP and 
protocol. These data are very encouraging for the development of 
these materials as very promising probes for in vivo oxygen detection. 
Unfortunately, as mentioned in the previous paragraph, the first 
formulation of the PtTAPIP@NPs presented a drift in the lifetime in 
physiological conditions of a non-negligible value for in vivo applications 
(circa 2 ms). Further quantitative investigation in vivo with this NP sample 
was prevented by this limitation. However, a parallel research effort has 
been devoted to the optimization of the synthetic steps of the 
PtTAPIP@NPs and very preliminary results show a good stability of the 
phosphorescent lifetime signal in the new particles with the modified 
formulation (data not show in this thesis) that will be tested in due course. 
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Figure3.23 phosphorescence decays changed with depth in the diving artery 
 
3.7 Conclusions and future steps 
 
The achievements described in this chapter are more than one 
starting from a new synthetic path that allows to prepare luminescent 
silica NPs in organic solvent–water mixtures by using a template-assisted 
method based on Pluronic F127 micelles. We found that Pluronic F127 
aggregates maintain their hydrodynamic properties in water mixtures 
containing a large amount (up to 40% v/v) of water-soluble organic 
solvents such as DMSO, DMF, acetonitrile or 2-butanone and, 
consequently, their capability to act as templates for the formation of 
silica NPs with uniform size, with a hydrodynamic diameter of 25–30 nm. 
We have demonstrated the feasibility of this approach for the 
fabrication of silica NPs doped with doping dyes presenting high 
hydophobicity and high propensity for aggregation. With this method, it 
is possible to perform functionalization of the dye with alkoxysilane 
groups in a strong solubilizing solvent such as DMF, and to directly use this 
reaction mixture in a one-pot procedure, avoiding the problematic step 
of purification and isolation of the luminescent silanized species. 
This important result has taken to the preparation of very promising 
nanostructured phosphorescent chemosensors for molecular oxygen via 
emission quenching, including sensing coupled to two-photon 
excitation. They are based on different active units but all of them 
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present appropriate features for oxygen sensing in the physiological pO2 
range. 
The first one described is based on persulfurated asterisks that are an 
example of all-organic chromophores with luminescence induced by 
environment rigidification. Inclusion of the asterisks into the core of PluS 
NPs provides a useful method for switching on their phosphorescence at 
room temperature and take the all-organic phosphorescent 
chromophores in water. This system may be an alternative to commonly 
used oxygen probes based on metal-containing chromophores. 
The second class of oxygen chemosensors that I have prepared and 
studied contains different metallo-porphyrin dyes. These NPs present 
properties that are compatible with oxygen sensing in biological 
environments, i.e., high colloidal stability, appropriate brightness, and 
efficient shielding from oxygen. They were tested in solution giving very 
promising results in terms of sensitivity and maintaining a residual 
luminescence that would allow their contemporary imaging. Very 
interestingly, a pilot test, in collaboration with Professor B. Weber from the 
Neuroscience Center of the University of Zurich, injecting into the tail vein 
PtTAPIP@NPs allowed the phosphorescent signal monitoring in time, in 
mouse brain, without having to inject the probe directly into the imaged 
region. A very high particle concentration solution was injected 
nevertheless it did not cause any evident negative consequence in the 
mouse and the NPs were urinary excreted very efficiently in circa 24 
hours, an evidence in favor of their benign nature. The phosphorescence 
intensity decays were measured at increasing depths and the signal was 
detectable up to 400 μm below the tissue surface. This value is higher 
than the 300 μm previously possible with other probes (with the only 
exception of the one recently prepared by professor Vinogradov and 
already presented in this chapter), a remarkable achievement for a very 
preliminary test using not yet optimized NPs and protocols. 
These data are very encouraging for the further development of these 
materials as probes for in vivo oxygen detection. 
 
Chapter based on results published in the papers J. Phys. Chem. C 2019, 123, 49, 29884-
29890 and Photochem. Photobiol. Sci., 2019,18, 2142-2149 
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CAP. 4 
ACTIVE MORPHOLOGICAL 
COLLOIDS FOR PROBING AND 
TAILORING INTRACELLULAR ANTIGEN 
PROCESSING 
 
Is the shape of synthetic microarchitecture important for the 
interactions with human cellular membranes? This is the question at the 
basis of my research project thta I carried out during my internship at the 
New York University under the supervision of Prof. S. Sacanna. The project 
in which is inserted the part that I have developed is based on the 
collaboration among three different groups, Prof, Geert Van Den 
Bogaart from Department of Tumor Immunology Radboud University 
Medical Center (Netherland), Prof. Shashi Thutupalli from Simons Centre 
for the study of living machines Tata Institute for Fundamental Research 
(India), Prof. Stefano Sacanna from department of chemistry University 
of New York (USA). The main aim of the project is to study the relationship 
among phagocytosis processes and the shape/morphology of complex 
architecture in the cells of the immune system.  Phagocytosis is the 
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process that occurs when the cell uptakes objects of an unconventional 
size and morphology.  The immune system needs to cope with a wide 
range of pathogens that can be different in terms of size, shape and 
mobilities. These pathogenic antigens are taken up by phagocytosing 
immune cells, including dendritic cells, for degradation by metabolic 
enzymes within the lumen of phagosomes. Dendritic cells can then 
activate antigen-specific killer and helper T cells, by presenting 
pathogen-derived peptide fragments in major histocompatibility 
complexes (MHC) to the T cells 1. The response of the immune system to 
artificial micrometres scaled objects is also very useful to the 
development the design and synthesis of efficient theranostic carriers2. 
Beside the drug/probe carrier suitability, the complex synthetic 
microarchitectures are also very useful to mimic the dynamic and the 
biochemistry of pathogens, such as bacteria, which usually are similarly 
sized.  
This project will demonstrate that the morphology of microarchitectured 
carriers, both for imaging, sensing or diagnostic, can play a key role for 
the cellular internalization and immune response. The main part of the 
research that I carried out at NYU has been focused on the design and 
preparation of complex monodisperse microarchitectures with 
magnetic and fluorescent features. The microarchitectures are then 
tested in biological assays. The project conveys four new concepts to 
the fields of phagocytosis, cell biology, biophysics, and immunology:  
1-Phagocytosis. A major technical innovation will be the generation of 
active colloids of non-trivial morphologies bearing antigenic proteins as 
phagocytic cargoes. These will be fuelled by H2O2 using light-activated 
hematite or platinum catalyst-based chemical engines3–8. H2O2 is 
produced in large amounts within the phagosomal lumen by the 
dendritic cells to kill ingested pathogens and to promote antigen 
preservation for MHC presentation9–15.  
2-Cell biology. Membrane regions of high curvature are recognized by 
many proteins and lipids involved in membrane fusion and fission or 
tethering of the cytoskeleton to membranes16,17. However, up to now, 
the cell biological mechanisms of antigen processing have almost 
exclusively been studied with spherical model particles. Irregularly-
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shapes and forces exerted by particles could induce membrane 
deformations and thereby affect phagosome maturation for the 
degradation of antigen.  
3-Biophysics. While it is widely recognized that metabolic activity drives 
transport of organelles within cells, the interplay between cellular 
crowding, activity and transport is poorly understood. We will create 
novel technological and conceptual tools to address the dynamics of 
phagosome transport in crowded intracellular environments, both in vivo 
and in vitro. High organellar and macromolecular crowding could lead 
to spontaneous flows, anomalous transport and directional orientation 
of anisotropic and morphologically diverse colloids18–20.  
4-Immunology. It is well-known, but not mechanistically understood, that 
pathogens can evade immune degradation by altering their shape by 
forming elongated hyphens21. Nevertheless, the influence of pathogen 
morphology on immune responses has been largely neglected, and by 
far most studies focus on pathogen-generated effector molecules/toxins 
that hijack host cell structure and function22. Also underappreciated is 
that pathogens can exert intra-phagosomal forces to circumvent 
immune clearance, as shown for Candida albicans which perforates the 
phagosomal membrane by forming hyphen23. Mimicking these 
processes by using H2O2 as a fuel or active irregularly shaped colloids is 
a novel approach, which will allow to answer a key open question in 
immunology: is the phagocyte able to discern whether the ingested 
pathogen is dead by sensing mechanical cues? This project will also 
enable particle design for triggering fast/strong or slow/weak immune 
responses, with potential applications in vaccination and drug delivery. 
The collaboration with the abovementioned three different groups, gives 
the possibility to investigate deeply the phagocytosis process with an 
interdisciplinary approach which combines three different moments: a 
first section is carried out by Prof. Sacanna group that will synthesize 
micrometer-sized colloids with distinct irregular morphologies and in this 
framework is also inserted the research work that I developed in his 
laboratories. These colloids will be equipped with platinum and light-
activated hematite catalyst based chemical engines that can propel 
the particles by converting H2O2 into oxygen. The H2O2 required for 
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fueling the active colloids is produced in large amounts (molar 
concentrations) for prolonged times (hours) after antigen uptake by 
dendritic cells (in contrast to macrophages and neutrophils)9–11. This H2O2 
normally serves to kill the ingested pathogens13 and to preserve 
antigenic peptides for T cell presentation9–11,14,15. Secondly, in vitro 
experiments conducted by Prof. S. Thutupalli will be used to quantify the 
mechanics of the active colloids in crowded environments. By studying 
the motion of the particles in well-defined densely packed suspensions, 
we will elucidate how colloid shapes and motilities affect migration in 
complex crowded cellular environments. By encapsulating colloids with 
a range of curvatures in artificial membranes, we will determine how 
forces and shapes affect the spatial organization of lipids and 
exogenously added proteins. These experiments will be combined with 
in vivo experiments by Prof. Van Den Boogart group with dendritic cells, 
aimed at identifying the locations of membrane fusion and fission on 
phagosomes bearing active irregularly shaped colloids and their 
transport within cells. The organization of the phagosomal membrane 
and cytoskeletal arrangements will be resolved by super-resolution 
microscopy. We will coat the particles with model antigenic proteins to 
determine how particle shape and motilities affect antigen 
degradation, activation of dendritic cells, and antigen presentation to T 
cells. 
4.0 State of the art 
Many synthetic strategies for the preparation of complex 
architectures have been developed by Prof. Stefano Sacanna and his 
research group to obtain and engineer active irregularly shaped colloids 
with a range of curvatures and symmetries, as phagocytic cargo 
mimicking pathogens. At the interface between chemistry, physics and 
material science, the Sacanna laboratory (SS Lab) has pioneered 
synthetic methods to create active colloidal building blocks and defined 
general self-assembly principles (Fig. 4.1A)8,24. By combining classic sol-
gel chemistry with a recently developed micro-emulsification 
methodology25, the SS lab can synthesize biocompatible colloidal 
particles with a wide range of morphologies. These particles will be 
further investigated in this project, coated with light-activated hematite 
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or platinum catalyst based chemical engines for H2O2-fuelled motility3–
8,26 and conjugated to fluorophores and/or model antigens. The particles 
can incorporate semiconductor or magnetic oxides (e.g., TiO2 or Fe2O3) 
to allow for external manipulation using magnetic and light fields. 
Several different particles were synthesized and tested with dendritic 
cells (Fig. 4.1A). These particles are composed of amorphous silica and 
organo-silica hybrids (e.g., 3-(trimethoxysilyl)propyl methacrylate), and 
between 2 and 8 μm in size. With the laboratory of Professor Geert Van 
Den Bogaart (GB laboratory), they were able to show that various 
particles are readily phagocytosed by blood-isolated dendritic cells and 
do not affect cell viability (Fig. 4.1B-D). Moreover, the SS laboratory 
already developed a protocol for the biotinylation of the colloids, which 
is non-trivial given that the biotin influences colloid formation. This 
biotinylation facilitates the conjugation of the colloids to antigen 
proteins and fluorophores by avidin-based interactions (Fig. 4.1E). 
 
Figure 4.1. Proof of concept: phagocytosis of irregularly shaped particles. A. Scanning 
electron microscopy image of irregurlarly-shaped colloids. Scale bar, 3 μm. B. Bright-field 
microscopy image of dendritic cells ingesting peanut-shaped particles from panel A (top-
left image). C. Fluorescence microscopy image of dendritic cell pulsed with the spider 
hexapod-shaped colloids from panel A (right image) with immunolabeling for actin 
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(magenta) and the early phagocytic marker SWAP70 (green). Cyan: DAPI. Scale bar, 5 
μm. D. Same as panel B, but now for latex beads (from ref27). E. Same as panel C, but now 
for hexapod shaped colloids with biotinylation. The spike protrusions were labelled with 
streptavidin-Alexa fluor 488 (Avidin) to increase their visibility. Scale bars, 5 μm. 
Although the first range of particles synthesized by Sacanna group are 
already very promising, there are still several modifications required for 
the prosecution of the research: 
1. coating of the differently shaped colloids with metal catalyst-
based chemical engines for H2O2-fuelled motility. 
2. increase the size range of the particles to approximately 10 μm; 
3. increase the density of the biotin coating. 
4. generate particles with a range of curvatures and symmetries. 
The Sacanna laboratory will work on the localized application of the 
metal catalyst-based chemical engines to the irregularly shaped colloids 
(aim 1). Platinum or hematite triggers the decomposition of H2O2 when 
suspended in an aqueous peroxide solution, and the oxygen formed 
leads to phoretic or bubble propulsion3–8,26, but this has never been 
applied to generate forces in living cells. Sacanna group will also 
attempt to synthesize larger particles (aim 2). The size range of the 
current particles (2-8 μm) is still somewhat too small for the microscopy 
planned in in vivo/in vitro tests. A larger size (more than 10 μm) is 
desirable for better resolving particle orientation within cells, 
heterogeneities of the phagosomal membrane, sites of membrane 
trafficking, and the arrangement of the cytoskeleton. Moreover, the 
density of biotin on the current particles is still relatively low and a higher 
density would facilitate addressing the rates of antigen degradation and 
presentation (aim 3). Finally, the SS Lab should generate more different 
shapes of colloids (aim 4). For instance, if it will be found that a certain 
curvature promotes tethering of phagosomes to the actin cytoskeleton, 
SS Lab will design particles with this curvature on one side allowing polar 
attachment of the cytoskeleton. In this part has been inserted the 
research work that I present in this chapter. 
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4.1 Aim of the work 
The goal of the entire project is to determine how the geometry and 
mechanics of phagocytic cargoes affect the cellular processes 
underlying phagosomal antigen degradation and presentation by 
dendritic cells. Together, the combination of colloid chemistry, in vitro 
and in vivo experiments will allow a full physic-
mechanical understanding of how particle 
morphologies and motilities affect 
phagosomal antigen degradation and 
presentation. The idea involves the use of a 
combination between inert and magnetic materials, in that specific 
case the use of SiO2 and hematite, in order to obtain active colloids able 
to mimic external pathogens and in the same time, able to respond to 
a specific external input. In particular, the aim of the part of the research 
that I developed at NYU during a six months period, will be to carry out 
the following 4 modifications: 
1. coating of the differently shaped colloids with metal catalyst-
based chemical engines for H2O2-fuelled motility. 
2. obtain particles in a size range of approximately 10 μm; 
3. get a high density of the biotin coating. 
4. generate particles with a range of different curvatures and 
symmetries. 
During this limited period, it will be also tried the first biological assays to 
verify the biotinylation and the cellular uptake by dendritic cells.   
4.2 Synthesis optimization and characterization 
In order to obtain some of the above-mentioned different types 
of colloidal material (aim 4), two different types of silica precursors have 
been used. The first one, TEOS, has been already discussed in chapter 3, 
but there is a need to quickly introduce 3-(Trimethoxysilyl)propyl 
methacrylate (TPM)  (Fig. 4.2) Despite all micellar assisted method seen 
until now, this type of architectures are based on the use of modified 
Stober method. Infact, the preparation of TPM spheres begins with the 
spontaneous formation of TPM emulsion droplets in water25. This 
Figure 4.2 TPM structure 
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phenomenon has been described previously for different alkoxysilanes 
in water under alkaline conditions. Since TPM can be polymerized at its 
methacrylate moiety, these emulsion droplets can also be used to 
fabricate solid colloidal particles, which has been used in the past to 
image Pickering emulsions25,28 as well as to make complex and 
anisotropic particles29–31. Since TPM will hydrolysed and subsequently self-
condense in water32, hydrolysis and self-condensation reactions are 
believed to be the driving forces for the formation of a TPM emulsion25,33. 
The rates of these processes highly increase with the pH of the solution32: 
the reported first-order rate constant for hydrolysis at pH 9 is 1.2 h, which 
means that 90% of the TPM monomers are already hydrolyzed after 2 h. 
Indeed, Sacanna et al.34 confirmed the release of methanol during TPM 
emulsion formation by 1HNMR, which indicates that the TPM is at least 
partially hydrolyzed in the emulsification process.  
4.2.1 Hematite cubes 
The fundamental part in the growth of anisotropic objects is the 
formation of very monodisperse structures that present precise angles. 
An example is constituted by the shaping of hematite (mixed iron oxides) 
cubes that has been carefully investigated including detailed reports on 
their physical behaviour.35 These mixed iron oxides-based 
microstructures not only are functional to act as magnetic cores for the 
precise growth of arms depending on their planar faces (Fig 4.329), but 
also for the development of monodisperse pathogen mimetics.  
 
In any case size distribution of these cubes has to be as narrower as 
possible since it can affect the formations of different silica arms and the 
photochemical-induced propulsion in solution. In general, the synthesis 
of these objects involves the use of condensed ferric hydroxide gel. 
Figure 4.3 TEM, SEM and rendering images of hematite cubes  
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Briefly, FeCl3·6H2O and NaOH were mixed in water thoroughly and aged 
inside the oven for days in a sealed Pyrex bottle. The final hematite cubes 
were isolated by repeated sedimentation and resuspension in deionized 
(DI) water. Tuning the incubation temperature and duration time is 
possible to obtain cubes different in size.  
The synthesis is very sensitive to humidity since the high hygroscopicity of 
FeCl3·6H2O and the highly reactive reagents involved, this is not trivial 
and needs to develop the correct operative skills. As shown in Fig. 4.4, I 
obtained the cubes after several initial trials, fixing temperature of the 
oven at 100°C and duration time of the incubation to 8 days. Thanks to 
the SEM imaging it has been possible to evaluate the degree of purity of 
the synthesis, and the dimension of the cubes. 
The cubes obtained have been used then as core building blocks both 
to obtain the hexapods as pathogen mimic (paragraph 4.2.2) and the 
swimmers (paragraph 4.2.3). 
It has to be underlined that the synthesis has been modified to tailor the 
size of cubes (from 500 nm to 1 μM), in order to investigate the most 
suitable dimension for our aims. 
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Figure 4.4 Optical microscope image (UP) and SEM image (BOTTOM) of hematite cubes 
dimension 1 μm 
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4.2.2 Silica Hexapods 
The focus of this work is the construction of anisotropic mimetic of 
pathogens as mentioned in 4.0 part. The main synthetic strategy shown 
in Fig 4.5 is to re-create a six arms colloids with magnetic core29 starting 
form hematite cubes, increasing their dimension until almost 10 uM in 
order to pursue the aim 2 of the project mentioned in the introduction. 
The water droplet formed on the surface of the seed particle acts as a 
confined microreactor for the formation of silica rods. To obtain multiple 
silica rods instead of a single silica rod, there is the need to control the 
number of droplets operated on hematite cubic seeds.  
Typically, for the water-pentanol emulsion, PVP polymers (10 wt %) are 
first dissolved in 1-pentanol, and then ethanol and studied amount of 
water are mixed, which yields a homogeneous solution. At this point 
Cubes were added in precise concentration since the water droplets 
and hematite cubes are comparable in size so they have to be in a 
controlled stoichiometry (for six arms hexapods each face of the cube 
has a single water droplet). Then, when additional water with sodium 
citrate in order to stabilize the emulsion, are mixed with the 
homogeneous solution, it becomes slightly opaque, which indicates that 
water-in-pentanol emulsion droplets were formed by phase separation. 
It was verified that the single emulsion droplet covered a cubic seed 
initially, but it could be divided into six small droplets due to the increase 
of interfacial tension when ammonia is introduced. After this step, the 
reaction mixture was kept in the oven for 5 minutes and TEOS was 
added. The reaction has been left to room temperature overnight.  
 
Figure 4.5 Rendering of the Synthesis of hexapods with magnetic hematite core 
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The first attempts, as showed a representative SEM images in Fig 4.6, 
showed how the recipe was good in terms of formation of six arms 
around hematite cubes but the synthetic pattern didn’t match with our 
purpose: monodispersity and big size. Infact too many silica big materials 
are present in solution after purification. 
 
The synthesis is very sensitive to a lot of parameters such as changing in 
temperature, reactor dimensions, stirring way, freshness of the reagents 
used, and obviously, operator skill. I worked on the previous recipe29 
working in all these parameters, keeping constant the adding order and 
the quantity reported on the previous work, in order to optimize the 
reproducibility of the synthesis. A final recipe has been found in the use 
of 8mL vial, strong hand shaking after every add, dramatic increasing of 
the temperature after the adding of NH3 putting the reactor in the oven 
for 5 min, faster adding of TEOS followed by gentle hand shaking, left to 
RT overnight. To improve in the monodispersity issue, I have decided to 
use bigger cubes despite as reported in the literature. This beacuse the 
main synthetic issues are related to the purification based on steps of 
centrifugation of the solution followed by using magnet close to the vial 
to catch and separate the magnetic objects from the silica growth 
randomly not attached to the ematite. The use of centrifuge at high rpm 
values for long time could led to the broken of the arms; this validate the 
Figure 4.6 representative SEM image of the first hexapods synthesis. Hematite Cubes 500 
nm 
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choice to use bigger hematite cubes since their major density followed 
by the stronger magnetism. So, to simplify the purification, and, to 
increase the size of the final hexapods microstructure, the synthesis has 
been carried out with cubes of 1 uM nm as seeds instead of 500 nm. The 
bigger hematite cubic seeds allowed to obtain clean hexapods 
structures. The recipe as developed gave amazing results in terms of 
monodispersity and reproducibility of the hexapods synthesis (Fig 4.7). 
 
Figure 4.7 Hexapods of circa 6 uM with hematite cubes core. 
At this point I worked only in the parameters directly involved in the 
formation of the arms. Infact I modulated the ratio between TEOS 
amount and water, looking for the possible relationship between them 
and the arm’s length. Since that the total concentration of cubes was 
fixed at 0.04% w/v inside the reaction batch, DI water was kept fixed at 
280uL and the quantity of TEOS was varied from 25% to 70% v/v respect 
to the amount of water. Varying the water amount could be risky, as 
expressed before, since the water amount can negatively affect the 
droplet formation around the cubes.  
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Figure 4.8 SEM images of 28%, 50%, 70% (from bottom to up) volume of TEOS respect to the 
water volume 
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As shown in Fig 4.8, the increasing in volume of TEOS is strictly correlated 
with the increase of the length of the arm, and it is possible to create a 
perfect ratio between amount of silica precursor and size of the 
hexapods from 4 to 11 uM. 
Given the excellent results, it has been tried to obtain hexapods with 
hollow cubes instead magnetic ones since their possible comparison on 
the future biological tests. The reaction to obtain hollow structures 
starting from hematite cube has been reported by L.Rossi et al29. Briefly 
mixture of absolute ethanol, water, tetramethylammonium hydroxide 
and PVP-stabilized hematite cubes was mechanically stirred and 
sonicated in a 2 L round bottom flask. The silica deposition was started 
by adding a mixture of TEOS and ethanol to the flask in repetitive 
portions. Next a solution of PVP in EtOH was added to the flask to prevent 
aggregation induced by dye molecules at the silica surface. Finally, the 
flask was sonicated for at least 2 more hours and stirred overnight. To 
remove unreacted molecules the dispersion was washed several times 
via centrifugation in ethanol. After centrifugal transfer of the silica 
coated particles to water, the hematite cores were dissolved by adding 
hydrochloric acid (37% wt) to a final concentration of 5 M. Once obtain 
hollow cubes, there is the possibility to proceed with the hexapods 
synthesis using them as seeds instead hematite cubes. The problems in 
the use of this way to obtain silica hollow hexapods are the already 
commented purification steps that would be useless. As matter of fact, 
the use of magnet will be worthless, and the centrifugation step doesn’t 
discriminate this low difference in density between hollow hexapods and 
silica material randomly create during the reaction. In order to 
overcome this problem and avoid all the difficult and long synthetic step 
to obtain silica hollow cubes, the idea was work directly in the already 
formatted hematite hexapods. The silica shouldn’t have problem in 
acidic condition necessary to dissolve hematite, hence it could be 
possible destroy the hematite putting the hematite hexapods directly in 
a concentrated HCl solution. For this reason, the etching has been 
carried out involving the use of a 9M solution of HCl, directly to the fresh 
formed hexapods with hematite core. As reported in the Fig 4.9, also 
from the changing in colour of the bulk of the solution is clear, the batch 
changed from red to white in 1h at 80°C.    
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In this way, it has been obtained hollow hexapods, avoiding the previous 
complicated steps of the hematite cubes coverage, and the impossible 
purification of the hexapods that it would have had to afford if they had 
used cubes of single silica as seeds, instead of magnetic cores.  
The following step will be performed in the hematite hexapods core in 
order to be fast in the purification step. Once well investigation on the 
synthetic pattern, it will be possible use the same procedures in the 
hollow silica hexapods. 
As mentioned in the introduction, part of this work involved also non-
trivial biotinylation step of the microstructures, which facilitates the 
conjugation of the colloids to antigen proteins and fluorophores by 
avidin-based interactions. However, It has been experimentally found 
that biotin tents to influence colloid formation. During the studies it has 
been also demonstrated that the synthesis of this type of material is very 
sensitive to every change of the precursor. It has been tried to 
investigate if it was possible to introduce a modified silane like APTES 
directly to the reaction mixture useful for the biconjugation. In this way it 
would have been possible to couple the arms of the hexapods with 
biotine. The resulted modification has led to a very irregular morphology 
of the hexapod. Indeed, as shown in Fig 4.10, the hexapods look 
deformed. It may also happen using very low amount of APTES respect 
to the TEOS (1% in mol). 
9M HCl 
Figure 4.9 SEM image of Silica hollow hexapods (left), Picture of the batches of red 
hematite core hexapods and silica hollow hexapods (right up), rendering of the 
schematization of the reaction. 
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Figure 4.10 Hexapods with 1% amount in mol of APTES respect to the TEOS  
To overcome this deformation, it has been decided to don’t modify the 
synthesis but in order to have bio-conjugable hexapods the reactive 
moiety has been introduced after the purification once the structure is 
perfectly formed. To verify the possibility of the modification of the arms, 
it has been introduced a fluorescent tag to the structure. It has then 
performed a labelling with RhodamineB-silane. The fluorescent labelling 
has occurred starting from clean hexapods in EtOH and silane 
rhodamine B previous synthesized using IST-Rhodamine B coupled with 
APTES. Thus, the fluorescent functionalization has been useful to 
demonstrate the possibility to carry on reaction on the hexapods without 
affecting their morphology. In Fig 4.11 are reported the optical 
microscope images of the labelled hexapods, which show that they 
maintain their morphology after the reaction, and their obtained 
fluorescence, indices of the successful of the reaction.  
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Once proved the suitability of functionalization of the formed hexapods, 
the biotinilation has been carried out with PEG-Biotine-Silane. Thanks to 
the peg linker it has been possible to obtain biotinylated 
microarchitectures since the uncondensed silica of the arms could 
hydrolyze with the silane of the PEG-biotine without perturbing the 
morphology of the silica arms. The formulated protocol starts simply 
diluiting 100 uL of concentrated clean hexapods in EtOH, then add 600 
uL Biotine-PEG-Silane 6 mg/mL and kept the solution under gently stirring 
overnight.  
Figure 4.11 Optical images under microscope of Hexapods bright field (left) and 
Rhodamine fluorescence (right) 
Figure 4.12 SEM image of Hexapod with hematite core after byotinilation 
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The Hexapods were then collected by magnet and SEM images in Fig 
4.12 showed how the biotinilization hasn’t affect at all the hexapods 
morphology.  
The presence of biotine on the hexapods surface has been proved 
staining them with a fluorescent streptavidine (AF488/647) in the group 
of Prof. Van der Bogaart.  In Fig 4.13 is reported the green fluorescence 
given by the complex biotine-streptavidin, and, furthermore, the blue 
emitting antigen Anti-streptavidin antibody complex with streptavidin, 
index of the perfect recognizing of the biotinylated hexapods. 
The emission localized at the extremities of the arms should due to the 
easier accessibility by the PEG-biotine-silane respect to the internal part 
of the exapods, and, moreover, because the tips could present not 
hydrolized silane which could better react with silane moiety of the PEG-
Biotine.  The hexapods functionalized with PEG biotine have been then 
tested in cellular internalization assay. The preliminary test with the 
monocyte-derived dendritic cells (moDC) showed in Fig 4.14, display the 
good internalization of the hexapods.  
 
 
 
 
Figure 4.13 In green biotinylated-Hexapods with streptavidin, in blue biotinylated-
Hexapods with streptavidin with anti-streptavidin antibody 
 
108 
 
4 
 
The hexapods are internalized within the phagosome by human 
monocyte-derived dendritic cells. It could be established that even 
particles with very unusual shapes can be taken up by dendritic cells. 
Further measurements have to be performed, but the first analysis show 
how the improvements in size is good for the biological characterization 
(aim 2). 
4.2.3 Swimmers based on TPM spheres and Hematite cubes 
I have been involved also in the design and preparation of active 
colloids able to move fuelled by hydrogen peroxide (swimmers) and 
activated by light. This structure can be used to understand the 
movements and trajectories when they would find themselves “under 
attack” of reactive oxygen species formed by dendritic cells during 
phagocytosis.  
In this paragraph it will be described the synthetic approach for the 
formation of swimmers as spherical particles of TPM including hematite 
cubes used as seeds. Usually the synthesis of hybrid architectures is quite 
complicated29 and I spent many efforts to optimize and simplify the 
preparation without compromising the swimming features and 
monodispersity.  
Figure 4.14 Phagocytosis by moDC. Red: F-Actin gray:DAPI,green/blue: Streptavidin and 
anti-streptavidin antibody. 
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The synthesis involves a water solution containing hematite cubes where 
0.1% of NH4OH is added together with increasing amounts of TPM. The 
process is a variation of the Stöber method, where droplets of oily TPM 
are hydrolysed in basic condition; the main difference from the 
reference method involving only silica (see chapter 3), is that there are 
hematite cubes embedded inside. 
Different reaction times from 40 min to 2 h were explored since the final 
dimension depends upon this parameter: the longer the time of reaction 
the bigger the size. The dimension of the resulting particles was checked 
with optical microscope. As shown in Fig 4.15, the particles result quite 
monodisperse. The particles have been used then to evaluate the effect 
of the addition of different amounts of HCl on the controlled dissolution 
of the TPM droplet. The study has been carried out to estimate the 
correct conditions to obtain the desired ejection of the cubes with 
respect to the spheres. In fact, we proved that exists a correlation 
between the ejection level and the concentration of the acid used: 
higher concentrations of acid lead to a bigger depletion, until the 
complete collapse of the sphere (at HCl 0.1M). After obtaining the 
controlled dissolution of the dimension of the “TPM head”, AIBN radical 
initiator is used to polymerize the methacrylate part of the TPM. The 
Swimmers have been kept in the oven at 100°C for 24 hours and 
collected by centrifugation and using a magnet to select only the ones 
containing the hematite tail. The SEM images reported in Fig. 4.16 have 
confirmed different level of the ejection of the cubes respect to the 
Figure 4.15 Optical microscope capture of cubes inside TPM spheres before acidic 
depletion left, rendering of depletion of the cubes increasing acidic conditions 
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sphere, for two different samples containing different amounts of acid 
(0-0,08 M) and therefore validating the synthetic approach. 
After the synthesis of the swimmers the experiments have been focused 
on the description of their motion in solution upon exposition of UV light. 
The formed swimmers were collected with centrifuge and put in a 
solution of H2O2 10% v/v in water and then recovered inside a glass 
capillary and settled in an optical microscope under blue UV-light. The 
swimmers follow initially the normal Brownian motion, but when blue light 
is turned on, the Fenton reaction 1 starts. Fenton reaction is reported 
below: 
  
 
 
 
 
This reaction takes to the formation of molecular oxygen on the surface 
of hematite cubes creating bubbles that act as a driving force for the 
swimmers ‘pushing’ them. The next step will be to study the trajectory of 
the swimmers, anyway, the new understanding obtained are steps 
forward in the rotor construction and fuelled synthetic micro colloids.  
 
 
Figure 4.16 Fully inserted cube inside TPM particles (left), complete ejected cube from TPM 
sphere (right) 
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4.3 Conclusions and future steps 
With the aim to understand phagosomal membranes, in 
particular how factors as pathogen morphologies, mechanical 
properties or intracellular motilities and forces affect phagosomal 
processing within immune cells, mimetic of external pathogens were 
developed using silica and magnetic hematite cubes. Moreover, to 
mimic pathogens with non-regular shapes I also prepared irregular 
shaped micoobjects like hexapods and circular ones. I succeeded in 
optimizing the synthesis of hexapods to obtain a procedure that allows 
the modulation of the arm’s length. I also developed a functional 
protocol for their easy biotinylation that allowed via the use of PEG-
biotine moieties the PEGylation of the hexapods to favour their cell 
internalization. Preliminary in vitro experiments were performed with the 
monocyte-derived dendritic cells (moDC) and they evidenced that this 
was a successful strategy, in fact, the hexapod uptake was confirmed 
proving that even particles with very unusual shapes and size can be cell 
internalized. Together with in vitro tests, the future steps would be the 
establishment of how particle shape and curvature affect the 
recruitment of intracellular markers guiding phagosomal membrane 
conversion. 
Parallelly, I also synthesized particles called ‘swimmers’ that are 
propelled by the formation of molecular oxygen bubbles during their 
reaction with hydrogen peroxide activated by light. These active 
colloids are formed by a tail constitute of a hematite cube and a 
spherical head obtained by the condensation of TPM. The optimization 
of the synthesis has taken to the formation of swimmers with tuneable 
dimensions and their motion under the activation of light was studied 
with an optical microscope. These structures can be used to understand 
the movements and trajectories that they would follow when “under 
attack” of reactive oxygen species formed by dendritic cells during 
phagocytosis. I was able to observe and record the change in motion 
of the swimmers from a normal Brownian motion, under the activation of 
the Fenton reaction by light and consequent bubbles formation that 
‘push’ them. The next step will be to study the trajectories of the 
swimmers. 
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CAP. 5 
 
BIORESORBABLE ELECTROSPUN 
NANOFIBER MAT RELEASING DIAGNOSTIC 
NANOTOOLS, FOR POST-SURGICAL 
IMPLANTATION 
 
5.0 State of the art 
The loss or failure of an organ or tissue is a frequent and 
devastating problem in health care, occurring in millions of patients 
every year. Organ or tissue damage is currently treated by 
transplantation from another donor individual or performing a surgical 
reconstruction by transferring tissue from another healthy area of the 
human body to the diseased one. Although these approaches have 
saved and improved the quality of millions of lives, they remain imperfect 
solutions and there is still a lot of room for improvement. In this framework, 
tissue engineering (TE) represents a new and promising pathway to help 
in the resolution of some of the problems associated to the traditional 
strategies currently adopted1. The field of tissue engineering has 
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noticeably increased over the last decade, offering nowadays the 
chance of new treatments for many disease states. This research area 
involves researchers in a multitude of disciplines, including cell biology, 
imaging, biomaterials science, chemistry and medicine.  The aim of 
tissue engineering is to restore, maintain, or improve tissue functions that 
are defective or have been lost by different pathological conditions, by 
either developing biological substitutes or reconstructing tissues2.  In 
addition to clinical applications, other uses include drug testing for 
efficacy and toxicology as well as basic studies on tissue development 
and morphogenesis3. However, in the most frequent paradigm of tissue 
engineering, isolated living cells are used to develop biological 
substitutes for the restoration or replacement of organ/tissue functions.  
The development of biomaterials for surgical implants has evolved 
through three stages, each of them with a distinctly different objective. 
The goal of the first generation of biomaterials was to achieve a proper 
combination of functional properties to match those of the replaced 
tissue without deleterious response by the host. They were intended to 
be bioinert, that is, to elicit minimal response from the host tissue. 
Consequently, a second generation of biomaterials was developed, 
whose goal was to be bioactive, that is, able to stimulate a nontrivial but 
desired – and therefore controlled-reaction with the tissue in which they 
were implanted.  This second generation of materials also included the 
development of biodegradable and bioresorbable materials. 
Nowadays, it has been developed a third generation of biomaterials, 
intended to be not only bioactive and resorbable, but also being able 
to stimulate specific cell response at molecular level, like cell proliferation 
and differentiation3. In this chapter the attention will be focused on the 
second generation, in the study of release matter from biodegradable 
mat. Both synthetic polymers and biologically derived (or natural) 
polymers have been extensively investigated as biodegradable 
polymeric biomaterials4, mainly because it is easy to control both their 
macro and microstructure. Furthermore, they offer multiple advantages 
of biocompatibility, chemical versatility and biological properties, which 
are necessary for the application of tissue engineering and organ 
substitution. Their properties depend on the composition, structure and 
arrangement of the constituting macromolecules. Synthetic polymers 
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are highly useful since their properties can be tailored for specific 
applications. They are usually cheaper, can be produced in large 
quantities and have a long shelf life. PLGA has been widely investigated 
for medical uses, such as suture materials51, bone fixation50, implants, 
prosthetic devices48, surgical sealant films and depot drug delivery 
systems49. Recently electrospun PLGA nano- and microfibers have also 
been studied for bone regeneration, wound dressing, and tissue 
engineering5,6. Besides its biodegradability and biocompatibility, the 
reason why this polymer is particularly attractive is the potential for 
controlled drug release7,8.Although numerous studies have utilized PLGA 
to prepare electrospun nano- and micro-fibers for controlled-release 
purposes, not much it is known yet about how the polymer solution 
properties influence the quality of electrospun PLGA fibers.. With 
Electrospinning, it is possible to fabricate fibrous polymer scaffolds with 
fiber diameters ranging from several microns down to several 
nanometres. Electrospinning has been widely investigated for producing 
scaffolds for tissue engineering9,10, drug delivery systems11, wound 
dressings12, artificial organs13 and vascular grafts14. It is a versatile, cost 
effective, and simple process for making micro- or nanoscale fibers by 
exposing polymer solution/melt to a high voltage15. A stable liquid jet 
can be discharged from the tip of the Taylor cone16 when the voltage is 
increasing to break the balance between Coulombic repulsion and 
surface tension. A whip-like motion of the liquid jet between the capillary 
tip and the grounded collector is formed If there is sufficient chain 
overlap and entanglements of the polymer molecules in the solution, 
with a lateral electric force, and this motion results in thinning of the jet 
and formation of micro- or nanoscale fibers. The electrospun fibers have 
been found to be a good mimic for the structure of the extracellular 
matrix (ECM) of the body17–19. The electrospun fibrous mats, with a high 
pore volume with variable pore sizes, can enhance cell differentiation, 
adhesion, and proliferation20. Different materials, such as synthetic or 
naturally derived polymers, can be processed alone or in combinations 
to promote various biological or physicochemical properties, such as 
biodegradation, biocompatibility, mechanical strength, hydrophobicity, 
or hydrophilicity, needed for different application purposes16.  
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5.1 Electrospinning 
ES is one of the most used techniques to fabricate polymeric 
fibers21 due to its versatility that allowes the use of a great variety of 
polymers and the inexpensive nature of the ES basic apparatus. To start 
a brief description of the technique it is necessary to mention the  many 
parameters22 that influence ES that can be divided in three main groups: 
a) environmental parameters like relative humidity (RH) and 
temperature 23, b) solution parameters related to the used solvent 
mixture24 and to the viscosity of the solution and c) operative parameters 
which are related to the applied voltage, needle to collector distance 
and feed rate of the solution through the metallic needle. To obtain 
good quality fibers the first data to consider is the molecular weight of 
the used polymer and the solution viscosity since they govern the so-
called physical entanglements25. Macromolecular chains dissolved into 
a mixture of solvents arrange into a random coil structures, and the 
presence of physical interconnections among them, i.e. physical 
entanglements, are mandatory in order to obtain a constant and 
continuous flow of macromolecules during the ES process necessary to 
successfully produce fibers26. Due to the entanglement interaction 
importance most of the polymers employed for the ES process present 
high molecular weight, usually way over tens of kilo Daltons.  
ES is an electrostatically driven process and it’s based on the feeding of 
a polymeric solution through a capillary tube into a high electric field 
Figure 5.1 Schematization of Electrospinning methods and SEM image of electrospun fibers 
of PLGA 
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(Fig. 5.1). When the solution reaches the electrified needle, it is subject 
to forces produced by the magnetic field, once these forces overcome 
the surface tension of the polymeric solution it leads to the formation of 
the so-called Taylor cone. After that a small and thin fluid jet is ejected 
and the fiber starts forming. The applied voltage leads to a whipping 
motion that has two main effects it allows stirring the fibers and, in the 
meantime, it promotes solvent evaporation and let the dry fibers to be 
collected over a grounded collector. This technique gives the possibility 
to control not only the fibers dimensions but also their architecture, 
obtaining fibers as random oriented, aligned, core shell, hallow and 
even with more complex structures27. The 3D structures of the ES fibrous 
systems, known in tissue engineering as scaffolds, are highly porous 
made up of fibers with high surface to volume ratio. This allows to greatly 
mimic the extracellularmatrix well-supporting cell activities involved in 
tissue regeneration processes28. Coupling this with the possibility to 
obtain new generations of scaffolds that can act as drug carriers, 
providing a controlled release of drugs while promoting the tissue 
regeneration, might represent a big step forward in the field of tissue 
engineering 10,29. In this context electrospinning can be considered a 
powerful and versatile tool to be applied to meet all the requirements 
for advanced medical applications that nowadays are of central 
interest for the scientific community. Noteworthy, the polymer, 
copolymer or blend of polymers used for this kind of applications must 
be first of all biocompatible and then present the suitable chemical and 
mechanical characteristics for each single application. Among all the 
possible choices   
5.1.1 PLGA   
Poly lactic-co-glycolic acid (PLGA) is a 
biodegradable and biocompatible 
copolymer approved by Food and Drug 
Administration (FDA) for food and medicine 
applications. Its synthesis involves the ring-
opening co-polymerization of two different 
monomers, the cyclic dimers (1,4-dioxane-2,5-
diones) of glycolic acid and lactic acid. 
During polymerization process, successive monomeric units (of glycolic 
Figure 5.3 PLGA structure 
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or lactic acid) are linked together in PLGA by ester formation, thus 
yielding a linear, aliphatic polyester as a product30. 
PLGA degrades by hydrolysis of its ester bonds in the presence of water. 
It has been shown that the time required for degradation of PLGA is 
related to the monomers' ratio used in the preparation: the higher the 
content of glycolide units, the lower the time required for degradation 
as compared to predominantly lactide materials. An exception to this 
rule is the copolymer with 50:50 monomers' ratio which exhibits the faster 
degradation (about two months)31. This tunability in degradation has 
made it very advantageous for the production of many medical 
devices, such as, grafts, sutures, implants, prosthetic devices, surgical 
sealant films, micro and nanoparticles32. PLGA undergoes hydrolytic 
degradation producing lactic acid and glycolic acid, that under normal 
physiological conditions, are by-products of various metabolic pathways 
in the body. Lactic acid is metabolized in the tricarboxylic acid cycle 
and eliminated as carbon dioxide and water. Glycolic acid is 
metabolized in the same way, and also excreted through the kidney33. 
Since the body can metabolize the products of its degradation, there is 
minimal systemic toxicity associated PLGA in medical application. It has 
also been reported that the acidic degradation of PLGA reduces the 
local pH low enough to create an autocatalytic environment34, involving 
in a pH variation which increase the rate of the degradation. 
 
5.1.2 Mechanism of PLGA degradation in DDS 
 
There are various factors which affect the release of drug from 
the PLGA-based Drug Delivery Systems (DDS). The drug release from 
PLGA-based DDS has been beautifully reviewed by Fredenberg et al35. 
The main mechanisms of drug release from PLGA-based DDS are three: 
(i) transport through water-filled pores, (ii) transport through the polymer, 
and (iii) dissolution of the encapsulating polymer. The last mechanism 
does not involve transport of drug from DDS, as in this case the drug is 
automatically exposed to the dissolution medium due to erosion of the 
polymer. The contact of PLGA with the medium causes its rapid 
absorption, hence creating water pockets which can be considered as 
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pores. In the initial phase this absorption is slow but becomes more and 
more efficient36,37 and it causes hydrolysis of PLGA. Hydrolysis leads to 
formation of degradation products, which then diffuse out of the 
polymer matrix creating small pores that, increasing in size with the 
proceding of the reaction, finally coalesce to form bigger ones37. The 
release profile of drug from PLGA-based DDS is rarely found to be 
monophasic, commonly is biphasic or triphasic. A DDS with colloidal 
nature, often shows altered release profile from a Fickian diffusion profile 
and a sigmoidal profile to a zero-order profile38,39. In the case of triphasic 
release profile showing DDS, the first phase is often termed as burst 
release, which is attributed to the presence of unentrapped drug 
present as adsorbed layer on the surface of particle, either nanoparticles 
or microparticles, or drug layer present close to the surface which is easily 
accessed by hydration of particle. The second phase is slow due to slow 
diffusion of drug from dense polymer matrix and absence of multiple 
larger pores. The third phase shows faster drug release as compared to 
the second one, which is attributed to the presence of larger pores and 
progressive degradation of the polymer40,41. 
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5.2 Aim of the work  
 
Aim of this part of my research was to prepare 
luminescent nanoparticles bearing a targeting agent 
for tumor tissues and to explore the possibility to 
release them from a carrier in a controlled way in view 
of medical applications. In particular, this project is 
inserted in a wider and more complex one in 
collaboration with prof. L. Focarete group of the 
University of Bologna. 
This part includes the first pilot attempts in view of the 
engineerization of a multicomponent biodegradable 
material able to release theranostic targeted NPs in 
situ in a postsurgical event. The idea is to implant the 
material in a patient after a tumour reset operation to 
release the theranostic nanoparticles in time during 
the reabsorption of the scaffold, allowing to monitor, 
and in case to cure, the neighboring tissues. 
The core of my study will be to evaluate if, using the 
electrospinning method, it is possible to create a 
bioresordable mat, containing targeted dye-doped 
PluS NPs, able to release them in a degradation 
dependent regime.  
In chart 1 it is highlighted the sequence of the steps followed in this study: 
a) the preparation of luminescent targeted nanoparticles, b) the 
insertion of these nanotools in a polymer matrix during electrospinning, 
c) the study of the particle release process and its correlation to the 
degradation of the matrix. 
First of all I synthesized luminescent core-shell silica NPs covalently doped 
in the core with Rhodamine B (previously silanized42) and functionalized 
on the surface with a complementary peptide to a peptidic chain over-
expressed by hepatic cancer cells43. The NPs, both decorated or not with 
the target moieties, were introduced in a biocompatible and 
biodegradable poly-lactic-co-glycolic acid (PLGA) mat and its 
Chart 1 Description 
of the project idea  
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degradation carefully monitored by different methods. The 
photophysical characteristics of the particles make it also possible to 
directly follow their release monitoring fluorescence in the incubation 
water.  
5.3 Results and discussion  
First step was to prepare PlusNPs presenting rhodamine B as dye, 
in order to be able to follow the release using it fluorescence. In order to 
covalently bind the dye inside the core of PluSNPs, rhodamine B was 
modified by the use of piperazine42 and, successively, coupled with silica 
moiety as shown in Fig.. 5.3, to obtain silane derivatized molecule. 
 
Figure 5.3 Synthesis of Rhodamine B silane 
 
RhB@NPs, were synthesized co-condensing Rhodamine B (0,25% amount 
respect to the mol of the TEOS) (Fig. 5.3) together with TEOS in the micelle 
assisted preparation step (see cap 3). The NPs were morphologically 
characterized by TEM and DLS analysis showing a good monodispersity 
and size completely in line with the attended measures for this synthetic 
procedure (see Fig. 3.3 in cap3). The photophysical characterization of 
he NPs was carried on and compared with the behavior of Rhodamine 
B in solution in water (Fig. 5.4):  
The absorption and emission spectra doesn’t change significantly: from 
the comparison between the profile of Rhodamine B free in solution and 
inside the NPs it is possible to see how, for the absorption spectra, the 
ratio peack/shoulder stay constant in the RhB@NPs profile, index of a 
 
124 
 
5 
very weak formation of the dye aggregates, it is present only a red shift 
with the same shape of 14 nm.  
In the emission spectra there is the same red-shift and, as demonstrated 
also from the low differences in their emission quantum yield (Tab. 5.1), 
the self-quenching of the dyes is not dramatic, as observed when this 
type of dye is constrain in a very little space. These data are in 
agreement of the calculated low number of dye/NP; from molar 
extinction coefficient and quantum yield of Rhodamine, indeed, it was 
also possible to obtain the number of dye/NP, almost 5 clearly from the 
ratio between the ε values, and calculate the NPs brightness44. 
Table 5.1 Photophysical data of RhB free in water and RhB@NPs in water 
 
 
 
The following step of insertion of the NPs in the polymer solution to obtain 
doped fibers with good characteristics was not trivial and required many 
attempts by Prof. Focarete group, in order to find the suitable solvent 
mixture and component concentrations. The studied the perfect solvent 
mixture to use due to the insolubility of NPs in only DCM solvent, in order 
to obtain good electrospun mat. Several parameters were changing 
working in humidity levels and temperature finding the perfect 
elettrospinning condition using 35% w/v of PLGA 50:50, 2% NPs 
wNPs/wpolymer in DMF/DCM 70:30.   Potential 18 Kv, distance needle-
collector 20 cm, RT and Rh 70-73% with a flux speed of 0.8 mL/h. 
 RhB  NPs 
ε 104 000 476 923 
φEM(H2O) 31%45 25% 
Ba 32 240 119 230 
aBrightness (B) defins as ε۰Ф44  
Figure 5.4 Normalized Absorption and emission spectra of RhB and NPs@RhB 
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Exploiting this acquired knowhow, It has been decided to use PLGA 50:50 
as polymer due to its well-known degradation mechanism that, for its 
ratio, presents the shortest time degradation of the series (circa 2 
months) that is compatible with the type of application of this work 
purpose. 
In order to study the NPs release it has been followed the degradation 
of two mats electrofilated in the same exact conditions but one doped 
with the nanoparticles (RhB@NPsmat) and the other one non-doped 
(plainmat). We used different techniques, in collaboration with the group 
of prof. M. L. Focarete, to monitor the degradation in time, measuring 
GPC, TGA and DSC variations and the weight loss of the two samples left 
in PBS 10mM (pH7.4) for 50 days. In order to correlate the release of the 
NPs with these degradation data we quantified, in the same time scale, 
the presence of Rhodamine B via spettrophotometric and 
spettrofluorimetric measurements in the incubation solution. In 
particular,the incubation medium was removed, investigated, kept in a 
vial and replaced with an exactly same volume of clean PBS 10mM, 
initially each day and then with a lower frequency.  
For each sample we measured the absorption and emission spectra of 
the RhB contained in the NPs but, due to the higher sensitivity of the 
technique the emission data were less error affected. We therefore 
calculated the percentage of the NPs released monitoring the emission 
intensities variations in the emission maximum at 535 nm The 
concentration of the NPs released was calculated respect to the sum of 
the initial loading of the RhB@NPsmat. A calibration line (data not shown) 
was defined preparing 7 differents solution with increasing amount of 
RhB@NPs, and measuring their emission. From the equation of the 
Figure 5.5 (left)SEM image of electospun NPs@RhB inside PLGA fibers, (centre)TEM image 
of Plainmat fiber and fiber of RhB@NPsmat, (right) Confocal image of RhB@NPsmat t 
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extrapolating line plotting the emissions of the RhB@NPs respect to the 
NPs concentration is possible to calculate the perfect concentration of 
the NPs. In this way, it was possible calculate the initial level doping of 
the RhB@NPsmat melting a weighted piece in DMF and measuring it 
emission. By the interpolation with the line was possible to estimate the 
total weight percentage of RhB@NPs loaded equal to 1.4% From 
cumulative sum of the release calculated using the same procedure for 
any solutions, was possible to create the cumulative release shown in Fig. 
5.6   
In Fig. 5.6 are displayed the trend in gray of the degradation and the 
tendency of the release of the NPs in pink, From the graph is clear how 
the both lines during the time have the same trend. This is also visible from 
the SEM image collected at the same time from both doped and 
plainmat (Fig. 5.6. bottom.). This means that the release of the NPs is only 
due to the degradation of the PLGA and not to a leaking from the pores, 
furthermore, working on the modulation of the release times is possible 
to modulate the release times.  This was an extremely important results 
because means that the insertion of NPs on the mat doesn’t affect it 
degradation, and moreover, modulating the percentage of the 
composition of the polymer used, it is possible modulating directly the 
time of NPs release.  
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At this stage of the work it has been investigated the influence of the 
modification of the NP surface on the doping and release in and from 
the polymeric matrix. We therefore proceeded with the modification of 
the outer shell of the NPs with a target moiety and in particular with a TTP 
(Tumor target peptides) that is able to specifically recognize a marker 
on the tumoral cells surface (such as membrane receptor) and driving 
drugs (in our case the NP) on the tumor tissue and to accumulate it there. 
For example, RGD46 or NGR peptides link integrins or receptors on the 
membrane, usually overexpressed in tumoral tissue. We chose a specific 
sequence CGIYRLRS that recognizes a peptide sequence over 
expressed specifically by hepatic cancer cells. These sequence was 
derived by comparative phage display bio-panning on fresh surgical 
samples of hepatic metastases versus matched normal liver biopsies and 
proved to be selective for the stromal and the epithelial components of 
the metastasis43.  
Figure 5.6 up: graph of the release on NPs@RhB from NPs@RhBmat (pink line) and 
degradation of the plainmat (gray line); bottom, SEM of the degradation of plain mat and 
RhB@NPsmat 
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In order to functionalize the NPs@RhB outer shell, we first modified the 
terminal part of PF127 used to form the micelles templating the synthesis 
of the NPs. We introduced an active site able to act as a reagent in a 
coupling reaction and in particular a carboxylic function. The synthetic 
procedure is shown in Fig. 3 and summarized hereafter: to a PF-127 and 
NaIO4 mixture were added water, acetonitrile and carbon tetrachloride 
after RuCl3 was added to the resulting biphasic solution and the reaction 
mixture was stirred overnight at RT, followed by repeated extractions with 
CH2Cl2. The reunited organic phases were dried over Na2SO4, filtered 
and evaporated to yield the final product in a yield, product that was 
characterized by NMR (see experimental section). 
The RhB@NPsCOOH synthesis was carried out as already reported (see 
cap 3) but using 70% of PF127 and 30% of COOH functionalized PF127. 
The resulting NPs, after dialysis, were again characterized by TEM (Fig. 
5.8) and DLS analysis, showing a core around 9.5 nm and a dH around 27 
nm with a very good monodispersion (PDI=0.06+0.02), completely in line 
with the morphology of the non-derivatized NPs.  
Figure 5.7 Schematization of PF127 functionalization 
 
6 7 8 9 10 11 12
Figure 5.8 TEM image of RhB@NPsCOOH. Scale bar 200 nm 
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Photophysical characterizations shown in table 5.2 did not present any 
significant difference from the data obtained for the previous NPs and 
the average number of dye/NP resulted again 5.  
Table 5.2 Photophysical data for RhB@COOHNPs and rhodamine B in water 
 
 
 
 
 
The further surface coupling reaction to introduce peptide CGIYRLRS 
(Fig. 5.9) was performed in borate buffer pH=8 with EDC.HCl and sulfo-
NHS and the peptide was added (see experimental section). The solution 
was left stirring overnight at room temperature and purified dialysis over 
2 days.  
Figure 5.9 Schematic representation of coupling reaction between RhB@NPsCOOH and 
peptide 
To investigate the number of peptide/NP present in the final product, 
that I will call for here after RhB@NPsPEP, we measured the zeta potential 
(ζ -potential) and we used the so called fluorescamine assay.  
 
 
 
 RhB  RhB@COOHNPs 
λAbs 568 584 
λEm 577 589 
ε 104 000 470 437 
φEM(H2O) 31% 24% 
brigthness 32 240 112 902 
aBrightness (B) defins as ε۰Ф44  
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Table 5.3 ζ -potential of NPs with different shell modification  
Sample 
ζ-potential 
(mV) 
RhB@NPs -6.12+0.05a 
RhB@NPsCOOH -7.04±0.09 
RhB@NPsPEP -2.51±0.02 
a)from literature pH 7.44 
The values of ζ -potential give a clear indication of the successful 
functionalization of the surface revealing a lowering of the value with 
the insertion of the carboxylic groups and a much less negative potential 
with after the funtionalization with the peptides. This was reasonably 
expected for RhB@NPsPEP where CGIYRLRS presents positive sites, and 
its coupling decreases the number of the free –COOH sites. However, 
these values don’t allow a precise quantification of the average number 
of peptides on the surface of each NP and for this we used the well-
known fluorescamine assay. Fluorescamine (4-phenylspiro-(furan-
2(3H),1'-phthalan)-3,3'-dione), is a non-fluorescent molecule that 
undergoes a chemical reaction in the presence of  primary amines to 
give a fluorescent product; De Bernardo et al. demonstrated it is possible 
to quantify the number of the reacted amines measuring the emission 
signal of the reaction product47. In order to prevent the detrimental 
amine protonation, the pH value must be controlled to and De Bernardo 
et al. suggest as the best pH range 8/8.5 for the quantification of amines 
in peptides and 8.5/9.5 for proteins. The quantum yield of the formed 
adduct, instead, is not depending on the environment, and it is constant 
in the pH range from 4.5 to 10.5. It has been decided to work at pH 8 that 
was obtained using a borate buffer solution. 
As a first step, it has been made a calibration curve using butylamine 
that was added in increasing volumes to 5 different solution of DMSO 
containing inert RhB@NPs to simulate the same environment of the 
measurements on RhB@NPsPEP. After 150 minutes of reaction were 
recorded the the emission spectra (λexc = 380 nm) in a diluited solution 
in borate buffer (pH=8) (details in Experimental section).    
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Plotting the emission of the fluorescamine respect to the concentration 
of butylamine it was possible obtain a calibration line. From the line 
equation extrapolation,  the obtained solution of RhB@NPsPEP was 
analyzed by emission of the rhodamine B and  it was possible to 
determine the number of the amine in solution, in particular the arg.inine 
residues, and from this data the average number of peptides present on 
the surface of each NPs.  This number resulted to be 6 peptides per NP. 
With the aim to make a comparison between the release of 
RhB@NPsCOOH and RhB@NPsPEP, two new mats were electrospun: 
RhB@NPsCOOHmat and RhB@NPsPEPmat. The nanofibers of PLGA 50:50 
w/w were obtained using the same procedure and parameters 
described above for RhB@NPs. The obtained mats presented good fibers 
of the same dimensions and aspect of the scaffolds prepared with the 
other particles (SEM Fig. 5.11 right) and again with a very good 
distribution, as reported for the RhB@NPsPEPmat in Fig. 5.11 only inside 
and along all the length of the fibers .   
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The characterization for RhB@NPsCOOHmat gave the same results, for 
this reason is not reported. From the extrapolation of the calibration line 
as explained above (see experimental section for the details), It resulted 
that the NPs loading for RhB@NPsCOOHmat was 1.34%, while for 
RhB@NPsPEPmat lower than expected, resulting in 0.64% respect to the 
total weight (PLGA+NPS). This could be due to the fact that the 
bioconjiugation reaction occurs in water in very diluted conditions and 
to take the NPs in the DMF/DCM mixture used for the electrospinning 
they must be concentrated using ultracentrifuge equipped with 100K 
filters, the repetitive step of concentration of the NPs may have caused 
a loss of NPs leading to an overestimate initial NP concentration used. 
This step will be optimized in the future but the important data for the 
purpuse of this study is the real initial loading amount to be able to 
calculate the percentage of released nanoparticles. 
Following the same procedure used for RhB@NPs and the same 
measurement techniques, RhB@NPsPEP and RhB@NPsCOOH release 
were followed putting the scaffolds in PBS 10mM (pH 7.4) at 37°C. 
Collecting periodically the PBS of incubation and replacing it with the 
same volume of a new solution, it was possible to quantify, measuring 
the emission at 535 nm, the cumulative percentage of the released NPs, 
from the sum of the NPs quantity released during the time respect to their 
calculated total weight loaded. In the graph in Fig. 5.12 are reported the 
3 differents trends: in gray the degradation of the mat (already 
explained above), in pink the RhB@NPsCOOH release, and in green the 
release of the RhB@NPsPEP. 
Figure 5.11 Confocal image and SEM image of RhB@PEPNPsmat 
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The gray line it was already discussed before in Fig. 5.6; The pink line is 
the release of the RhB@NPsCOOH; the kinetic of the release is slow, the 
amount of NPs release in the first 10 days is less than 5% but in line with 
the result for the RhB@NPs showed in Fig. 5.6. Differently, the total amount 
of the release is 40% respect to the other NPs (Fig. 5.6). The green data 
are the ones obtained for the release of RhB@NPsPEP. The kinetic of the 
release is a little bit faster, infact in the first 336 hours (14 days) were 
released less than 10% of loaded RhB@NPsPEP with an initial burst 0f 4% 
after the first incubation day. However, a very interesting evidence is that 
the release of the RhB@NPsPEP is higher in percentage at any time with 
respect to the release of the RhB@NPsCOOH and even more than 
RhB@NPs. This could tentatively be due to the fact that the PLGA 
interacts with the PF127 of the NPs favouring their retention, in the 
RhB@NPsCOOH and even better for RhB@NPsPEP the presence of the 
COOH for the first one, and quite bulky peptide groups for the second 
one, could partially impede this interaction facilitating the release. 
5.4 Conclusions and future steps 
During this work carried out in collaboration with Prof. ML. 
Focarete from the University of Bologna, we were able to obtain an 
electrospun nanofiber mat of PLGA that is a biocompatible and 
biodegradable polymer, doped with luminescent PluS NPs bearing or 
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not target moieties on their surface. In particular, after many attempts, 
we found the correct electrospinning parameters to obtain the PLGA 
fibers doped at a high degree and presenting the NPs homogeneously 
dispersed. The characteristic luminescence of the Rhodamine B doped 
NPs allowed the measuring of the emission intensity in the incubation 
water of the mat and the direct calculation of the number of particles 
released in time. All the experimental evidences indicate that the 
release of the NPs correlates very well with the degradation of the PLGA 
fibers in physiological conditions. This is a very important result since, 
being possible to modulate time profile of the degradation changing 
the polymer composition, it is consequently possible to tune the release 
of the eventual theranostic agent over time. Furthermore, the 
functionalization of the outer shell with a metastasis-specific peptide for 
hepatic cancer cells has shown that any modification of the outer shell 
of the NPs influences the interaction among the polymer and the 
nanoparticles themselves. This has again a non-negligible influence on 
the release and, in particular, the hindering peptide, decreasing the 
PEG-PLGA affinity, results in the same release profile in time but 
presenting a percentage of released NPs higher than the one of the non-
targeted NPs at all times.  
These very promising results will push further this research line and the 
next step will be to insert in the PluSNPs a therapeutic agent, such as an 
active species to allow photothermal therapy, transforming the particles 
in theranostic targeting agents. These new nanotools will be then 
inserted in a mat and tested in in vitro experiments. 
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CAP. 6 
LUMINESCENT METALS COMPLEXES 
AND GOLD NPS AS POTENTIAL BUILDING 
BLOCKS IN NANOMEDICINE  
This last chapter of my thesis merges some research work that I 
have developed on different species that could have, or could take to, 
interesting properties to be exploited in building block moieties for the 
design of multifunctional platforms for applications in nanomedicine. In 
particular, it has been focussed the attention on NIR emitters that are 
luminescent component of election for medical application in vivo due 
to the range 650-1350 nm of the so called biological optical window, 
that indicates where light has its maximum depth of penetration in 
tissues. In the framework of two different collaborations, I have studied 
rhenium and lanthanide metal complex from a photophysical point of 
view both in solution and in the solid state. 
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Moreover, besides luminescent components useful as signalling units, 
medical applications need therapeutic ones and, among them, gold 
nanoparticles have an important role since functionalized gold 
nanoparticles with controlled geometrical and optical properties are 
widely studied for laser phototherapy of cancer cells and for the 
targeted delivery of drugs, DNA and antigens. I present here a basic 
study that aims to assess the possible pro-oxidant or antioxidant effects 
induced by gold nanoparticles. In fact, noparticles are often found to 
be toxic, and one of the most frequently reported mechanisms of 
nanoparticle toxicity is the generation of free radicals. Therefore, the 
elucidation of the possible pro-oxidant activity of nanoparticles is among 
the key features determining their safety and suitability for specific 
applications. 
 
6.1 Rhenium(I) complexes.   
Effects of the substituents on the 
terpyridine k3N rhenium(I) dicarbonyl 
complexes in NIR emission 
 
There is always a need to expand the range of already known 
luminescent tools suitable for a large number of applications in different 
field and the NIR emitters are of particular interest for energy, 
telecommunication and medical purposes, for example the NIR region 
is the one of interest for in vivo applications. 
Professor G. Hanan with his group designs, prepares and characterizes 
since many years a wide range of NIR emitting metal complexes 1–3, and 
in the latest period he moved his attention in particular on Re-
complexes4. Since the first report on this subject in the early 1970s,1 low 
spin d6 polypyridyl rhenium(I) carbonyl complexes have drawn the 
interest of the scientific community. Their photophysical and 
electrochemical properties have been thoroughly studied and applied 
in a multitude of the fields such as solar energy harvesting devices5 and 
solar to chemical energy conversion6, light emitting devices7 as well as 
photodynamic therapy and cellular imaging8,9. G. Hanan et al4 recently 
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focused their attention on tri-coordinated terpyridine complexes as they 
offer a suitable geometry for predictable assembly depending on the 
facial or meridional arrangement of the ligands. In a recent report, 
Dempsey et al. working with a Re bipyridine complex successfully 
pushed their absorption to the red, matching the κ3N terpyridine values, 
by modifying the nature of the ligands completing the coordination 
sphere10. The simplicity of the synthesis of the Re precursors and their 
supramolecular architecture as well as the ease of fine-tuning of the 
optical properties by varying the bidentate ligand certainly contributed 
to the ascension in popularity of this class of compounds. 
However, the κ3N terpyridine based complex [Re(CO)2(py)(κ3N-
4pytpy)]+ (with py standing for pyridine and 4pytpy being 4’(4-pyridyl)-
2,2’:6’,2’’-terpyridine), published by professor Hanan, is the only case 
presenting a near-infrared emission band at room temperature, with a 
maximum around 940 nm4.  
 
Figure 6.1 structures of complexes that compose the series called here 1, 2 , 3  and 4. 
Inspired by this very interesting result, they decided to investigate the 
effect of varying substituent and ancillary ligand on the emission of κ2N 
and κ3N terpyridine rhenium complexes in order to gain a better 
understanding of the parameters influencing their electronic properties. 
To this goal, they prepared four series of compounds (numbered as 1 to 
4), with different ancillary ligands, that are schematized in Fig. 6.1. Each 
series is composed by complexes that differ for the substituent of the 
terpyridine ligand as shown in Fig.6.2.  
1 2-3-4 
Y= Br (2), 
pyridyl (3) 
PPh3 (4) 
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Figure 6.2 Substituted terpyridine ligands used in the different rhenium complexes series. 
 
First Prof. Hanan group performed DFT calculations on all the complexes 
and they showed how the conversion of 1a-e into 2a-e causes a 
significant increase in energy for the higher occupied levels. The found 
trend was expected since the replacement of a strongly π-accepting 
CO ligand by the terpyridine ligand should lead to the destabilization of 
the metal centered π orbitals, how showed in Fig 6.3.  
Moreover, they found a stabilization of LUMO levels increasing the 
conjugation of the terpyridine once in its meridional coordination mode. 
The LUMO of complexes 1a-e is delocalized over the coordinated 
bipyridine-like moiety and the increase in conjugation does not really 
affect its energy while the LUMO+1 and LUMO+2 involve individual 
pyridine ring and the extended conjugation modifies their relative 
energies. Going from the neutral 2a-e to the cationic complexes 3a-e 
and 4a-b leads to an overall stabilization by several hundred meV 
similarly when looking at the unoccupied levels but with a stronger 
impact on the occupied levels from the triphenylphosphine in 4a-b 
compared to the pyridine in 3a-e. 
 
141 
 
6 
 
My contribution in the framework of this research has been to 
photophysically characterize all the complexes. 
 
6.1.1. Aim of the work 
The aim of my contribution in this work in collaboration with 
Professor G. Hanan is the careful and exhaustive photophisical 
characterization of different κ2N and κ3N terpyridine Re(I) carbonyl 
complexes of general formula [Re(κxN-Rtpy)(CO)yL]n+. By varying the 
coordination modes of terpyridines ligands, their substituent and the 
nature of the axial ligands in these complexes, it is possible to tune their 
electronic and photophysical properties as theoretical calculation had 
predicted. 
The photophysical characterization of the κ3N terpyridine rhenium 
complexes shown in Fig 6.4 and their comparison with the DFT 
calculation results will help to gain a better understanding of the 
parameters involved in their NIR emission. The good correlation of the 
Figure 6.3 Partial energy diagram centered on frontier orbitals for all complexes modeled 
in an acetonitrile continuum by DFT (PBE0/LanL2DZ). LUMO levels red, Homo in green 
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results could demonstrate the possibility to finely tune the properties of 
these complexes via simple structural variations, opening up a path to 
the design of application specific complexes. 
 
Figure 6.4 structures of the complexes of the series 2, 3 and 4 
 
6.1.2 Result and discussion 
The synthesis of all the complexes shown in fig 1 was carried on in 
Montreal following the synthetic procedures already reported in 
literature11,12.I describe here the photophysical characterization of the 
compounds reported in Fig. 6.5 while the ones of the  series 1, k2N 
terpyridine complexes, are not present in this thesis because already 
studied in a previous research and presenting the emission in the UV-VIS 
range. The spectroscopic characterization of series 3 and 4 were 
performed in CH3CN solution while this was not possible for series 2 due 
to the very low solubility of these complexes that are neutral. Thus, the 
measurement for series 2 were performed in DMSO. For all compounds, 
the measurements were conducted on solutions with a concentration of 
5 x 10-5 M. The absorption spectra of all the series are reported in Fig 6.5.  
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All the κ3N complexes absorption spectra present three large transitions 
bands in the visible region between 400 nm and 700 nm as it can be seen 
by the insets of Fig. 6.5. The replacement of the bromide by pyridine 
going from series 2 to series 3 leads to a blueshift of these bands of some 
tens of nanometers, and the triphenylphosphine complexes 4 present an 
even larger blueshift. The transitions in the visible correspond in all cases 
to Metal-Ligand to Ligand Charge Transfer (MLLCT). The various 
substituents allow for fine-tuning of the absorption maxima, the more 
electron rich ligand Lb leading to higher wavelengths in all cases while 
the aromatic substituents on the 4’ position for Lc, Ld and Le cause a 
slight redshift compared to La. The 4-pyridyl in Le presents a stronger 
effect, in agreement with its higher electron withdrawing properties. 
Figure 6.5 Absorption spectra of respectively, series 2 (in DMSO) , 3 and 4 (in CH3CN) 
Absorption spectra of series b. 
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The emission spectra were recorded exciting all compound at 440 nm 
and using a Ge detector that presents a high sensitivity in the NIR range.  
Figure 6.6 Emission spectra of complexes of series 3 and 4 
In table Table 6.1 are reported the wavelength of the emission maxima 
and the corresponding emission quantum yields (ΦEM) for all the 
investigated complexes. The species of the 2 series are all non-emissive, 
the presence of bromide could be envisaged to a have role in this, even 
if TD-DFT predicted an emission below 900 nm. Exchanging the bromide 
ligand for pyridine or triphenylphosphine we obtain series 3 and 4 that, 
instead, show emission in the NIR region with maxima in the range 780-
940nm as reported in table 6.1. The emission wavelengths vary 
depending on the substituent in the 4’ position of the terpyridine 
presenting the lower wavelength for the electron rich ligand Lb and the 
most red-shifted maxima for the electron poor ligand Le. 
Table 6.1 Data of quantum yield emission of series 2, 3 and 4complexes 
 2a-e 3a 3b 3c 3d 3e 4a 4b 
λEM - 870 840 876 865 940 800 782 
aΦEM 
(%) 
- 0.13 0.18 0.13 0.11 0.02 0.71 0.4 
a calculated respect standard IR125 13 
The quantum yield of these complexes are quite unexpectedly higher in 
comparison with other neutral κ2N complexes already studied. This could 
be explained by the change in the nature of the emissive state, as 
supported by theoretical calculations made by the group of Prof. 
Hanan. Indeed, while the κ2N-tpy halide complexes have a complex mix 
of MLCT, LLCT and LC contributions in their lowest transition, in the κ3N 
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complexes, the lowest transition are purely metal-ligand-to-ligand 
(MLLCT) in nature, the density being transfer from the {Re(CO)2} fragment 
to the terpyridine ligand π* orbital.  
 
6.1.3 Conclusions 
The results reported in this section demonstrate the structure-
properties relationship in a series of carbonyl rhenium(I) complexes 
based on substituted terpyridine ligands of general formula [Re(κxN 
Rtpy)(CO)yL]n+. In these compounds, the terpyridines can adopt both 
bidentate (κ2N) and tridentate (κ3N) coordination modes associated 
with three or two carbonyls, respectively. The experimental evidences 
show that the κ3N complexes’ absorption profiles present three large 
bands covering the whole visible range between 400 and 800 nm. The 
substituents on the tpy ligand influence the position of the absorption 
maxima, the more electron rich ligand b leading to higher wavelengths 
in all cases. The aromatic substituents on the 4’ position for c, d and e 
cause a redshift compared to La, the 4-pyridyl having a stronger effect, 
in agreement with its higher electron withdrawing properties. 
It was interesting to note that no emission is observable with Br⁻ as axial 
ligand L but when L is changed from the halide to pyridine or 
triphenylphosphine, these cationic complexes become near-infrared 
emitters. The emission maxima are in the range between 840-950 nm for 
the pyridine compounds and 780-800 nm for the triphenylphosphine 
ones. The quantum yields are unusually high for this class of complexes 
with values between 0.02 and 0.7 %. Theoretical calculations made in 
Montreal indicate that this could be attributed to a change in the nature 
of the excited state going from a κ2N-tpy halide complexes presenting 
MLCT, LLCT and LC contributions in their lowest transition, to  κ3N 
complexes where the lowest transition are purely metal-ligand-to-ligand 
(MLLCT) in nature. 
All these results demonstrate that it is possible to finely tune the properties 
of these complexes via simple structural variations, opening a path to 
the design of application specific complexes including the biomedical 
ones that very often require NIR emission properties. 
 
146 
 
6 
6.2 Lanthanide (Ln) complexes. 
Studies of Ln-Ag bimetallic 
coordination framework. 
 
In the past decades metal–organic frameworks (MOFs) have 
emerged as a new class of porous materials showing great potential in 
building fluorescent materials7–10 as well as gas adsorption/separation14–
16, heterogeneous catalysis17, drug delivery18, and other applications19. 
MOFs are constructed from organic ligands and inorganic metal nodes, 
possessing high porosity and large internal surface areas. The structure 
of MOFs is not only tunable through designing the organic ligand and 
choosing metal clusters, but also can be modified via postsynthetic 
modifications20,21. Recently, rigid MOFs have been demonstrated to be 
able to fix fluorescent ligands and exhibit excellent fluorescence 
properties22, making MOFs effective candidates having potential to 
design and construct various fluorescent materials. Fluorescent MOFs 
have been widely evaluated for chemical sensing21, 
optoelectronic/electrochemical devices23–25, light-emitting devices and 
biomedicine20. Combination of lanthanide metalloligands and transition 
metal ions in one MOF could represent a suitable way for isolating new 
convenient materials with interesting luminescent properties for different 
applications.  The research on luminescent LnMOFs has been focused 
on their visible emission features, whereas emissive NIR LnMOFs (usually 
Ln3+ = Yb3+, Nd3+ and Er3+) are barely studied, mainly because: (i) most 
ligands are poor sensitisers of Yb3+, Nd3+ and Er3+, with molar absorption 
coefficients typically lower than 10 L mol1 cm1 , 2 and (ii) the energy gap 
between the first excited emitting state and the fundamental level is 
quite small (ca. 5400 and ca. 6500 cm1 for Nd3+ and Er3+, respectively) 
and easily matched by the C–H, CQC, O–H, and N–H vibrations of the 
organic framework, which provide suitable non-radiative channels. In 
order to investigate the possibility to work in the range of NIR emission. 
Among the investigation on the possibility to obtain new suitable species 
based on lanthanide Metalloligands it was studied their use in the 
assembly of Ln-Ag bimetallic coordination framework. 
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6.2.1 Aim of the work  
The goal of this project, published in collaboration with Prof. L. 
Carlucci, was the preparation and successively the characterization 
both photophysical and by X-ray of NEt4[Ln(L1 )4] [Ln = Eu (1a, 1a*), La 
(1b), Nd (1c), Tb (1d)] . NEt4[Ln(L2)4] [Ln = Eu (1e), Nd (1f). The high 
flexibility in the stereochemistry of these metalloligands allows for the 
formation of a new type of secondary building unit (SBU) in the reaction 
with silver cations. This SBU consists of a “pincer-like” moiety, in which a 
silver cation coordinates to two central carbon atoms of two different 
diketonate ligands of the same metalloligand. The different polymeric 
products could be organized on the basis of the number of these SBUs. 
Accordingly, species with 0, 1, and 2 “silver-pincers” per ML have been 
obtained. Were then also synthesized and  characterized the assembled 
lanthanide-silver coordination networks with the [Ln(L1)4] – 
Metalloligands; in particular 1D Coordination Networks [Ln(L1 )4Ag] [Ln = 
Eu, La, Nd, and Tb (2a−2d)] and 2D Coordination Networks [Ln(L1 )4Ag Ln 
= Eu, La, and Nd (3a−3c). In particular, for what concern the aim of my 
work, it has been deeply study the entire characterization of the 
abovementioned MOF, especially the role of the silver ion in the 
coordination network structures. 
6.2.2 Results and discussion 
 
After all synthetic work reported in the paper26 and the entire X 
ray characterization made by Prof. L. Carlucci, there were performed all 
photophysical characterization. In particular the studied species were: 
HL1 NEt4[Eu(L1 )4] (1a) , 1D-[Eu(L1 )4Ag] (2a), 2D-[Eu(L1 )4Ag] (3a), 2D-[Eu(L1 
)4Ag2]PF6 (4a), NEt4[La(L1 )4](1b), NEt4[Nd(L1 )4](1c), 1D-[Nd(L1 )4Ag] (2c), 
2D-[Nd(L1 )4Ag] (3c), NEt4[Tb(L1 )4] (1d), HL2, NEt4[Eu(L2 )4] (1e) and 
NEt4[Nd(L2 )4] (1e). In fig. 7 are reported the structures of HL1 and HL2.  
Figure 6.7 structures of HL1  and HL2 
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The high flexibility in the stereochemistry of these metalloligands allows 
for the formation of a new type of secondary building unit (SBU) in the 
reaction with silver cations. This SBU consists of a “pincer-like” moiety, in 
which a silver cation coordinates to two central carbon atoms of two 
different diketonate ligands of the same metalloligand.  
To clarify the studied structures is reported below the schematic 
representation of the silver pincer-like SBUs observed in two polymer 
families described below. One silver pincer-like SBU (top) is formed by 
one ML and one silver cation interacting with the central carbon atoms 
of two diketonate ligands. Such neutral SBU is present in polymeric 
families 2 and 3. Two silver pincer-like SBUs (bottom) are formed by one 
ML and two silver cations, each of which interacts with the central 
carbon atoms of two diketonate ligands. Such cationic SBU is present in 
polymeric family 4.  
The entire photophysical characterization was performed and resumed 
in table 6.2. All the monomeric lanthanide complexes NEt4[Ln(L1)4] were 
characterized both at room temperature and at 77 K in 
dichloromethane solution.  
Figure 6.8 left:Schematic representation of the silver pincer-like SBUs observed for 
polymeric families 2 , 3 and 4. One silver pincer-like SBU (top) is formed by one ML and one 
silver cation interacting with the central carbon atoms of two diketonate ligands(2 and 3). 
Two silver pincer-like SBUs (bottom) are formed by one ML and two silver cations, each of 
which interacts with the central carbon atoms of two diketonate 
ligands(4).Rigth:Comparison of the two families of 2D polymeric structures (3 in the upper 
row and 4 in the lower row). In the left column (a and d) the molecular drawings; in the 
middle column (b and e) the corresponding schematic drawings, in which the different 
types of SBU have been highlighted in pink; and in the right column (c and f) the simplified 
networks obtained by considering the silver and lanthanide atoms as nodes (in blue) or 
the SBUs as nodes (in red). 
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Table 6.2 Photophysical Properties of the Ligands, the Metalloligands, and the 
Heterometallic Coordination Networks a 
Compound 
Abs Max 
(nm) 
Em Max 
(nm) 
Lifetimes 
(uS) 
HL1 255, 352 405 3 ns 
1a 252, 368 615 41, 21 pw 
2a  615 pw 20 pw 
3a  615 pw 15 pw 
4a  615 20 pw 
1b 256, 365 380 b 2 ns b 
1c 256, 367 893, 1065 c 
2c  894pw, 1070 pw c 
3c  894 pw, 1070 pw c 
1d 256, 367 390b 2 ns b 
HL2 243, 338 400 5 ns 
1e 290, 350 615 140, 480 pw 
1f 255, 367 890, 1064 c 
a All the values determined in dichloromethane solution at room temperature, apart from 
the ones in round brackets, determined at 77 K, and the ones with the subscript “pw”, 
measured for the microcrystalline powders. b Data relative to the LC emission. c Not possible 
to measure with our instrumentation 
 
All the solid measurements were performed constrain the solid powder 
between two glass slides and were recorded the emission spectra.  
As presented in Tab 6.2, HL1 presents absorption maxima at 255 and 352 
nm and a large and not structured fluorescence band centered at 405 
nm at room temperature (both in solution and in the solid state) with a 
low emission quantum yield (<10−4). This band has been attributed to a 
spin allowed fluorescence transition because of its energy and excited 
state lifetime. Similar characteristics are visible also for HL2, but with 
slightly higher absorption energies and emission that is at 400 nm in 
solution, with a similar quantum yield to HL1.  
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A first parameter to be observed is the energy of the ligand-centered 
states in the complexes. Due to their low intrinsic absorption, a high 
brightness for lanthanide ions is possible only if there is an efficient 
antenna effect through the light excitation of suitable ligands, together 
with and an efficient energy transfer process to the metal-centered 
states of the metal ions. With this aim, we carefully characterized the 
lanthanum complex 1b since La3+, presenting the close shell electronic 
configuration of xenon, does not usually have metalcentered (MC) 
emission bands27. The absorption spectrum of the complex presents the 
features of the ligand absorption profile, but with a shift in the lower 
wavelength band to 365 nm, as expected upon metal complexation. 
Since the absorption spectrum of 1b is superimposable with those of all 
the other complexes with HL1 , similar complexation environments are 
supposed to be for all the 1a−1d species (Fig 6.9)  
 
Figure 6.9 left: Absorption spectra in CH2Cl2 of the free ligand HL1 (black) and of the 
metalloligands 1a (blue), 1b (green),  1c (yellow), 1d (red). Right Emission spectrum in CH2Cl2at 
77 K of 1b, ex 350 nm 
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 A broad fluorescence band at ca. 380 nm is visible for the emission 
spectrum of 1b at room temperature, with a lifetime of 2 ns, while at 77 
K a lower-energy (555 nm), longer-lived (2.2 ms) band is present, 
attributable to a 3 LC transition. According to these data, is notable that 
the 3LC state (19250 cm−1) is lower in energy than the MC5D4 state of the 
Tb3+ ion, suggesting that the ligand HL1 is not able to sensitize the typical 
MC emission of this ion. Indeed, 1d does not present no typical MC 
emission is present from 1d in solution, even at low temperature.  
The emission spectrum of compound 1a reveals the typical MC bands of 
the europium ion (Fig. 10), and it is possible to observe the 0 D5 → 7 FJ 
transitions with J from 0 to 4. The presence of the forbidden 0 D5 → 7 F0 
and 0 D5 → 7 F3 transitions and, above all, the high value of the ratio 
between the 0 D5 → 7 F2 and 0 D5 → 7 F1 intensities are in line with a low 
symmetry environment of the Eu3+ ion, lacking an inversion center, in 
agreement with the geometry observed in the crystal structure (Fig. 10 
left). For this case, the energy of the 3LC transition is compatible with a 
good energy transfer from the ligand to the metal center. However, low 
values were observed for the measurements of its lifetime (Table 6.2) an 
unespected result for similar compounds (lifetimes in the range of 
hundreds of microseconds), evidencing the presence of favorable 
nonradiative deactivation pathways. The energy of the MC state is close 
to the one of the 3LC transition, so that the sensitization of the MC state 
is possible but with the establishment of a thermally activated equilibrium 
Figure 6.10 left: View of the europium the tetra-chelate complex in the crystal structure 
1a. Hydrogen atoms have been omitted for clarity.  Right: Emission spectra of 1a 
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between the two states. This assumption is supported by a 10-fold 
increase of the emission lifetime observed at low temperature (77 K). The 
neodymium complex 1c is also efficiently populated by the ligand, 
presenting the typical IR bands at 893 and 1065 nm with an interesting 
emission quantum yield of ca. 2%. The luminescence spectra of the two 
complexes 1e and 1f are very similar to those observed for their L1 
homologues, but with a longer lifetime (Table 6.2), probably due to the 
higher energy of its 3LC state, a condition that would shift the above-
mentioned equilibrium in favor of the europium MC state. Due to the 
lack of luminescence of the lanthanum and terbium complexes, it was 
possible to characterize only the 1D and 2D polymers containing 
europium (2a, 3a, and 4a, Figure 6.11) and neodymium (2c and 3c)  
Figure 6.11 Emission spectra of 2a, 3a and 4a 
As a general remark, both the microcrystalline powders and the single 
crystals were characterized, with identical results obtained (data not 
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showed). A comparison between the data obtained for the 
metalloligands and the corresponding silver−lanthanide coordination 
networks showed that no significant change the photophysical behavior 
of this specie was observed in the presence of the silver centers. This 
means that the presence of silver pincer-like secondary building units 
does not add other efficient nonradiative deactivation pathways for the 
excited states. Furthermore, the series of 2D structures containing 
europium and bearing different counteranions (4a−4c) presents again 
analogous characteristics and the data are not reported in Table 6.1. 
6.2.3 Conclusions 
In this work we explored the use of two new tetrakis-chelate 
Ln−MLs, containing the 1,3-disubstituted diketonate ligands HL1 and HL2 
, in order to prepare HMOFs by reaction with silver cations. It was found 
that this approach gives good results only using the metalloligands 
based on the 4-cyanophenylsubstituted diketonate HL1, obtaining 
different families of 1D and 2D HMOFs. The photophysical 
characterization of the ligands and the metalloligands evidenced that 
lanthanum and terbium complexes are not emissive while the europium 
ones present quite low intensities and lifetimes due to similar energies of 
the MC and 3LC states that give rise to a thermally activated equilibrium. 
However, the sensitization of neodimium complexes is very efficient. The 
heterometallic coordination networks have similar photophysical 
behavior evidencing that, both in 1D and 2D structures, the presence of 
silver ions does not add other efficient nonradiative deactivation 
pathways. The results here presented point out some of the features of 
the lanthanide metalloligands and of their interaction with silver cations 
that could be fruitfully employed in the development of new HMOFs with 
tailored structures and properties. 
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6.3 Gold Nanoparticles. 
 The Role of Onium Salts in the Pro-
Oxidant Effect of Gold Nanoparticles in 
Lipophilic Environments.  
 
Free radicals are highly unstable due to unpaired electrons. In the 
body, they are either produced by the natural metabolic process or 
byoxidative stress caused by toxins28,29. At high concentrations, radicals 
and radical derived reactive species are all hazardous to living 
systemand damage the body at cellular level30. Free radicals are 
scavenged or removed by molecules known as antioxidants31. The 
protective role of antioxidants against free radicals has been widely 
studied32 for promoting the development of antioxidants for the 
treatment of diseases associated with oxidative stress. Nanoparticles 
can potentially influence autoxidation in various ways, depending on 
their ability to generate or trap radicals, displaying pro-oxidant or 
antioxidant effects, respectively (Scheme 1)33. Nanoparticles are often 
found to be toxic, and one of the most frequently reported mechanisms 
of nanoparticle toxicity is the generation of free radicals34–37. Therefore, 
the supposed pro-oxidant activity of nanoparticles is among the key 
features determining their safety and suitability for specific applications. 
With the aim to develop novel nano-antioxidants33,38,39, we were 
interested to know if gold nanoparticles (AuNPs) can be used as inert 
carriers of small active molecules without having an intrinsic pro-oxidant 
activity, which would contrast with the desired radical trapping effect. 
Interestingly, a promising radical trapping ability in a model system (i.e., 
toward the 2,2’-diphenylpycrylhydrazyl radical) has been already shown 
for thiol-capped AuNPs bearing a-tocopherol40 or salvianic acid15 
pendants. Despite the availability of many studies that addressed the 
problem of the toxicity of AuNPs35, little is known about the stability of 
AuNPs in solution under autoxidation conditions, that is, in the presence 
of oxygen, of an oxidizable substrate and of different hydroperoxides. In 
particular, hydroperoxides accumulate during autoxidation experiments 
and can be involved in the initiation step (Fig. 6.12) by the Fenton 
reaction, already reported in Cap. 4. Differently from the aim seen 
before, now is fundamental for its radical production by iron and copper 
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NPs41,42 as the reaction between dissolved or surface metal ions and 
hydroperoxides produces hydroxyl radicals (HO·).  
Surprisingly, also gold 
nanoparticles, have 
been reported to 
induce radical 
formation in the 
presence of 
hydroperoxides, and 
have been mentioned 
as mimics of peroxidase 
enzymes, which 
catalyze the radical 
production inside the 
cell for specific functions43.  Then, there is a possible initiating role of 
AuNPs in the autoxidation reaction; this is an effect, however, apparently 
depending on the surface functionalization (NPs passivated with strong 
ligands are less active) and on the reaction conditions (low pH and 
intense light)43. The ability of AuNPs to catalyze the homolytic 
decomposition of hydroperoxides may pose a serious obstacle to their 
use in real systems, as hydroperoxides are ubiquitously found in small 
amounts in most oxidizable materials and are formed every time that a 
peroxyl radical is quenched by a chain-breaking antioxidant. Despite 
the fact that most materials requiring stabilization toward oxidative 
degradation are lipophilic (edible oils, fuel, lubricants, etc.), there are no 
reports in the literature about the pro-oxidant behavior of AuNPs in 
lipophilic (apolar) environments. With this work, we aim at filling this gap 
of knowledge by studying, in a quantitative fashion, the pro-oxidant 
activity of thiol-capped AuNPs in apolar solvents, as well as the role of 
thiols and surfactants used in the preparation of nanoparticles, so to 
pave the way to their rational use as scaffolds for the development of 
liposoluble nano-antioxidants. 
6.3.1 Aim of the work 
Given the potential use of based AuNPs as inert scaffolds for the 
design of novel nano-antioxidants, the aim of this published work in 
 
Figure 6.12. Effect of nanoparticles on the autoxidation 
of an organic substrate (RH). 
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collaboration with Prof. R. Amorati and L. Valgimigli, is to investigate if 
relatively inert thiol-capped gold nanoparticles have a role in the 
induction of the radical formation in the presence of hydroperoxides. In 
particular I sinthesized dodecanethiol-capped AuNPs (~5 nm), prepared 
via the Brust-Schiffrin method which involve transfer agent 
tetraoctylammonium bromide (TOAB) left from the synthesis and 
decreased on repeated washing of the nanoparticles, and, parallely, I 
synthesized AuNPs (~9 nm) prepared via the Ulman method without 
onium salts. In collaboration with Prof. R. Amorati group it has been 
examined the pro-oxidant activity of the first one (AuNPs1) with different 
levels of TOAB impurieties taken off from the solution by successive 
washing, comparing with the second one (AuNPs2) synthesized without 
any trace of transfer agent. Moreover, alternative onium phase-transfer 
agents Oct4NBF4, Hex4NBF4, Hex4NPF6 were comparatively investigated44. 
6.3.2 Results and discussion 
Firstly, AuNPs were synthesized. As mentioned before, to be able 
to effort the behaviour of the amount of TOAB in the NPs, it was 
necessary to follow two different synthetic method to obtain Gold NPs, 
Brust-schiffrin method which involve the phase transfer and Ullman 
method which don’t involve the use of phase transfer. 
AuNPs via Brust and Schiffrin method45. 
For the preparation of the gold nanoparticles we slightly modified the 
original procedure proposed by Brust et al.45 based on a two-phase 
method. Briefly, a water solution of HAuCl4۰3H2O were stirred with 
toluene solution of TOAB. The TOAB amount is half of the one reported in 
the original paper, this change was introduced to try to decrease his 
persistence as an impurity after purification of the product, as discussed 
later. After the complete transfer of the [AuCl4] anion to the organic 
phase, confirmed by the colour change from yellow to colourless and 
from colourless to deep red, 1-dodecanethiol was added to the organic 
phase. The separation of the two phases, followed by the addition of 
NaBH4 water solution (0.35 M) to the organic one, lead to a quick colour 
change to deep purple due to gold reduction and formation of metal 
nanoparticles. The mixture was stirred for 1 hour at room temperature 
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before particle purification (see detailed synthesis in the experimental 
section). The organic phase was separated, and ethanol slowly added 
to obtain particle precipitation. The NPs were then collected by 
centrifugation and redissolved in 8 ml of toluene. TEM analysis allowed 
to measure an average diameter of 4.5+0.5 nm (Fig. 6.13A). 
AuNPs through a modified Ulman method46:  
Shortly, HAuCL4 3H2O was dissolved distilled THF resulting in a pale yellow 
color. 1-dodecanethiol and left overnight in the dark. The reduction was 
then initiated with a one-shot addition of LiAlH4 in THF (instead of lithium 
triethylborohydride used in the Ulman method) and with successively 
add every 30 min over two hours until gas evolution ceased. The solution 
was again stirred overnight in the dark. The nanoparticles were cleaned 
by three cycles of precipitation by using EtOH followed by centrifugation 
and re-dispersion in THF. TEM analysis allowed to measure an average 
diameter of 9.0+0.3 nm (Fig. 6.13B), which is perfectly in agreement with 
the data obtained by DLS, (dH=8.5 nm, PDI=0.3) and with the UV/Vis 
spectrum (λmax=516 nm)47 (data not showed).  
Then, it was quantified the prooxidant activity of AuNPs by measuring  
their ability to initiate the autoxidation using the styrene substrate as 
standard oxidizable, in the presence of hydroperoxides. The 
autoxidation was initiated by mixing the AuNPs with the azoinitiator 2,2’-
azobisisobutyronitrile (AIBN) for the positive control and tert-butyl 
A B 
Figure 6.13 TEM images and size distribution analysis (inset) of: A) AuNPs synthesized by the 
Brust-Schiffrin method and deposited from toluene scale bar 20 nm; B) AuNPs via Ulman 
method and deposited from THF, scale bar 80 nm  
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hydroperoxide (tBuOOH), for the rest of the measurements, in the apolar 
solvent chlorobenzene. Measuring the kinetics of O2 consumption with 
an automatic gas recording apparatus38 it was possible calculate the 
rate of autoxidation. Styrene is a peculiar oxidizable substrate because 
it mainly forms a polyperoxide (i.e. phenylethane units joined by a peroxy 
O-O linkage), rather than hydroperoxides and this avoids autocatalysis 
due to hydroperoxide accumulation during the autoxidation48.  
The rate of production of free radicals (Ri) could be obtained by using 
the reference antioxidant 2,2,5,7,8-pentamethyl-6-hydroxychromane 
(TOH), structural analogue of α-tocopherol lacking the phythyl chain, 
which is able to strongly inhibit the autoxidation of styrene by reactions 
2 and 3.  
The rate of initiation Ri was determined experimentally by using Equation 
(4), where n is the stoichiometric coefficient of the antioxidant, that is, 
the number of radicals trapped by each antioxidant molecule (for TOH, 
n=2), and t is the length of the inhibited period. 
Ri=n[antiox]/τ                                            4 
 
 
TOH + ROO• → TO• + ROOH                        2 
TO• + ROO• → non-radical products           3 
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Figure 6.14 Oxygen consumption measured during styrene autoxidation in 
chlorobenzeneat 30 °C in the presence of (a) dodecanethiol-capped AuNPs (0.86 nM); 
(b) tBuOOH (3.8 mM); (c) AuNP and tBuOOH; (d) AuNP, tBuOOH and TOH (1.3 µM). 
 
159 
 
6 
Were performed then, measurements of O2 consumption during the 
autoxidation of the styrene  in chlorobenzene at 30°C in 4 different 
solutions: in presence of AuNPs1 0.86nm, with tBuOOH 3.8 mM, , AuNPs1 
and tBuOOH and the last one with AuNPs1 and tBuOOH and TOH 1.3 uM 
(Fig 6.14). 
AuNP1 obtained by the Brust-Schiffrin method, taken alone, do not 
initiate the autoxidation of styrene in chlorobenzene, while tBuOOH 
provide a slow initiation due to its self-decomposition (lines a and b, 
respectively). Instead, when AuNPs and tBuOOH are mixed together, a 
linear decrease of O2 concentration is observed (line c), indicating a 
clear pro-oxidant activity. When the reference antioxidant TOH (1.3 μM) 
was added to the oxidizing mixture, the O2 consumption was inhibited 
for about 800 seconds (line d), to start again upon consumption of the 
antioxidant, when the oxidation rate was the same as that observed in 
the absence of inhibitor. This experiment clearly indicates that the O2 
consumption is due to the on-setting of styrene autoxidation as the 
effect of radical production by the contemporary presence of tBuOOH 
and protected AuNPs. From the duration of the inhibited period, a Ri 
value 3.1x10-9 M s-1.  
Among these results, the experiments were repeated at different 
reactant concentrations, showing a fair linear dependence on 
[tBuOOH] and [AuNPs1] (Fig 6.15) 
 
Figure 6.15 Rate of radical production after mixing dodecanethiol-capped AuNPs and 
tBuOOH in chlorobenzene (30°C), as a function of the reactant concentrations. Graph (a): 
[AuNPs] = 0.86 nM; Graph (b): [tBuOOH] = 3.8 mM. 
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To clarify the mechanism of initiation, we investigated all the parameters 
that can affect the pro-oxidant behavior of AuNP1, together with the 
effect of each component used in the synthesis. There was performed a 
photophysical characterization by UV/Vis spectra of the AuNPs mixed to 
tBuOOH before and after the reaction (data not showed) which not 
reveal any significant change, indices that the radical production is not 
associated to coalescence or dissolution of the AuNPs. In analogy, the 
Ri values recorded for reactions occurring in the dark or under ambient 
light were the same (data not showed).  
Continuing with the investigation of the influence on the pro-oxidant 
behavior of the species used during the synthesis of the it was mixed 
C12H25SH (capping agent of AuNPs1) and tBuOOH we didn’t seen any 
radical formation (see Table 6.1), while mixing of TOAB and tBuOOH 
induced substantial radical generation, as shown in Figure 6.16A. 
Therefore, a calibration line was performed mixing increasing amount of 
TOAB (until 6 uM).  
 
Figure 6.16 Graph(A): Oxygen consumption measured during styrene autoxidation in 
chlorobenzene at 30 °C in the presence of: (a) tBuOOH; (b) tBuOOH and TOAB; (c) tBuOOH, 
TOAB and TOH. [tBuOOH] = 3.8 mM; [TOAB] = 3.8×10-7 M; [TOH] = 2.5x10-6 M. Graph (B): Rate 
of radical production observed after mixing TOAB and tBuOOH (3.8 mM). 
From the Fig 6.16 is clear how TOAB is a very powerful hydroperoxide 
decomposer, being effective even at submicromolar concentrations. 
After these results it was better investigate the behaviour of the TOAB 
together with the AuNPS1. It is known that AuNPs synthesized by this 
method retain a significant amount of TOAB [30] (the phase-transfer 
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reagent used in the synthesis) as an impurity, but it was also hypothesized 
that it could help the stability of the system. The content of TOAB can be 
substantially decreased by consecutive cycles of precipitation with 
ethanol–centrifugation–solubilization in toluene or by Soxhlet extraction. 
The experiments of O2 consumption were then performed in AuNPs1 
washed 3 times, in order to eliminate any trace of species which could 
influence the reaction, and the Ri for every solution is reported in table 
6.3. In particular the NPs were collected by centrifugation (6188 g for five 
minutes) and were re-dissolved in toluene (8 mL). Half of the volume was 
used and called BS1w (Brust–Schiffrin one washing step) while ethanol 
was added to the other half to make the particles precipitate again. The 
process was, in fact, repeated to have a second washing step and a 
third washing step indicated, respectively, in the text with BS2w and 
BS3w. In this contest were also used the AuNPs2 which don’t present any 
trace of phase transfer.  
Table 6.3 Pro-oxidant activity of dodecanethiol-capped AuNPs in the presence of tBuOOH 
(3.8 mM) in chlorobenzene from the rate of radical initiation (Ri), and estimated TOAB 
molecules per nanoparticle.[ 
 tBuOOH mM Ri / 10‒9 M s‒1 NTOAB /NNP 
blank 3.8 0.03±0.02  
C12H23SH (45 mM) 3.8 <0.01  
AuNPs1 BS1w (0.86 nM)b - <0.01  
AuNPs1 BS1w (0.86 nM)b 3.8 2.8±0.2 230±16 
AuNPs1 BS2w (0.86 nM)b 3.8 0.18±0.02 12±1 
AuNPs1 BS3w (0.86 nM)b 3.8 0.20±0.02 13±1 
AuNPs2 Ulm (0.3 uM)c 3.8 0.27±0.06 - 
b The concentration of 0.86 nm corresponds to 5.2x1011 AuNP per mL solution. c 1.8x1014 AuNP per mL 
solution. 
From the data exposed in table 6.3 is clear that the pro-oxidant activity 
of the AuNPs drastically decreases after the second washing cycle, 
remaining approximately constant with the third cycle. The Ri values 
decreased about 10-fold, from 2.8x10-9 to 1.8x10-10 Ms-1 . This lower value, 
however, is still 6-fold larger than that due to the spontaneous 
decomposition of tBuOOH, indicating a residual pro-oxidant activity that 
could be ascribed either to traces of TOAB still present, or to an intrinsic 
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activity of the thiol-capped gold surface. Comparing the AuNP1 after a 
different number of washing cycles, there was no significant difference, 
it can be concluded that some persistent impurity of TOAB is left on the 
surface. Indeed, Schiffrin et al. reported that a persistent impurity of 
1.33% by weight cannot be removed by repeated washing49. 
Considering the size of our particles, such amount would correspond to 
about fifteen molecules of TOAB per nanoparticles. Lastly, when AuNPs2 
were mixed to tBuOOH, however, these nanoparticles showed no pro-
oxidant activity. The concentration useful to see comparable value of Ri 
with the BS3W is obtained only using them in a concentration 300-fold 
larger. It can be, therefore, concluded that the intrinsic pro-oxidant 
behavior of thiolcapped AuNPs is negligible under our conditions. The 
number of TOAB per Au nanoparticle was estimated assuming that gold 
spheres of 2.25 nm of radius (TEM data) constitute our samples, with a 
gold density of 19.32 g/cm3 and that each thiol terminating capping 
agent occupies an average area of 21 Å2. We could calculate the 
surface area, the volume and consequently the weight of each gold 
core (9.22 x 10-19g). The number of thiols on each NP resulted circa 300, 
therefore,adding the weight of the organic part to the particle core we 
could calculate a total weight of 1.02 x10-18 gr for each NP. For a 0.86 nM 
concentration of NPs, assuming that the persistent TOAB could be the 
1.33% of the total weight49, we obtained a TOAB concentration of 1.29 x 
10-8 M after repeated washing. These data yield an attended number of 
TOAB/NP of 13. 
Moreover, further measurements were performed in order to study the 
activity of different ammonium ions, having Cl- as counterion. In 
particular we set to investigate alternative phase-transfer agents that 
could, in case, be used to replace TOAB it in the Brust–Schiffrin synthesis. 
As the bromide ion had been indicated in some studies as the cause of 
oxidative instability of thiol-protected gold nanoparticles, surfactants 
having the relatively more inert BF4- and PF6- counterions were 
considered with different chain length. Data, reported on the paper44, 
showed how the length have weak influence in the pro-oxidant activity 
and as expected the replacing with PF6- and BF4-counterions giving less 
behavior pro-oxidant, but it never disappear. 
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6.3.3 Conclusions 
In order to evaluate the the Pro-oxidant activity of AuNP in apolar 
solvents, were synthesized AuNP1 (gold Nps Synthesized by Brust–Schiffrin 
method) and it has been measured the consumption of O2 given by the 
reaction between the styrene and initiator tBuOOH and TOH as 
reference antioxidant in presence of AuNPS1. Studing deeply all species 
involved in the reaction, it was found that mixing of TOAB and tBuOOH 
induced substantial radical generation. It has been demonstrated than 
the TOAB which is present in the AuNPs1 synthesized using Brust-Schiffin, 
play a fundamental role in their pro-oxidant activity. Infact, AuNPs were 
washed over 3 times giving 3 differents batch BS1W, BS2W and BS3W 
presenting a numbero of TOAB/NPs respectively 221, 12 and 13. The rate 
Ri of the consumption of the oxygen decrease drastically with the 
number of the TOAB. Furthermore, AuNPs2 (synthesized by Ullman 
method) which don’t present any trace of phase transfer, infact showed 
pro-oxidant activity comparable with BS3W only by using them at a 300-
fold larger concentration. It is possible to conclude that TOAB has a 
strong catalytic hydroperoxide-decomposing activity in apolar solvents, 
being active at sub-micromolar concentrations. We have shown that, 
besides TOAB, also other onium salts with different polar heads and alkyl 
tails catalyze the production of free radicals when mixed to 
hydroperoxides. Such initiating effect of onium salts is one possible 
reason of the long known toxicity of AuNPs stabilized by these 
compounds50,51. For instance, the cytotoxicity of CTAB 
(cetyltrimethylammonium bromide)-capped nanorods on human colon 
carcinoma cells (HT-29) is caused by the free CTAB in solution, and it is 
strongly reduced by different capping agents52. As the apolar organic 
system studied herein is representative of the bio-membrane interior, our 
results suggest that AuNPs can release onium salts in phospholipid 
bilayers, thereby promoting lipid peroxidation associated with the loss of 
integrity and function. We believe this awareness will prove very valuable 
in the design of novel less-toxic nanomaterials. 
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EXPERIMENTAL 
SECTION 
Chemicals 
All reagents, solvents and chemicals were purchased from Sigma-
Aldrich, Fisher or Alfa-Aesar and used directly unless otherwise stated 
(purity: reagent or analytical grade). Peptide sequence presented in 
chapter 5 was purchased by Sigma-Aldrich. 
Common purification methods 
Normal flash chromatography was performed for molecular part, dialysis 
steps and/or centrifugation for nanomaterials e micromaterials. Dialysis 
was performed vs. water at room temperature under gentle stirring with 
regenerated cellulose dialysis tubing purchased by Sigma Aldrich, mol 
wt. cut-off > 12 KDa, avg.  diameter 33 mm).  
 
Photochemical & Instruments 
Electronic absorption spectra 
For the acquisition of electronic absorption spectra, a double beam 
spectrophometer UV/Vis Perkin Elmer Lambda-45 was used. The spectra 
were recorded at 25”C using 1cm quartz cells.  
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The components of the spectrophotometer are: source: formed by two 
lamps, a tungsten filament lamp which works between 1100 nm and 320 
nm and a deuterium lamp operating between 320 nm and 190 nm; 
monochromator: a diffraction lattice; sample: a solution of the sample 
contained in a cuvette, generally of quartz; reference: the solvent, 
contained in a second cuvette; a photomultiplier tube detector; 
chopper, a mechanical device which allows the light to be alternatively 
transmitted through the sample and the reference, or to be suppressed 
in order to measure the dark current of the photomultiplier used as 
detector; mirrors. The amount of the absorbed light is provided by the 
difference of the intensity of incident light I0 and the intensity of 
transmitted light It and it is expressed as transmittance T: 
T=It/I0 
or as absorbance A: 
A=-log10T=log10(I0/It) 
From the registered spectra moreover it is possible to determine the 
probability of every transition by calculating the molar absorption 
coefficient ε, expressed in M-1 cm-1 , according to Lambert-Beer law:  
A= εcl 
 where A is the absorbance of the sample, c is the molar concentration 
of the sample, and l is the optical path length of the cuvette (usually 1 
cm).  
Emission and excitation spectra 
The registration of the emission and excitation spectra was performer 
using a spectrofluorimeter Perkin Elmer LS55 and a spectrofluorimeter 
Fluorolog 3 ISA Jobin Yvon – Spex, Instruments S.A.  
These instruments consist of a xenon lamp source, pulsed in the case of 
Perkin Elmer LS55, continuous-wave in the case of Fluorolog 3; two 
monochromator excitation light and for emission light; two 
photomultipliers, one in order to correct the signal as a function of the 
emission spectrum of the lamp, and the second, for the detection of the 
emission signal of the analyte; sample lock and a chopper. The slits 
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determine the bandwith of the excitation and emission light. In order to 
register an emission spectrum, the excitation monochromator must be 
positioned at a determined wavelength, which normally relates to the 
absorption maximum or lower wavelengths, and a scan with the 
emission monochromator is performed. Solutions having an absorbance 
lower than 0.1 at the excitation wavelength have to be used so that the 
relation between the emission intensity and the concentration is linear. 
In order to register an excitation spectrum, the emission monochromator 
is positioned at a fixed wavelength which generally corresponds to the 
emission maximum or higher wavelengths, while the excitation 
monocromator scans the spectrum region in which the sample absorbs. 
If we want to obtain a correct spectrum, we need a solution of sample 
possessing an absorbance lower than 0.1 all over the wavelength range 
chosen to register the excitation spectrum. In this way the registered 
emission intensity is directly proportional to the absorbance value, and 
the obtained spectrum results proportional to the absorption one (this is 
strictly true if the species follows Kasha’s rule).  
 
Luminescence quantum yield assessment  
For solid samples, emission quantum yield was calculated from 
corrected emission spectra registered by an Edinburgh FLS920 
spectrofluorimeter equipped with a barium sulfate coated integrating 
sphere (4 in.), a 450W Xe lamp (λ excitation tunable by a 
monochromator supplied with the instrument) as light source, and a R928 
photomultiplayer tube, following the procedure described by De Mello 
et al4. In all other cases, same instruments seen above for emission 
spectra were used. 
The luminescence quantum yield φl , defined as the ration between the 
number of emitted photons and the number of photons absorbed by a 
species in the same time and for a determined excitation wavelength. 
For the evaluation of luminescence quantum yield with a relative 
method there is a necessity of a reference, a known φl. The species used 
as a reference should emit in the same spectral region in which the 
sample emits so that emission spectra are obtained in the same 
experimental conditions. For the assessment φl of we adopted the 
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following experimental procedure1: the absorption spectra of the 
sample and of the reference were registered and, when possible, 
isosbestic points were used as excitation wavelength for the registration 
of emission spectra.  
Excited state lifetime measurements technique 
Time-resolved phosphorescence measurements were carried out using 
a custom-made fiber-optic phosphorometer constructedaround a 
multichannel data acquisition board (USB NI-6361, National Instruments) 
operating at 2 MHz frequency. The excitationources in the instrument are 
light-emitting diodes (LED’s) (LedEngin, LZ1), and the detector is an 
avalanche photodiode module(C12703, Hamamatsu). The 
luminescence decays were analyzed using non-linear least-squares 
method. The IRF of the instrumentis1ms (FWHM). All the custom software 
(hardware control, data collection and processing) was written in C/C++ 
(Qt, Nokia). Routine data analysis was performed using Origin 7.0 
(OriginLab). 
Dynamic light scattering 
Hydrodynamic diameter  
DLS measurements were performed using a Malvern Instruments DLS 
ZetaSizer Nano-ZS (Fig E1) equipped with a 633 nm laser diode. Samples 
were housed in disposable polystyrene cuvettes of 1 cm optical path 
length, using water as solvent. 
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With this instrument it is possible to determine the dimension and the Z-
potential of the particles having a diameter between 1 nm and 10 μm.  
Its components are: 
• Laser: He-Ne laser (λexc = 633 nm), that lights the sample. 
• Cell: it contains the sample. 
• Detector: positioned at 173° or at 90° with respect to the incident 
laser beam, it registers the lightscattered by the sample. 
• Attenuator: it modulates the intensity of the laser beam. 
• Correlator: it compares the output signals as a function of time 
• Nano Software: it translates the information, by providing the 
dimensions of the several populations of particles present in the 
sample. 
The DLS technique allows the measurements of submicrometric particles. 
It exploits the study of Brownianmotions to determine the hydrodynamic 
diameter of particles suspended in solution. The higher the dimensions, 
the lower the particle speed of displacement: as a consequence the 
Figure E1  blocks scheme of DLS instrument 
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smallest particles move more rapidly. It is necessary to know the viscosity 
and the temperature of the system for DLS measurements and in 
particular the system has to be kept at a constant temperature in order 
to avoid internal convection currents that can affect the measurements. 
Stokes-Einstein equation defines the dimensions of a particle from its 
translational diffusion coefficient, 
d(H)=kT/3πηD 
where d(H) is the hydrodynamic diameter espressed in m, k is Boltzmann 
constant in J∙K-1, T is the absolute temperature, η is the viscosity in Kg∙m-
1∙s-1 and, is the diffusion coefficient in m2∙s-1. The obtained diameter is a 
value referred to particles dispersed in a fluid, so it is reported as 
hydrodynamic diameter, which is defines as the diameter of a rigid 
sphere that diffuses at same speed of the particle. Its value is not only 
dependent of the particle dimensions, but also of the concentration and 
the kind of ions present in the dispersant. Some changes in the superficial 
structure are able to influence the diffusion speed and as a 
consequence the hydrodynamic diameter of the particle: for example, 
a polymeric shell covering a nanoparticle can reduce the diffusion 
speed and thus enhancing its hydrodynamic diameter. The charge and 
the concentration of ions in the dispersant also influence the diffusion 
speed of the particle: an increase of the ionic strength causes a 
decrease of the hydrodynamic diameter. According to Rayleigh 
approximation, the light scattering of the particles irradiated by the laser 
is mainly isotropic if the particles have dimensions that are negligible with 
respect to the wavelength used (generally less than λ/10)about 60 nm if 
a He-Ne laser is used). With this hypothesis the scattered light intensity I 
becomes directly proportional to the sixth power of the particle diameter 
d and inversely proportional to the fourth power of the incident light 
wavelength λ: 
I ∝ d6 
I ∝ λ-4 
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The proportionality to d6 specifies that the ratio between the scattering 
intensity of a particle having a diameter of 50 nm and that of one having 
a diameter of 5 nm is equal to 1 million. The proportionality to λ-4 indicates 
that a high scattering intensity is obtained using short wavelengths. If we 
imagine that a stationary state is reached, we would observe a speckle 
pattern after the laser irradiation (Figure E2 left). 
The black zones are due to the effect of a destructive interference of 
scattered light of different particles (Fig. E2 rigth). Observing the system 
from a dynamic point of view, that is considering that Brownian motion 
occurs, the single points of the pattern are in continuous motion.  
The correlator is necessary to measure the frequency spectrum of these 
intensity fluctuations. It compares the signals by measuring their degree 
of similarity in a determined time range. For a random process, such as 
diffusion, it is not possible to correlate two signals that are temporally 
distant, that is when δt is in the order of milliseconds (Figure 3). On the 
other hand, if δt is in the order of microseconds to nanoseconds, it is 
possible to observe that the signal intensity at the time t is correlated with 
the signal in the subsequent instant t+δt. 
Figure E2 left representation of speckle pattern rigth destructive interference of scattered 
light of different particles 
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If the particles are big, the signal slowly fluctuates, and the correlation 
persists for a long-time interval. On the other hand, if the particles are 
small, they rapidly move and the correlation decreases more quickly. In 
Fig. E3 the differences in the shape of the correlogram as a function of 
particle dimensions is shown: the left correlogram represents a sample 
containing big particles and it is characterized by a slow decay; the right 
one relates to small particles and it is characterized by faster decay.  
The hydrodynamic diameter is obtained from the correlogram mainly by 
using two approaches: 
• Monoexponential fitting of the correlation function in order to 
obtain the average dimension (Zaverage diameter) and an 
estimate of the width of the distribution (Polidispersity index, PDI);  
• Multiexponential fitting of the correlation function in order to 
obtain the particle size distribution. 
 
The particle size distribution is obtained from the relative scattering 
intensity graph of the several particle size classes (intensity size 
distribution). It is also possible to obtain this distribution as a function of 
particle volume, or particle number. Let us consider, for example, a 
sample containing two populations of spherical particles having a 
diameter of 5 and 50 nm respectively and present in the same number 
(Fig E4). As far as the number of particles is concerned, the graph consists 
of two peaks, one at 5 nm and the other at 50 nm, with a 1:1 ratio. If we 
Figure E3 intensity fluctuations of thr scattered light as a funtionn of time 
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convert the number distribution in volume distribution, the two peaks 
ratio is 1:1000, because the volume of a sphere is equal to 
4π
3
(
d
2
)
2
. 
If we switch to intensity distribution, the ratio becomes equal to 1:106 
according to Rayleigh approximation. 
In output are obtained data: 
• Hydrodinamyc volume 
• Correlation function 
• PDI, polydispersity index is the index of a hypothetical width of a 
monomodal gaussian distribution  
Finally it is important to underline that sample absorbing and/or emitting 
at the analysis wavelength are not suitable for DLS technique. 
 
 
-Potential 
SiNPs -Potential values were determined using a Malvern Nano ZS 
instrument. Samples were housed in disposable polycarbonate folded 
capillary cell (750 µL, 4 mm optical path length). Electrophoretic 
Figure E4 Number, volume and intensity distribution of a sample containing 
spherical particles of 5 and 50 nm diameter in equal number 
Figure E5 PDI equation and gaussian distribution 
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determination of -Potential was made under Smoluchowski 
approximation in acqueous media at moderate electrolyte 
concentration.  
The Z-potential is a physical property shown by every particle in solution 
and it is fundamental to formulate a stable colloidal suspension.  There 
are two fundamental mechanisms that influence the stability of a 
colloidal system: Steric repulsion which involve the absorption on the Ps 
surface of the polymers added in solution to prevent the Ps contact. 
Electrostatic Stabilization: this is the 
effect between Ps interaction due to 
the charged species distribution in 
the system. 
Every mechanism has it advantages, 
but focusing on Electrostatic 
Stabilization, there is a need to considerate that the presence of an 
overall charge on the surface of the particle influences the distribution 
of the ions around it, resulting in an increasing amount of the counter-
ions close to it surface. This leads to a double electric layer formation 
around any Ps. The liquid layer which surrounds the particle has 2 parts, 
the internal one (Stern layer) which 
has the ions well attracted and the 
external one (diffuse layer) where are 
the weak attracted ions. In the diffuse 
layer there is an imaginary edge 
which contain the entire Particle. This 
means that the ions inside this board 
move with the particle when it moves 
in solution, while the external ions stay 
with the solution bulk. The difference 
between this board and the bulk of 
the solution is the ζ-Potential. The ζ -
Pot are calculated measuring the 
electrophoretic mobilities (the 
movement of a charged particle 
respect to the solution under the influence of an applied electric field) 
Figure E7 representation of charged 
layers around the NPs surface  
Figure E6 schematization of steric (left) 
and electrostatic (right) stabilization 
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where is used a capillary cell equipped with electrodes capable to 
accept the applied potential, resulting in a movements of the Ps towards 
proper electrode, measuring its speed. The particle speed in electric field 
unit is defined as its electrophoretic mobility. The Z-Pot is linked with 
electrophoretic mobility by Henry equation  
Where Ue is the electrophoretic mobility, ζ is ζ -Pot, ε is the dielectric 
constant, è la viscosità e f(Ka) is the Henry function. The Malvern Zeta 
sizer instrument uses the combination of the Doppler laser velocimetry 
and phase analysis light scattering (PALS) in a patented technique 
called M3-PALS to measure the electrophoretic mobility. 
 
TEM 
The instrument used for the TEM analysis is a Philips CM 100 TEM operating 
at 80 kV. For TEM investigations, a holey carbon foil supported on 
conventional copper microgrids was dried under vacuum after 
deposition of a drop of NP solution diluted with water (1:50). We 
obtained the size distribution by analysing images with a block of several 
hundreds of NPs using software ImageJ.  
In this instrument, the beam of electrons from the electron gun is focused 
into a small, thin, coherent beam by the use of the condenser lens. This 
beam is restricted by the condenser aperture, which excludes high 
angle electrons. The beam then strikes the specimen and parts of it are 
transmitted depending upon the thickness and electron transparency of 
the specimen. This transmitted portion is focused by the objective lens 
into an image on phosphor screen or charge coupled device (CCD) 
camera. Optional objective apertures can be used to enhance the 
contrast by blocking out high-angle diffracted electrons. The image then 
passed down the column through the intermediate and projector lenses, 
is enlarged all the way. The image strikes the phosphor screen and light 
is generated, allowing the user to see the image. The darker areas of the 
image represent those areas of the sample that fewer electrons are 
transmitted through while the lighter areas of the image represent those 
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areas of the sample that more electrons were transmitted through. As 
the electrons pass through the sample, they are scattered by the 
electrostatic potential set up by the constituent elements in the 
specimen. After passing through the specimen they pass through the 
electromagnetic objective lens which focuses all the electrons scattered 
from one point of the specimen into one point in the image plane. 
 
SEM 
The SEM instrument used is MERLIN Zeiss Type FESEM, field emission 
scanning electron microscope. Sofware used is SmartSEM v5.06.  
The scanning electron microscope uses a focused beam of high-energy 
electrons to generate a variety of signals at the surface of solid 
specimens. The signals that derive from electron-sample interactions 
reveal information about the sample including external morphology 
(texture), chemical composition, and crystalline structure and 
orientation of materials making up the sample. In most applications, 
data are collected over a selected area of the surface of the sample, 
and a 2-dimensional image is generated that displays spatial variations 
in these properties. Areas ranging from approximately 1 cm to 5 microns 
in width can be imaged in a scanning mode using conventional SEM 
techniques (magnification ranging from 20X to approximately 30,000X, 
spatial resolution of 50 to 100 nm). The SEM is also capable of performing 
analyses of selected point locations on the sample; this approach is 
especially useful in qualitatively or semi-quantitatively determining 
chemical compositions (using EDS), crystalline structure, and crystal 
orientations (using EBSD). The design and function of the SEM is very 
similar to the EPMA and considerable overlap in capabilities exists 
between the two instruments. The difference in the FESEM is that the 
beam gun in SEM is thermoionic and in FESEM is electromagnetic. thus, 
in FESEM the electron beam is more powerful. 
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CONFOCAL microscopy 
For cap2 biological assay the microscope used is Nikon d-eclipse C1 
equipped with lasers 405, 488 and 543 nm.  
 
OPTICAL MICROSCOPE 
The used microscope is Leica DMI3000B equipped with lens 100x/1.4-0.7 
2PLSM2 using 2PA 
It was performed at University of Zurich, follow the ref for a very 
exhaustive explanation of the instrument and technique. 
The two-photon absorption is a nonlinear optic phenomenon where two 
photons are absorbed simultaneously to populate the excited state of 
the dye. 
The probability of two photon absorption (2PA) depends on the σ(2), the 
2PA cross-section, the ability of the choromophore to absorb light via 2P 
mechanism and Φ the photon flux by the equation: 
𝛼 = 𝜎(2)𝛷2 
The probability  𝛼 have a quadratic dependence of rate on flux, this 
means that higher number of photons need to be focused in a small 
volume to have an observable two photon absorption. This property is 
used in the two-photon excitation microscopy, where using a high-
power femtoseconds focused laser is possible to have two photon 
excitation only in the focal spot increasing greatly the resolution 
compared to confocal microscopy. 
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Cap2 
Synthesis of 2 
 Cat Solvent Time&T Yield 
I Cu(PPH3)3Br 5% DCM O.N, rt 74% 
II Sodium Ascorbate 2% 
CuSo4H10O5 1% 
H2O/t-Bu 
(1:1) 
48h, rt 65%(desililated 
product) 
III Cu(PPH3)3Br 10%  O.N, rt 99% 
IV Cu(PPH3)3Br 10%  O.N, rt 55% 
 
Molecule 1 (1.1 eq.) is solubilized in dry DCM together with the catalyst. 
The reaction is left stirring overnight and the product of the reaction is 
direct used for the purification step by flash chromatography DCM-
MeOH (9:1-7:3) 1H NMR (400 MHz,CDCl3) δ 8.93 (s, 1H), 8.50 (s, 1H), 8.41 
(s, 1H), 7.75 (m, 9H), 7.66 (m, 7H), 7.46 (d,J = 8.0 Hz, 1H), 7.12 (d, J = 7.7 Hz, 
1H), 5.01 (t, J = 6.4 Hz, 2H) ,4.92 (s, 2H), 4.69(s, 2H), 3.91 (m, 2H), 2.34 (s, 
2H), 1.06 (s, 9H), 0.29 (s, 6H). 
Synthesis of 3 
1(2 eq,) crownether and p-formaldeyde (3 eq) were added in a dry 
toluene and left the reaction refluxing for 24h. The product 3 is collected 
by rotavapor Y=90% 1H NMR (400 MHz, CDCl3) δ=8.90 (dd, J = 4.1, 1.6 Hz, 
2H), 8.44 (dd, J = 8.6, 1.7 Hz, 2H), 7.43 (dd, J = 8.5, 4.2 Hz, 2H), 7.17 (d, J = 
6.8 Hz, 2H), 4.92 (s, 4H), 4.19 (d, J = 2.4 Hz, 4H), 4.02 (s, 4H),3.73 (t, J = 5.4 
Hz, 8H), 3.64 (s, 8H), 2.97 (t, J = 5.4 Hz, 8H), 2.52 (t, J = 2.4 Hz, 2H).HPLC-MS 
(ESI): Rt: 6.23-7.47-5.63 min, m/z calcd [M+H]+:713.35, found: 713.0. 
Synthesis of 4 
HDMS (20 eq) and 3 were added in a dry flask and kept in reflux 
conditions for 24h. Under Argon flux were added dry DCM, (3-
Azidopropyl) triphenylphosphonium Bromide (1.9 eq) and Cu(PPh3)3Br 
10% mol. The reaction was left stirring overnight and the product was 
collected by rotavapor. Y=90% 1H NMR (4010MHz, CDCl3) δ 8.75 (d, J = 
4.0 Hz,2H), 8.40 (d, J = 8.4 Hz, 2H), 8.28 (s, 2H), 7.71 (m, 30H), 7.38 (m, 2H), 
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4.98 (d, J =6.2 Hz, 4H), 4.90 (s, 4H), 4.67 (s, 4H), 3.89 (s, J = 21.0 Hz, 8H), 3.63 
(m, 8H), 2.87 (s, 8H), 2.32 (s, 4H), 0.31 (s, 18H), 0.05 (s, 12H). 
 
Trials for first attempt (Fig 2.4): 
Trial Mol 1 Crown p-formaldehyde Solvent Yield 
I    Toluene 0% 
II 2 eq 1 eq 2 eq CH3Cl 0% 
III    EtOH 0% 
 
 
Cap 3 
Dye silanizaton (40 mg, 1 eq.) was dissolved in a 20 mL scintillation glass 
vial with 4 mL of DMF. CDMT (31.6 mg, 1eq x every COOH.), NMM (37.6 
μL, 2eq x every COOH) and APTES (42.1 μL, 1eq x every COOH.) were 
added to this solution. Upon the addition of NMM and APTES, a red slurry 
formed and quickly dissolved. The reaction mixture was stirred overnight 
in the dark. The mixture reaction containing the conjugate dye-APTES 
was directly used for the nanoparticle synthesis without further 
purification. 
Purification silanized compound: It is possible to obtain clean silanized 
dye for further analyses using a precipitation in ether. This method 
doesn’t allow to obtain the powder for the quantum yield calculation 
but is useful for the complete characterization of the solid dye, otherwise 
impossible to purify. A large amount of cold ether is put in a round flask 
and kept under stirring. A very small amount of product is dropped into 
the ether very slowly. (the ractio between ether and dye should be 1/20 
vol/vol). The precipitation starts visiblly by naked eyes and the powder is 
collected by rotavapor.  
NPs Synthesis A precise amount of silanized porphyrin dye mixture 
(obtained by silanization batch was added to a mixture of 100 mg of 
Pluronic F127, NaCI (68.6 mg), organic solvent and 1 M acetic acid. The 
total volume of the organic solvent and 1 M acetic acid was 1.55 mL. 
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Various volumes of porphyrin dye mixtures were added to obtain the 
desired NPs doping level (0.5%, indicated as %mol of dye vs. mol TEOS). 
The mixture was then solubilized under magnetic stirring at 25 °C, and 
TEOS (180 μL, 0.80 mmol) was added to the resulting homogeneous 
solution followed by TMSCI (10 μL, 0.08 mmol) after 180 min. The mixture 
was kept under stirring in the dark for 24 h at 25 °C before dialysis. The 
dialysis purification was carried out against water and finally diluted to a 
total volume of 10 mL with water.  
Asterisk IR spectrum: Blue line Asterisk molecule cm-1=3388.05, 3086.80, 
2654.89, 2547.79, 1682.61, 1590,03  
Red line silanized Asterisk  molecule cm-1= 3261.70, 2971.32, 2928.44, 
2882.08, 2475.30, 2353.78, 1634.92. 
 
Cap 4 
HEXAPODS SYNTHESIS: For hexapods on hematite cubes with 1 um of 
edge length, PVP (1.0 g, Mn = 40 kg/ mol) powders were dissolved in 1-
pentanol (10 mL) by magnetic stirring at 80 °C for 12 h. Once the PVP 
powders were completely dissolved, anhydrous ethanol (1 mL), distilled 
water (280 μL), hematite cube suspension (2.5 wt %, 200 μL), and sodium 
citrate aqueous solution (0.18 M, 100 μL) were added into 1-pentanol 
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solution with PVP and mixed for a minute handly. Then, ammonia (28 wt 
% in water, 200 μL) was mixed by hand shaking, and TEOS (x μL) was 
introduced into the mixture. After all ingredients were mixed by hand 
shaking, the bottle was left to age for 12 h. Then, powders were collected 
by ultracentrifuge at 3000 rpm for 30 min and redispersed in ethanol, 
which was repeated twice. For matchstick-like particles, we repeated 
the same experimental procedures but with more distilled water (200 μL). 
For matchstick-like particles with a 570 nm hematite cube, more 
hematite cubes (4 wt %) were used as seeds. 
X= 80 μL for 1.5 μm arm length, 140 for 1.5 μm arm length, 200 for 5 μm 
arm’s length 
BIOTINYLATION: The formulated protocol starts diluiting 100 uL of 
concentrated clean hexapods in EtOH in a 1 ml centrifuge Eppendorf. 
Then ere added 600 uL Biotine-PEG-Silane 6 mg/mL previously dissolved 
in EtOH and kept the solution under gently stirring overnight 
STREPTAVIDIN RECOGNITION (made by the collaborators at university of 
Netherland GB group ): Protocol details reported: the biotinylated 
hexapods were washed 3 times in water, 5 min-1000 rpm. Alexa Fluor 647-
Streptavidin was added (50ug/mL). The incubation time was 2h15min. 
The particles were washed 3 times in water 5 min 1000 rpm and 100 uL of 
PBS were added together with rabbit anti-streptavidin antibody (poly 
Rabbit, Novus, NB100-175) 25ug/mL. 
SWIMMERS In 100 ml of water were dissolved 3mg of hematite cubes 
(previously dissolved and sonicated in 1 mL of water) where 0.1% of 
NH4OH is added together. At this point 1 mL of TPM is added and the 
reaction was left stirring for 1 hour. After the sphere dimension check 
under optical microscope HCl is added. For complete ejection of the 
cubes were added 700 uL of HCl. Decreasing the volume of HCl is 
possible to modulate the ejection of the cubes. After that 10 mg of AIBN 
were added to the solution and it was left in the oven overnight at 100°C. 
The purification was performed by several steps of centrifugation in 
water and 3 steps were performing using a magnet to collect only the 
magnetic spheres.  
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The mobility of the swimmers was evaluated using a glass capillary filled 
with the clean swimmer solution together with a 10uL of Hydrogen 
peroxide. The capillary is linked with the common microscope glass by a 
transparent glue which close the extremities of the capillary. Under 
optical microscope was evaluated the “swimming” behavior turning on 
the blue light. When the light is turned on the Fenton reaction starts, and 
the swimmers starts to move. When the light is turned off, they stop to 
swim and continue to move just by the Brownian motion. 
Cap5 
Rhodamine B piperazine amide3. A 2.0 M solution of trimethyl aluminum 
in toluene (22.6 mL, 45.2 mmol) was added dropwise to a solution of 
piperazine (7.8 g, 91 mmol) in 35 mL of CH2Cl2 at room temperature. After 
one hour of stirring a white precipitate was observed. A solution of 
rhodamine B base (10.0 g, 22.6 mmol) in 20 mL of CH2Cl2 was added 
dropwise to the heterogeneous solution. Gas evolution was observed 
during the addition period. After stirring at reflux for 24 h, a 0.1 M aqueous 
solution of HCl was added dropwise until gas evolution ceased. The 
heterogeneous solution was filtered, and the retained solids were rinsed 
with CH2Cl2 and a 4:1 CH2Cl2/MeOH solution. The combined filtrate was 
concentrated, and the residue was dissolved in CH2Cl2, filtered to 
remove insoluble salts, and concentrated again. The resulting glassy solid 
was then partitioned between dilute aqueous NaHCO3 and EtOAc. 
After isolation, the aqueous layer was washed with 3 additional portions 
of EtOAc to remove residual starting material. The retained aqueous 
layer was saturated with NaCl, acidified with 1 M aqueous HCl, and then 
extracted with multiple portions of 2:1 iPrOH/CH2Cl2, until a faint pink 
color persisted. 
The combined organic layers were then dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The glassy purple solid was 
dissolved in a minimal amount of MeOH and precipitated by dropwise 
addition to a large volume of Et2O. 
1H NMR (400 MHz, CD3OD): δ  1.25-1.38 (t, 12, J=7.5), 3.20 (br s, 4), 3.68-
3.80 (m, 12), 7.13-7.34 (d, 2, J=2.5), 7.52-7.58 (dd, 2, J=2.6, 10.0), 7.31-7.38 
(d, 2, J=9.5), 7.7.53-7.57 (m, 1), 7.81-7.85 (m, 3) 
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Rhodamine silanizaton (40 mg, 1 eq.) was dissolved in a 20 mL scintillation 
glass vial with 4 mL of DMF. CDMT (31.6 mg, 1eq x every COOH.), NMM 
(37.6 μL, 2eq x every COOH) and APTES (42.1 μL, 1eq x every COOH.) 
were added to this solution. Upon the addition of NMM and APTES, a red 
slurry formed and quickly dissolved. The reaction mixture was stirred 
overnight in the dark. The mixture reaction containing the conjugate 
dye-APTES was directly used for the nanoparticle synthesis without further 
purification. 
RhB@NPs Synthesis Solid silanized Rhodamine (0.025% in mol of TEOS), 
NaCI (68.6 mg) and 100mg of PF127 were dissolved in 3.1 mL of 1M acetic 
acid solution. The mixture was then solubilized under magnetic stirring at 
25 °C, and TEOS (180 μL, 0.80 mmol) was added to the resulting 
homogeneous solution followed by TMSCI (10 μL, 0.08 mmol) after 180 
min. The mixture was kept under stirring in the dark for 24 h at 25 °C before 
dialysis. The dialysis purification was carried out against water and finally 
diluted to a total volume of 10 mL with water.  
PF127-COOH PF-127 (1.0 mmol) and NaIO4 (8.2 mmol) were placed in a 
250-mL round-bottom flask. Water (60 mL), acetonitrile (24 mL), and 
carbon tetrachloride (21 mL) were added to this mixture; RuCl3 (0.044 
mmol) was added to the resulting biphasic solution and the reaction 
mixture was stirred overnight at RT, followed by repeated extractions with 
CH2 Cl2 . The reunited organic phases were dried over Na2 SO4 , filtered, 
and evaporated. 1H NMR (300 MHz, CDCl3, 25°C, δ ppm): 4.02−4.04 (d, 
4H, −CH2COOH); 3.73−3.77 (t, 4H, −OCH2CH2OCH2COOH); 3.52 (s, 
−OCH2CH2O−) and 3.39−3.42 (m, −OCH2C−CH3O−)  922H; 3.26−3.29 (m, 
−OCH2CHCH3O−) 65H, 1.00-1.02 (d, −OCH2CHCH3O−)  195H; 
Peptide coupling The functionalization of NP-COOH with the peptidic 
sequence CGIYRLRS was carried out by mean of a one-step coupling 
reaction. To 3 mL of a 20 µM aqueous solution of NP-COOH were added 
30 µmol and 60 µmol of 0.2M aqueous solution of EDC·HCl and sulfo-NHS, 
respectively. 10 mL of a 2 mg/mL solution of peptide in borate buffer 0.01 
M (pH= 9.0) was then added and the mixture was left under magnetic 
stirring at room temperature over-night. The solution was purified by 
dialysis versus Milli-Q water for 36 hours. The resulting functionalized 
 
186 
 
E
X
P 
nanoparticles were characterized by DLS and photophysical 
measurements. 
Peptide quantification: The number of peptides per nanoparticle was 
quantified adapting the well reported fluorescamine assay (4-
phenylspiro-(furan-2(3H),1’-phtalan)-3,3’-dione). In order to avoid the 
hydrolysis of fluorescamine by water, the standard solutions for the 
calibration curve were prepared in dimethyl sulfoxide (Table E1, line 
equation and extrapolation pg 129).  
Table E1 Solutions used to make calibration line 
 
 
 
 
 
 
For the quantification of the number of the peptide around the NPs, 96 
µL of a 15 µM aqueous solution of unfunctionalized Rhodamine-doped 
nanoparticles was diluted in 400 µL of DMSO and 40 µL of 10 mM solution 
in dimethyl sulfoxide of fluorescamine was added. After the addition of 
2 mM solution of butylamine (used as standard) in the final range of 
concentration 11-137 µM, the reaction was left under stirring for 150 
minutes at room temperature. The final mixtures were diluted in 3 mL of 
borate buffer (pH = 9), conditions that cause the hydrolysis of the 
unreacted fluorescamine. Fluorescence spectra were recorded in the 
400-750 nm range (λexc = 380 nm) and the emission intensities were 
plotted versus butilamine concentration, in order to obtain a calibration 
curve. Following the same procedure, the NPs-peptide sample was 
analysed. The fluorimetric titration gave an average of 6 peptide 
sequences per nanoparticles. 
Degradation of the mat: 2g of electrospun mat was dissolved in 50mL of 
PBS buffer 0.1M at 37°C. The PBS is removed entirely constantly, and the 
mat dried by the vacuum pump. At this point the weight of the mat is 
Conc. 
Butylamine 
(μM) 
NPs (μL) DMSO (μL) 
Fluorescamine 
(μL) 
0 96 400 40 
2 96 400 40 
5 96 400 40 
10 96 400 40 
25 96 400 40 
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registered and SEM picture was performed. It is put again in 50 mL of 
fresh PBS. This action has been repeated for 50 days.  
Nanoparticles quantification in the electrospun PLGA mat: A 20 µM 
(corresponding to 160 µg/mL) aqueous solution the Rhodamine-doped 
nanoparticles (used as standard) was diluted in DMF in the range 28-96 
µg/mL concentration. Fluorescence measurements were carried out in 
the range 550-750 nm (λexc=535 nm) and a calibration curve was 
obtained. A small piece of electrospun PLGA was dissolved in DMF and 
fluorescence measurements were carried out as reported above. The 
fluorimetric titration gave an average loading of 0.64% w/w of the 
peptide nanoparticles and 1.3% of unfunctionalized nanoparticles. 
 
Cap 6 
Gold NPs 
Modified Ulman synthesis: 200 mg of HAuCL4 3H2O was dissolved in a vial 
with 5 mL of distilled THF resulting in a pale yellow color. 125 uL of 1-
dodecanethiol was added under nitrogen atmosphere and left 
overnight in the dark. The reduction was then initiated with a one-shot 
addition of 500uL of LiAlH4 in THF in three repetitions, every 30 minutes 
until gas evolution ceased. The solution was again stirred overnight in the 
dark. The nanoparticles were cleaned by three cycles of precipitation 
by using EtOH followed by centrifugation at 2000 rpm for 5 minutes and 
re-dispersion in THF.  
AuNPs via Brust and Schiffrin method. A water solution of of HAuCl4۰3H2O 
(30 mM) were stirred in a round flask with toluene solution of TOAB (50 
mM). After the complete transfer of the [AuCl4] anion to the organic 
phase, confirmed by the colour change from yellow to colourless and 
from colourless to deep red, 1-dodecanethiol (170 mg) was added to 
the organic phase. The separation of the two phases, followed by the 
addition of NaBH4 water solution (0.35 M) to the organic one, lead to a 
quick colour change to deep purple due to gold reduction and 
formation of metal nanoparticles. The mixture was stirred for 1 hour at 
room temperature before particle purification by centrifugation 2500 
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rpm for 5 minutes. EtOH was added in different amount dependently on 
the desired excess of TOAB.  
 
1 G. A. Crosby, J. N. Demas, J. Phys. Chem. 1971, 75, 991. 
2 J. M. Mayrhofer, F. Haiss, D. Haenni, S. Weber, M. Zuend, M. J. P. Barrett, 
K. D. Ferrari, P. Maechler, V. Revol, C.-D. Schuh, C. Urban, A. Hall, M. E. 
Larkum, E. Rutz-Innerhofer, H. U. Zeilhofer, U. Ziegler, B. Weber, Biomed. 
Opt. Express 2015, 6, 4228. 
3 T. Nguyen, M. B. Francis Org. Lett. 2003, 5, 18, 3245 
4 J. C De Mello Adv. Mater. 1997, 9, No. 3 
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Appendix  
 
A.1 Principles of photophysics 
Electromagnetic radiation and matter can interact in different ways. 
Photochemistry is interested in the conversion of the energy (h) of a 
photon absorbed by a chemical species in electronic energy, causing 
the transfer of an electron toward an orbital possessing higher energy. 
The species turns from its electronic ground state A to an electronic 
excited state A*, which possesses a different electronic configuration:  
A + hν →A* 
This different electronic distribution causes the excited states of a 
chemical species to have physicochemical properties so different from 
those of the ground state that they can be considered different 
chemical species. For this reason, it is possible to define photochemistry 
as the chemistry of excited states. A photon can be absorbed and 
provoke the formation of an electronic excited state only if its energy h 
exactly corresponds to the energy difference between the excited and 
the ground state. Absorption electronic transitions occur in a time scale 
of the order of femtoseconds (10-15 s), creating excited states which are 
transient and can deactivare in different ways, shown in the Jablonski 
diagram (Figure A.1). In this diagram electronic states (the singlets S0, S1 
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and the triplets T1 and T2) are represented by thicker lines. The distinction 
between states with different spin multiplicity is due to the fact that 
transitions between these states are partially not allowed. Thinner lines 
represent the vibrational levels of the electronic states. After the energy 
absorption and reaching an excited vibrational level of an S2 electronic 
excited state, the molecule goes rapidly (< 10-12 s) to the ground 
vibrational level of that excited state (vibrational relaxation); then 
internal conversion occurs, passing from the ground vibrational level of 
S2 to the isoenergetic vibrational level of S1, the electronic state at lower 
energy (< 10-12 s). Another vibrational relaxation is then observed toward 
the ground vibrational state of S1, and at this stage the excited molecule 
can deactivate in two ways:  
1- Non-radiative deactivation: the energy is released as 
vibrational energy generating heat. If this process occurs 
between two states with the same spin multiplicity we speak 
about internal conversion (10-12 -10-6 s), while if the states have 
different spin multiplicity, we have intersystem crossing (10-11 -
10-6 s). The successive vibrational relaxation leads in the first 
case to the ground vibrational level of S0, in the second case 
to that of T1;  
2-  Radiative deactivation: it is a process that generates 
luminescence and it is defined fluorescence if it occurs 
between states with the same spin multiplicity, 
phosphorescence if it occurs between states with different 
spin multiplicity. Similarly, to S1, T1 can deactivate to S0 by 
radiative deactivation (phosphorescence, 10-4 -102 s) or by 
nonradiative deactivation (intersystem crossing, 10-3 -10 6s, 
and successive vibrational relaxation to S0). Long-lived states 
such as T1 can undergo photochemical reactions, for 
example with oxygen, producing other chemical species. 
Generally speaking, since the time scale to decay to S1 and 
T1 are shorter than that necessary to pass from S1 and T1 to 
S0, only lowest energetic states of each spin multiplicity (that 
is S1 and T1) live enough to undergo luminescence (Kasha’s 
rule) or photochemical reactions. 
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A.2 Electronic Excitation Energy Transfer 
With the term electronic excitation energy transfer we indicate the 
process in which an excited molecule of a donor D* decays to its ground 
state D with the simultaneous transfer of its excitation energy to a 
molecule of acceptor A, which is thus led to an excited state A*: 
D* + A → D + A* 
it is possible to observe this phenomenon exciting D in a spectral region 
in which it absorbs but A does not: if energy transfer occurs, D* emission 
is quenched and at the same time the appearance of the emission of 
A* is observed, which is called sensitized emission. In the case in which D 
and A are different molecules of the same chemical species we speak 
about homo energy transfer. It is possible to observe also intramolecular 
energy transfer in the case of a (super)molecule containing a donor and 
an acceptor, separated by a spacer B: 
D*-B-A → D-B-A* 
Two possible mechanisms of energy transfer exist, radiative one and non-
radiative one. The radiative mechanism (also called trivial energy 
transfer) does not require the diect interaction of D and A, but it occurs 
via the electromagnetic field produced form the photons emitted by D, 
which can be absorbed by A, provided that an overlap between the 
Figure A1 Jablonski diagram for a generic molecule 
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emission spectrum of D and the absorption one of A exists. This 
mechanism consist of two different steps: 
D*→D + hν’ (emission of the donor) 
A+ hν’→A* (absorption of acceptor) 
It is possible to correlate the probability of absorption of A of a photon 
emitted by D*, that is the probability of energy transfer (aD*→A), with the 
overlap between the emission spectrum of D and the absorption one of 
A. In particular a relation stands between aD*→A and the overlap 
integral J, defined as  
J = ∫ 𝐹𝐷(𝜆
∞
0
)εA(𝜆)𝜆4d 𝜆 
where is the normalized emission spectrum of D (the area under the 
spectrum is equal to 1) and is the absorption spectrum of A in dm3 ·mol-
1 ·cm-1 . So as J increases, the probability of radiative energy transfer 
linearly increases. This probability is also directly proportional to the 
concentration of A, to the optical path length and inversely proportional 
to the luminescence quantum yield of D. The radiative energy transfer 
can occur over extremely long distances: solar irradiation on Earth is a 
striking example. It is necessary that the transition of absorption in the 
acceptor is spin-allowed so that the radiative energy transfer can occur: 
thus singlet(D*)-singlet(A*) and triplet(D*)-singlet(A*) transfers are 
allowed, while singlet(D*)-tripletto(A*) and tripletto(D*)-tripletto(A*) 
transfers are not allowed The non-radiative mechanism, on the other 
hand, requires an intermolecular interaction between D and A 
mediated by the electromagnetic field. The energy transfer between 
the partners occurs in resonance conditions, involving isoenergetic non-
radiative transitions between D* and A. Also, in this case the probability 
of energy transfer is directly proportional to J. The theoretical description 
of the process leads to obtain that the interaction between D* and A 
consists of a Coulombic term (Förster mechanism) and of an exchange 
term (Dexter mechanism) (Figure A.2) 
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Figure A2 Energy transfer via coulombic mechanism (Foster)  and with exchange 
mechanism (Dexter) 
The Coulombic mechanism arises from the coupling of the electronic 
transition moments of electric dipole of the transitions and . This 
interaction is governed by Förster’s equation, which correlates the 
energy transfer kinetic constant with the distance RDA: 
𝑘𝐸𝑇 =
1
𝜏𝑑
(
𝑅0
𝑅𝐷𝐴
)6 
Where τD is the lifetime of the donor in the absence of the acceptor and 
is the Förster distance, that is the distance between D and A at which 
the energy transfer rate (kET) is equal to the decay rate of the donor in 
the absence of the acceptor (𝑘𝐸𝑇 =
1
𝜏𝑑
). At this distance half of the 
molecules of D decay via energy transfer. Förster distance is correlated 
to the overlap between the emission spectrum of D and the absorption 
spectrum of A by means of the following relation: 
𝑅0
6 = 2.303
9000∙𝜒2∙ϕ𝐷
𝑛4∙𝑁𝐴∙128𝜋
5 ∫ 𝐹𝐷 (𝜆)εA(𝜆)𝜆
4d 𝜆 
where is the orientational factor which describes the relative orientation 
of the electric dipole moment of D and A (it is assumed to be equal to 
2/3 in the case of freely rotating D and A), is the fluorescence quantum 
yield of D in the absence of A, is the refractive index of the solvent, is the 
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Avogadro’s constant, is the luminescence spectrum of D normalized to 
1, is that absorption spectrum of A expressed in dm3 ·mol-1 ·cm-1 . The 
higher the overlap between the emission spectrum of A and the 
absorption spectrum of A, the higher the value of R0. Typical values are 
about 20-100 Å. 
It is possible to define an efficiency of energy transfer 
𝜂 =
𝑘𝐸𝑇
𝑘𝐸𝑇+𝑘𝐷
  
which is linked to RDA by means of the following relation 
 𝜂 =
𝑅0
6
𝑅0
6+𝑅𝐷𝐴
6  
which highlights that the efficiency of the energy transfer process is 
equal to 0.5 when RDA=R0. It is possible to experimentally obtain η from 
the fluorescence quantum yield of D in the presence of A (ϕDA ) and in 
its absence (ϕDA), or from lifetimes in the two conditions (τDA, τD): 
 𝜂 = 1 −
𝜙𝐷𝐴
𝜙𝐷
  
𝜂 = 1 −
𝜏𝐷𝐴
𝜏𝐷
  
The processes of Förster type energy transfer are generally allowed if the 
transition in D and in A does not involve spin changes of the single 
species. On the contrary Dexter type energy transfer dominates. The 
exchange interaction requires a simultaneous double electronic 
exchange involving the LUMO of D and the HOMO of A (Fig. A2) and it 
is a short-range interaction, becoming important when RDA is ≤ 5 Å. 
According to Dexter model, the kinetic constant for the exchange 
mechanism decays exponentially with RDA: 
𝑘𝐸𝑇
𝑒𝑥 =
2𝜋
ћ
𝐾𝐽𝑒𝑥 ∙ 𝑒−
2𝑅𝐷𝐴
𝐿   
where K is a factor related to the specific orbitalic interaction, Jex is the 
normalized overlap and L is an average Van der Waals radius which 
simulates molecular dimensions. 
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τ Lifetime 
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λ Wavelength 
Φ Quantum yield 
A Absorbance 
2PA Two photon absorption 
2PLSM  
AFM Atomic force microscopy  
AIP Aggregation induced phosphorescence 
APTES (3-Aminopropyl)triethoxysilane 
CDMT 6-Chloro-2,4-dimethoxy-s-triazine 
CmC Critical micellar concentration 
DCHQ diaza-18-crown-6 8-hydroxyquinoline 
DCM Dichloromethane 
DDS Drug Delivery System 
DMF Dimethyl formamide 
DMSO Dimethyl sulfoxide 
EPR Enhanced permeability and retention 
FDA Food and drug administration 
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MRI magnetic resonance imaging 
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NP Nanoparticle  
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PBS Phosphate buffer 
PDT Photo dynamic therapy 
PEG polyethylene glycol 
PET Positron emission tomography 
PET Photo electron transfer 
PF127 Pluronic F127 
PLGA Poly lactic co glycolic acid 
PluSNPs Pluronic Silica Nanoparticle 
PPT photoinduced proton transfer 
PS Photosensitizer 
PVP Polyvinylpyrrolidone 
ROS Reactive oxygen species 
SEC Size exclusion chromatography 
TEOS Tetraethyl orthosilicate 
TGA thermogravimetry 
THF Tetrahydrofuran 
TMSCl Trimethylsilyl chloride 
TOAB Tetraoctylammonium bromide 
TPM 3-(Trimethoxysilyl) PropylMethacrylate 
UF ultrafiltration 
UV Ultraviolet 
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